data_1azj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1azj _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -79.24 145.06 33.79 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.953 1.301 . . . . 0.0 112.37 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.3 m -80.29 158.17 26.21 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.734 1.214 . . . . 0.0 113.82 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -38.59 132.55 1.14 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.875 1.67 . . . . 0.0 112.573 167.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 70.05 -23.12 0.16 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.69 137.72 45.46 Favored Glycine 0 CA--C 1.55 2.261 0 O-C-N 120.233 -1.542 . . . . 0.0 113.561 168.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -71.87 133.89 45.73 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 120.694 -1.474 . . . . 0.0 112.183 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.5 t -106.07 -33.34 7.91 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.73 2.012 . . . . 0.0 113.847 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.16 -166.45 23.07 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 120.664 -1.273 . . . . 0.0 115.769 -169.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.05 -98.2 0.97 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.147 1.832 . . . . 0.0 113.349 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.77 71.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 126.053 1.741 . . . . 0.0 114.604 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.19 41.68 2.18 Favored Glycine 0 CA--C 1.544 1.889 0 C-N-CA 125.611 1.576 . . . . 0.0 113.878 -173.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -80.94 132.27 35.4 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -150.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.2 p -96.1 -164.0 1.11 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.228 1.811 . . . . 0.0 113.389 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.06 -151.99 41.37 Favored Glycine 0 CA--C 1.551 2.329 0 O-C-N 119.67 -1.894 . . . . 0.0 115.863 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -71.64 62.02 2.93 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 123.993 3.128 . . . . 0.0 114.97 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.1 p -71.76 32.04 0.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -170.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -145.74 97.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 120.006 -1.684 . . . . 0.0 112.121 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.8 m -59.99 155.85 15.9 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.39 152.69 45.24 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.857 1.263 . . . . 0.0 112.622 162.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 t -62.3 171.37 1.89 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.21 -57.6 1.11 Allowed Glycine 0 CA--C 1.543 1.792 0 C-N-CA 124.172 0.891 . . . . 0.0 112.951 -164.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.7 p -76.52 145.95 38.76 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.1 m -99.09 142.28 30.79 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.806 2.043 . . . . 0.0 113.871 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.6 t -70.84 86.28 0.69 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.846 1.259 . . . . 0.0 110.82 163.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -64.08 177.39 0.81 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 117.875 2.546 . . . . 0.0 117.875 -165.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 p -140.37 50.75 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 122.515 1.15 . . . . 0.0 113.544 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -56.65 -44.6 81.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.328 1.851 . . . . 0.0 113.362 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -147.38 164.51 22.59 Favored Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 126.072 1.749 . . . . 0.0 110.02 162.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -43.37 -39.49 9.13 Favored 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 123.97 3.113 . . . . 0.0 116.969 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.17 -33.05 44.37 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -95.5 83.55 3.82 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.638 1.975 . . . . 0.0 113.523 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 t -105.16 104.93 14.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.643 0.777 . . . . 0.0 111.776 156.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -115.91 157.59 24.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.638 2.375 . . . . 0.0 112.16 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.9 m -71.26 79.83 0.72 Allowed 'General case' 0 CA--C 1.554 1.111 0 O-C-N 121.472 -0.767 . . . . 0.0 112.806 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.432 1.893 . . . . 0.0 112.162 168.291 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -67.8 128.33 36.09 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.737 1.615 . . . . 0.0 111.572 174.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.3 m -72.12 161.96 30.14 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.953 1.301 . . . . 0.0 113.599 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -43.18 135.9 3.12 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.252 1.021 . . . . 0.0 113.115 172.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 69.83 -12.06 0.49 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.05 140.83 46.96 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.033 -1.667 . . . . 0.0 113.305 170.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.18 151.66 36.85 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.681 1.741 . . . . 0.0 112.875 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.7 t -127.62 -48.33 1.4 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.565 1.546 . . . . 0.0 113.062 -168.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.97 17.97 2.55 Favored Glycine 0 CA--C 1.548 2.106 0 N-CA-C 120.288 2.875 . . . . 0.0 120.288 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.11 68.69 2.82 Favored Glycine 0 CA--C 1.545 1.924 0 CA-C-N 120.756 2.278 . . . . 0.0 113.463 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.6 mt -46.3 128.66 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.664 1.185 . . . . 0.0 113.347 -173.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.13 -56.42 0.6 Allowed Glycine 0 N--CA 1.474 1.195 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -145.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.7 157.0 15.57 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.994 0.902 . . . . 0.0 112.586 150.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 p -140.8 137.48 33.36 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.694 1.598 . . . . 0.0 110.631 158.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.72 -173.04 46.0 Favored Glycine 0 CA--C 1.544 1.845 0 O-C-N 120.949 -1.095 . . . . 0.0 114.221 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -65.38 88.89 0.21 Allowed 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 123.414 2.743 . . . . 0.0 113.781 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 p -72.9 31.88 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -170.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.5 t -141.82 98.49 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 119.613 -1.93 . . . . 0.0 114.145 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m -65.85 157.26 30.97 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 96.47 0.47 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.178 1.391 . . . . 0.0 111.864 169.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 t -37.09 -13.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 119.913 3.301 . . . . 0.0 119.913 -166.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.07 -35.9 60.25 Favored Glycine 0 CA--C 1.547 2.032 0 CA-C-N 119.571 1.078 . . . . 0.0 113.685 160.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 p -111.12 173.43 6.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.846 2.058 . . . . 0.0 111.614 169.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 t -125.78 172.54 9.75 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.9 t -77.5 70.28 3.87 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.436 1.494 . . . . 0.0 110.973 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -57.64 167.61 1.04 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -169.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.83 117.06 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.035 1.334 . . . . 0.0 113.233 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -105.71 -53.32 2.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.562 1.545 . . . . 0.0 110.153 162.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.71 149.76 6.21 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.956 2.502 . . . . 0.0 110.426 176.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.82 17.76 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.587 0 C-N-CA 124.941 3.761 . . . . 0.0 118.458 -160.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.59 -27.94 12.8 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 126.087 1.755 . . . . 0.0 113.104 160.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -80.49 166.31 21.32 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.629 1.571 . . . . 0.0 112.467 161.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 t 153.63 81.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.032 2.533 . . . . 0.0 112.051 168.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -120.02 150.05 41.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.346 1.858 . . . . 0.0 112.585 -165.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.3 m -62.92 79.27 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.676 1.19 . . . . 0.0 113.309 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.258 1.538 0 C-N-CA 129.222 3.009 . . . . 0.0 112.267 178.233 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.26 136.12 39.65 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.755 1.222 . . . . 0.0 111.173 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -69.69 150.67 46.73 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.785 1.234 . . . . 0.0 113.929 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -42.88 133.93 3.48 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.939 1.695 . . . . 0.0 112.389 169.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 67.19 -13.73 0.2 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -171.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.02 126.69 33.88 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 120.202 -1.561 . . . . 0.0 113.628 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -75.76 132.18 40.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.039 0.936 . . . . 0.0 110.813 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.39 4.08 1.56 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -160.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.39 59.66 0.12 Allowed Glycine 0 CA--C 1.543 1.791 0 CA-C-N 118.771 0.714 . . . . 0.0 114.867 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.23 86.26 0.45 Allowed Glycine 0 N--CA 1.474 1.217 0 O-C-N 121.322 -1.105 . . . . 0.0 110.546 163.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.9 mt -54.19 109.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 118.81 1.305 . . . . 0.0 112.483 -162.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.87 -45.51 1.0 Allowed Glycine 0 CA--C 1.546 1.987 0 C-N-CA 125.364 1.459 . . . . 0.0 111.318 -151.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -177.43 0.49 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.305 1.442 . . . . 0.0 113.238 159.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.9 p -156.78 141.14 16.62 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.249 -0.907 . . . . 0.0 112.453 158.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.03 172.71 27.61 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 115.763 1.065 . . . . 0.0 115.763 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -45.88 117.83 2.02 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 125.065 3.843 . . . . 0.0 115.55 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.2 p -89.13 3.19 52.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.457 2.303 . . . . 0.0 115.782 -172.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 t -119.08 106.16 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.078 1.351 . . . . 0.0 112.697 -172.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.71 171.2 11.99 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 130.55 45.09 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.352 1.461 . . . . 0.0 113.634 167.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.3 t -55.06 117.47 3.49 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.138 -0.976 . . . . 0.0 112.025 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.15 -40.68 1.83 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.919 1.247 . . . . 0.0 113.008 -164.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.5 p -107.33 -178.87 3.76 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.875 1.27 . . . . 0.0 113.558 171.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -151.9 143.35 23.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.403 2.281 . . . . 0.0 111.673 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -67.3 82.33 0.14 Allowed 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.081 -1.637 . . . . 0.0 113.068 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -54.23 173.59 0.07 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.97 111.21 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.5 mt -98.81 -47.74 5.19 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.261 1.425 . . . . 0.0 112.32 166.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.21 161.84 29.6 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 126.785 2.034 . . . . 0.0 110.013 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.26 -9.31 6.33 Favored 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.118 1.879 . . . . 0.0 115.669 175.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.0 -18.93 23.8 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -120.66 107.58 12.97 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.841 1.656 . . . . 0.0 111.584 173.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.7 t -135.06 120.59 19.28 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.292 1.037 . . . . 0.0 112.333 156.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -136.7 145.15 44.39 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.149 2.179 . . . . 0.0 112.585 -164.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.3 m -64.67 84.13 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 120.64 -1.288 . . . . 0.0 114.123 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 C--O 1.252 1.19 0 C-N-CA 128.872 2.869 . . . . 0.0 113.167 173.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -102.36 138.62 39.05 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.426 1.49 . . . . 0.0 111.946 168.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 m -68.98 162.78 26.05 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.48 1.912 . . . . 0.0 114.958 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -47.63 137.66 8.97 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.598 1.159 . . . . 0.0 112.48 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 67.53 -15.49 0.18 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.957 2.103 . . . . 0.0 115.694 -168.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -50.27 132.07 29.57 Favored Glycine 0 CA--C 1.545 1.959 0 O-C-N 120.589 -1.319 . . . . 0.0 114.033 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.02 126.2 35.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.648 1.179 . . . . 0.0 112.196 -174.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.98 8.53 3.5 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -159.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.25 34.65 0.09 OUTLIER Glycine 0 CA--C 1.547 2.034 0 N-CA-C 117.642 1.817 . . . . 0.0 117.642 167.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.58 85.66 1.55 Allowed Glycine 0 CA--C 1.541 1.664 0 CA-C-N 119.028 1.414 . . . . 0.0 112.217 170.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.5 mt -53.9 118.2 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.988 1.315 . . . . 0.0 113.245 -164.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.18 -44.2 1.23 Allowed Glycine 0 CA--C 1.541 1.695 0 C-N-CA 125.238 1.399 . . . . 0.0 110.597 -153.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.42 173.71 3.86 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 160.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.1 p -157.98 85.07 0.88 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.969 -1.082 . . . . 0.0 112.429 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.4 167.83 33.04 Favored Glycine 0 CA--C 1.549 2.192 0 N-CA-C 116.426 1.331 . . . . 0.0 116.426 -169.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -63.61 113.42 2.12 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.977 3.785 . . . . 0.0 113.325 -170.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.5 p -72.26 -0.89 13.35 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -165.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 t -115.3 107.54 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 120.393 -1.442 . . . . 0.0 113.244 -167.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.7 m -66.24 168.36 8.79 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.07 151.37 47.01 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.964 1.305 . . . . 0.0 112.402 162.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -67.04 162.95 21.02 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.11 -56.88 4.8 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.811 1.196 . . . . 0.0 112.243 -168.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.405 ' HG1' ' C ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -86.59 162.9 17.75 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 127.672 2.389 . . . . 0.0 113.472 166.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 t -142.66 172.93 12.03 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.355 -1.466 . . . . 0.0 114.257 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 t -73.66 73.67 1.5 Allowed 'General case' 0 CA--C 1.555 1.166 0 O-C-N 120.58 -1.325 . . . . 0.0 113.269 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -66.4 93.3 0.22 Allowed 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.547 -1.346 . . . . 0.0 113.803 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.59 68.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 127.94 2.496 . . . . 0.0 115.408 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -62.46 -49.94 73.45 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 120.14 -1.6 . . . . 0.0 113.236 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -160.71 174.41 3.91 Favored Pre-proline 0 CA--C 1.569 1.675 0 O-C-N 120.641 -1.287 . . . . 0.0 114.448 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.41 -22.16 15.53 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.869 3.713 . . . . 0.0 118.189 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.1 -23.97 15.98 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.096 1.358 . . . . 0.0 113.508 170.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -120.72 93.63 4.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.992 1.717 . . . . 0.0 112.079 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 t -123.57 115.84 22.16 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.488 1.115 . . . . 0.0 109.747 150.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -148.04 147.13 29.25 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -158.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.5 m -67.55 78.79 0.18 Allowed 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.405 ' C ' ' HG1' ' A' ' 23' ' ' THR . 3.5 mm? . . . . . 0 C--O 1.259 1.6 0 C-N-CA 125.397 1.479 . . . . 0.0 112.815 167.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -85.13 145.69 27.5 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.256 1.822 . . . . 0.0 111.916 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.2 p -80.42 159.83 25.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.955 1.702 . . . . 0.0 114.929 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -40.9 135.19 1.76 Allowed 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 126.09 1.756 . . . . 0.0 112.803 168.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 65.37 -21.25 0.09 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -171.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -45.31 121.78 4.93 Favored Glycine 0 CA--C 1.546 2.021 0 O-C-N 120.097 -1.627 . . . . 0.0 112.544 163.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.54 100.85 5.43 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.905 -1.35 . . . . 0.0 112.715 -173.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -65.61 -36.66 84.37 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 125.384 1.473 . . . . 0.0 114.503 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.04 -142.35 6.42 Favored Glycine 0 CA--C 1.548 2.152 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.45 50.43 37.95 Favored Glycine 0 CA--C 1.543 1.833 0 O-C-N 120.633 -1.51 . . . . 0.0 112.776 -159.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -51.33 118.4 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 125.685 1.594 . . . . 0.0 112.774 -169.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.53 -53.26 0.81 Allowed Glycine 0 CA--C 1.537 1.443 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -145.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -52.22 152.56 3.25 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 122.133 -0.628 . . . . 0.0 111.603 137.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.6 p -150.93 134.59 16.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.752 1.621 . . . . 0.0 110.728 166.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.26 -168.41 41.41 Favored Glycine 0 CA--C 1.549 2.167 0 O-C-N 121.173 -0.954 . . . . 0.0 114.872 -173.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.82 75.1 0.07 OUTLIER 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 125.153 3.902 . . . . 0.0 115.961 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.0 p -60.71 32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 128.954 2.902 . . . . 0.0 118.291 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 t -141.45 97.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 O-C-N 119.504 -1.997 . . . . 0.0 112.702 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.43 169.43 7.47 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.41 106.82 14.59 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.878 2.071 . . . . 0.0 113.971 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -35.17 114.29 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.288 1.435 . . . . 0.0 113.996 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.55 -45.34 1.16 Allowed Glycine 0 CA--C 1.543 1.832 0 C-N-CA 124.368 0.985 . . . . 0.0 112.314 -151.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.97 153.65 47.35 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.403 2.281 . . . . 0.0 112.107 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.7 m -111.04 156.86 20.66 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.054 2.542 . . . . 0.0 113.29 -174.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.6 t -63.23 77.19 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 O-C-N 120.128 -1.608 . . . . 0.0 110.72 165.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -77.88 92.28 4.24 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.242 1.017 . . . . 0.0 111.9 -158.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -63.98 59.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 128.035 2.534 . . . . 0.0 115.497 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -58.77 -46.45 87.46 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.659 -1.901 . . . . 0.0 111.703 170.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -145.29 153.31 52.18 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.786 1.634 . . . . 0.0 112.09 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.24 -36.03 96.02 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.133 2.555 . . . . 0.0 113.254 169.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.79 -6.59 2.78 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 166.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -130.11 -158.02 0.86 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 129.303 3.041 . . . . 0.0 109.288 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t 136.53 76.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 130.059 3.344 . . . . 0.0 108.285 159.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -97.26 155.29 16.93 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.032 1.333 . . . . 0.0 112.789 -164.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.4 m -70.4 78.73 0.55 Allowed 'General case' 0 CA--C 1.549 0.916 0 O-C-N 120.892 -1.13 . . . . 0.0 112.962 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.0 mt . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 116.711 -1.614 . . . . 0.0 114.592 162.921 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -89.01 133.07 34.46 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.769 2.028 . . . . 0.0 110.463 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 m -70.14 160.55 31.86 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.863 1.265 . . . . 0.0 114.345 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -49.77 134.34 20.65 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.254 1.022 . . . . 0.0 111.648 170.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 65.87 -8.0 0.34 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.0 125.09 38.77 Favored Glycine 0 CA--C 1.541 1.678 0 O-C-N 120.093 -1.629 . . . . 0.0 112.678 170.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.76 107.39 0.69 Allowed 'General case' 0 CA--C 1.554 1.106 0 O-C-N 120.954 -1.321 . . . . 0.0 110.836 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.0 t -88.51 1.1 55.51 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.291 1.836 . . . . 0.0 113.589 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.5 121.84 0.67 Allowed Glycine 0 CA--C 1.539 1.584 0 O-C-N 120.846 -1.158 . . . . 0.0 114.442 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.81 69.27 0.28 Allowed Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 162.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.5 mm -41.67 116.72 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -159.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.01 -55.22 0.74 Allowed Glycine 0 CA--C 1.539 1.533 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -147.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -52.93 153.36 3.41 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.539 0.736 . . . . 0.0 112.713 144.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.3 p -151.58 150.92 30.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.755 2.022 . . . . 0.0 111.401 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.92 -167.81 32.25 Favored Glycine 0 CA--C 1.542 1.756 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.61 84.28 0.09 OUTLIER 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.255 3.303 . . . . 0.0 113.765 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -68.51 42.5 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 127.08 2.152 . . . . 0.0 115.945 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -146.16 102.61 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 119.959 -1.713 . . . . 0.0 113.175 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.4 m -60.58 158.05 13.16 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.76 151.69 33.35 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.986 1.314 . . . . 0.0 112.487 161.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.2 t -59.58 166.92 2.21 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.31 -59.49 0.26 Allowed Glycine 0 CA--C 1.546 2.011 0 C-N-CA 124.271 0.938 . . . . 0.0 113.469 -161.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.5 p -72.1 150.8 43.56 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.747 1.219 . . . . 0.0 114.189 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.2 p -125.45 143.95 50.76 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.839 -1.163 . . . . 0.0 113.371 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.8 t -67.6 74.12 0.16 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.435 1.494 . . . . 0.0 110.407 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -22.59 6.37 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 119.375 3.102 . . . . 0.0 119.375 -151.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.297 6.8 p 41.76 47.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.94 -45.33 90.69 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.687 1.595 . . . . 0.0 112.459 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -154.07 163.67 23.26 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 125.295 1.438 . . . . 0.0 110.9 168.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.35 -19.35 21.76 Favored 'Trans proline' 0 CA--C 1.556 1.594 0 C-N-CA 122.256 1.971 . . . . 0.0 116.831 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.47 -14.9 26.14 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 170.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -135.19 105.45 6.31 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.509 1.524 . . . . 0.0 113.299 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -121.15 96.65 5.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.03 2.532 . . . . 0.0 110.201 153.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -96.0 142.76 27.84 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.861 1.264 . . . . 0.0 111.772 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.3 m -68.66 87.88 0.34 Allowed 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.604 -1.31 . . . . 0.0 112.322 170.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.077 -1.439 . . . . 0.0 111.949 171.197 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -90.52 138.46 31.54 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.867 1.667 . . . . 0.0 112.069 171.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -66.87 173.9 3.3 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.781 1.633 . . . . 0.0 114.257 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.26 140.65 26.06 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.919 1.288 . . . . 0.0 112.475 167.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 63.78 42.57 6.07 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.86 130.74 9.23 Favored Glycine 0 CA--C 1.544 1.902 0 C-N-CA 126.001 1.763 . . . . 0.0 112.627 167.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -74.78 66.08 1.45 Allowed 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 119.639 1.72 . . . . 0.0 114.681 -172.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.8 t -31.09 -39.16 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 129.682 3.193 . . . . 0.0 117.613 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.38 83.6 0.12 Allowed Glycine 0 CA--C 1.537 1.41 0 O-C-N 121.233 -0.917 . . . . 0.0 115.339 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.91 63.98 0.27 Allowed Glycine 0 CA--C 1.543 1.784 0 C-N-CA 124.582 1.087 . . . . 0.0 112.525 167.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.3 7.6 tt -74.01 27.3 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 119.405 3.113 . . . . 0.0 119.405 -128.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.82 -38.63 76.2 Favored Glycine 0 CA--C 1.544 1.876 0 O-C-N 120.408 -1.433 . . . . 0.0 111.945 138.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -50.1 150.01 2.56 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.103 1.361 . . . . 0.0 113.279 159.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.1 p -142.13 154.69 45.07 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.322 1.449 . . . . 0.0 111.856 166.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.46 -167.8 34.63 Favored Glycine 0 CA--C 1.542 1.747 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -65.54 69.64 0.34 Allowed 'Trans proline' 0 CA--C 1.554 1.505 0 C-N-CA 124.824 3.683 . . . . 0.0 114.36 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 p -60.95 32.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -173.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.0 t -132.95 96.83 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 O-C-N 119.622 -1.924 . . . . 0.0 112.677 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.04 170.04 2.37 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 127.651 2.381 . . . . 0.0 117.163 -175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.7 120.0 29.7 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.953 1.701 . . . . 0.0 113.526 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 t -34.04 103.04 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.683 1.993 . . . . 0.0 115.43 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.23 -53.8 0.79 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.761 1.648 . . . . 0.0 110.715 -165.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.7 p -86.8 157.82 19.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.319 1.848 . . . . 0.0 112.955 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -142.85 165.2 28.03 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -73.15 74.48 1.26 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 128.245 2.618 . . . . 0.0 110.922 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -8.59 2.65 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 -154.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 14.9 p 30.49 63.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.0 mt -60.68 -34.76 74.82 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 120.474 -1.391 . . . . 0.0 113.06 167.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.21 159.16 5.19 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 127.802 2.441 . . . . 0.0 111.119 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -46.77 -34.02 14.98 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 124.061 3.174 . . . . 0.0 115.774 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.15 -27.39 66.39 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 172.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -144.07 104.91 4.19 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.583 1.553 . . . . 0.0 113.489 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 t -116.15 138.48 51.22 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.662 1.585 . . . . 0.0 111.837 146.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -138.44 148.81 44.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.562 1.945 . . . . 0.0 112.03 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.4 m -67.51 102.07 1.09 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.918 0.887 . . . . 0.0 111.783 168.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.894 2.078 . . . . 0.0 112.085 174.166 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -99.22 129.29 45.45 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.63 1.572 . . . . 0.0 112.365 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -53.69 154.82 3.5 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.966 1.706 . . . . 0.0 115.163 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -49.35 133.07 20.17 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.803 0.841 . . . . 0.0 111.337 164.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 73.08 -23.55 0.21 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.438 2.295 . . . . 0.0 115.73 -167.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.4 112.0 2.11 Favored Glycine 0 CA--C 1.545 1.958 0 O-C-N 120.505 -1.372 . . . . 0.0 113.823 171.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -76.86 123.95 27.0 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -166.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 71.8 m -62.9 -44.77 95.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.803 1.241 . . . . 0.0 114.015 173.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.89 -129.28 4.26 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.562 2.029 . . . . 0.0 112.683 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.47 54.5 19.36 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 121.686 -0.891 . . . . 0.0 110.874 -151.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -49.08 121.14 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.152 0.981 . . . . 0.0 113.021 -171.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.18 -50.39 0.89 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -142.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.94 163.05 0.54 Allowed 'General case' 0 CA--C 1.563 1.452 0 O-C-N 121.774 -0.839 . . . . 0.0 112.315 141.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.1 p -151.6 4.82 0.44 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.18 -134.07 8.22 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 116.794 1.477 . . . . 0.0 116.794 -171.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.91 138.42 16.6 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.624 2.883 . . . . 0.0 113.997 -167.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.4 p -105.68 -19.37 13.78 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.549 1.94 . . . . 0.0 115.217 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.36 96.65 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 O-C-N 120.174 -1.579 . . . . 0.0 114.03 -162.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.0 m -56.49 159.88 3.48 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.37 146.68 42.81 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.349 1.86 . . . . 0.0 113.777 167.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.0 t -59.79 111.74 1.57 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.765 1.226 . . . . 0.0 113.413 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.01 -55.18 0.52 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.1 1.809 . . . . 0.0 111.409 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 t -87.52 -176.58 5.64 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.673 1.589 . . . . 0.0 112.315 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -153.64 143.45 21.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.426 2.29 . . . . 0.0 110.672 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 t -58.08 81.17 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 127.582 2.353 . . . . 0.0 114.196 -171.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -74.48 83.99 1.99 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.505 1.922 . . . . 0.0 114.652 -164.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.91 76.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 C-N-CA 128.395 2.678 . . . . 0.0 115.608 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.7 -41.09 24.23 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.689 -1.257 . . . . 0.0 113.168 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -138.69 155.44 73.41 Favored Pre-proline 0 CA--C 1.553 1.093 0 O-C-N 120.756 -1.215 . . . . 0.0 112.765 173.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -38.58 -46.34 2.49 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.639 2.893 . . . . 0.0 115.027 165.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.91 -57.24 5.28 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -83.97 122.33 28.61 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.5 t -137.64 135.94 37.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.031 0.933 . . . . 0.0 111.43 149.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -129.4 147.5 51.23 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.253 1.421 . . . . 0.0 113.383 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.54 67.14 2.01 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 120.463 -1.398 . . . . 0.0 110.952 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 C--O 1.251 1.183 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.087 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -76.13 163.22 27.31 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 118.634 0.652 . . . . 0.0 110.855 153.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -87.1 -169.57 2.68 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -65.44 150.34 48.51 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.066 1.347 . . . . 0.0 111.184 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 61.1 16.07 6.81 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.37 126.07 7.95 Favored Glycine 0 CA--C 1.544 1.862 0 O-C-N 119.928 -1.732 . . . . 0.0 113.353 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -71.7 92.17 1.17 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.774 1.229 . . . . 0.0 111.616 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 p -103.78 12.62 34.37 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.682 2.393 . . . . 0.0 114.196 -169.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.04 68.83 0.07 OUTLIER Glycine 0 CA--C 1.544 1.894 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.82 88.08 0.47 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 162.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.1 mt -53.23 108.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 118.459 1.129 . . . . 0.0 112.838 -161.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.81 -42.28 1.27 Allowed Glycine 0 CA--C 1.544 1.885 0 C-N-CA 125.302 1.43 . . . . 0.0 111.228 -153.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -179.84 0.24 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.038 0.935 . . . . 0.0 112.905 155.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.2 p -151.24 139.37 20.16 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.045 -1.034 . . . . 0.0 111.894 157.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.78 173.85 24.08 Favored Glycine 0 CA--C 1.544 1.896 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.2 113.28 1.13 Allowed 'Trans proline' 0 CA--C 1.546 1.115 1 C-N-CA 125.329 4.019 . . . . 0.0 117.332 -168.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.4 p -82.74 20.73 1.1 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 128.706 2.802 . . . . 0.0 116.137 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.23 114.35 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 120.043 -1.661 . . . . 0.0 113.059 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.2 m -83.19 174.75 10.5 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 127.64 2.376 . . . . 0.0 116.643 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 117.86 9.81 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.645 1.578 . . . . 0.0 112.812 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -39.3 113.01 0.29 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.187 1.395 . . . . 0.0 114.283 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.8 -25.76 7.46 Favored Glycine 0 CA--C 1.545 1.955 0 C-N-CA 124.762 1.173 . . . . 0.0 114.319 -162.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.3 p -124.94 149.92 47.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.182 1.793 . . . . 0.0 114.398 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.1 m -115.74 137.39 52.13 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.795 2.838 . . . . 0.0 112.544 -173.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.84 84.03 0.31 Allowed 'General case' 0 CA--C 1.559 1.316 0 O-C-N 120.266 -1.521 . . . . 0.0 112.435 172.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -55.63 171.23 0.22 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 118.673 2.842 . . . . 0.0 118.673 -161.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.48 49.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.598 -1.314 . . . . 0.0 113.872 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.17 -50.62 67.42 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.711 1.604 . . . . 0.0 112.96 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -162.51 161.7 19.79 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 126.646 1.978 . . . . 0.0 110.118 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -56.81 -13.13 10.53 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.051 2.501 . . . . 0.0 117.323 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.53 -23.14 17.81 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 125.664 1.585 . . . . 0.0 114.831 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -115.0 97.4 6.2 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.64 1.576 . . . . 0.0 112.036 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.6 t -113.91 120.01 39.22 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.966 0.906 . . . . 0.0 110.774 148.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -130.26 146.3 51.85 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.909 1.684 . . . . 0.0 111.843 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.1 m -63.9 85.8 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.5 mt . . . . . 0 C--O 1.25 1.088 0 C-N-CA 127.931 2.492 . . . . 0.0 112.81 177.264 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 44.5 p . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 118.852 -0.594 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -63.01 168.6 3.91 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 119.749 1.159 . . . . 0.0 112.051 147.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -117.97 -173.98 2.55 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.413 1.485 . . . . 0.0 110.915 163.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -47.89 135.24 12.54 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.123 0.969 . . . . 0.0 112.653 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 75.45 1.58 3.67 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.642 2.377 . . . . 0.0 114.838 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.06 114.52 4.79 Favored Glycine 0 CA--C 1.541 1.703 0 O-C-N 118.094 -2.879 . . . . 0.0 116.326 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -53.94 139.75 33.02 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 118.473 1.137 . . . . 0.0 112.924 160.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 p -154.8 -13.89 0.12 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -163.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.46 72.67 0.11 Allowed Glycine 0 CA--C 1.542 1.774 0 N-CA-C 117.358 1.703 . . . . 0.0 117.358 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.27 114.64 0.62 Allowed Glycine 0 CA--C 1.543 1.789 0 C-N-CA 125.918 1.723 . . . . 0.0 111.571 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 mm -54.38 115.96 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 118.875 1.337 . . . . 0.0 112.987 -170.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.63 -48.49 0.94 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 125.592 1.568 . . . . 0.0 110.255 -154.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.16 168.48 6.71 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 121.786 -0.832 . . . . 0.0 112.16 158.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.5 p -153.35 148.76 27.12 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.123 -0.986 . . . . 0.0 111.926 152.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.87 -165.97 24.1 Favored Glycine 0 CA--C 1.544 1.897 0 C-N-CA 124.268 0.937 . . . . 0.0 115.246 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.43 156.37 21.97 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 124.153 3.235 . . . . 0.0 114.057 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 p -129.28 54.74 1.79 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.305 1.042 . . . . 0.0 113.383 -169.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.5 t -152.14 122.43 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 121.089 -1.007 . . . . 0.0 113.017 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.2 m -82.18 172.12 13.53 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.62 2.082 . . . . 0.0 116.62 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.81 117.05 23.03 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.709 1.604 . . . . 0.0 112.763 168.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 t -47.38 136.27 9.77 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.93 -65.18 0.25 Allowed Glycine 0 CA--C 1.541 1.675 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -151.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.8 p -88.64 161.0 17.12 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.539 1.135 . . . . 0.0 113.516 171.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 t -149.48 166.54 28.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.454 -1.404 . . . . 0.0 113.67 170.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 t -82.1 85.81 6.71 Favored 'General case' 0 CA--C 1.552 1.058 0 O-C-N 120.244 -1.535 . . . . 0.0 113.771 -166.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -88.38 90.73 8.52 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 122.353 1.073 . . . . 0.0 113.678 -163.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -70.9 81.46 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -176.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.44 -47.31 82.15 Favored 'General case' 0 CA--C 1.555 1.141 0 O-C-N 120.324 -1.485 . . . . 0.0 114.929 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.82 144.79 1.57 Allowed Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 125.503 1.521 . . . . 0.0 111.259 -169.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . 0.278 8.2 Cg_endo -48.92 -37.91 37.58 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 124.246 3.298 . . . . 0.0 119.176 -153.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.87 -40.14 95.84 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 120.323 1.42 . . . . 0.0 113.652 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -91.06 154.76 19.17 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.469 1.908 . . . . 0.0 113.36 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.4 t 158.79 112.94 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 128.687 2.795 . . . . 0.0 111.158 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -151.95 148.28 27.56 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -153.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 m -79.08 92.31 5.0 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.166 1.787 . . . . 0.0 112.004 168.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.271 -1.824 . . . . 0.0 111.767 165.845 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -79.02 142.54 36.49 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.271 1.828 . . . . 0.0 111.916 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -73.16 159.01 34.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.668 1.587 . . . . 0.0 115.193 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -40.03 136.86 1.07 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 126.069 1.747 . . . . 0.0 113.107 166.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 66.89 -11.11 0.27 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -174.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.12 152.17 20.0 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-N 120.433 1.47 . . . . 0.0 114.133 168.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -89.04 114.01 25.17 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 117.679 0.739 . . . . 0.0 112.031 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.4 t -92.59 -44.39 8.63 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 126.755 2.022 . . . . 0.0 115.57 -171.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.08 35.38 0.45 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 119.423 2.529 . . . . 0.0 119.423 -168.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.62 66.08 2.75 Favored Glycine 0 CA--C 1.545 1.948 0 CA-C-N 119.301 1.55 . . . . 0.0 113.447 175.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.4 mt -41.35 115.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.568 1.547 . . . . 0.0 113.825 -167.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.69 -54.27 0.79 Allowed Glycine 0 N--CA 1.476 1.324 0 N-CA-C 108.291 -1.923 . . . . 0.0 108.291 -151.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -55.91 156.69 4.97 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 121.498 0.666 . . . . 0.0 112.311 140.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.7 p -143.94 138.54 28.56 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.004 1.722 . . . . 0.0 111.115 162.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.26 -174.64 44.93 Favored Glycine 0 CA--C 1.55 2.223 0 N-CA-C 116.584 1.394 . . . . 0.0 116.584 -174.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -65.98 80.46 0.28 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 125.043 3.829 . . . . 0.0 114.202 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.3 p -63.79 33.15 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -167.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.0 t -139.02 93.79 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 O-C-N 119.566 -1.958 . . . . 0.0 114.182 -171.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.8 m -58.79 159.21 7.06 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.046 2.138 . . . . 0.0 115.991 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.33 158.56 11.53 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.116 1.366 . . . . 0.0 113.065 164.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.7 t -69.96 176.34 3.8 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.17 -58.25 2.33 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 121.023 -1.048 . . . . 0.0 112.828 -166.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.4 169.55 17.07 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 126.228 1.811 . . . . 0.0 113.201 168.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.1 t -134.95 170.1 16.39 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.847 2.459 . . . . 0.0 114.832 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.5 t -86.12 69.19 10.47 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 127.889 2.476 . . . . 0.0 112.194 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -54.26 160.75 1.53 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 118.974 2.953 . . . . 0.0 118.974 -161.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.11 59.4 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 127.41 2.284 . . . . 0.0 112.857 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.42 -55.03 6.91 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.304 -1.497 . . . . 0.0 112.695 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -157.32 152.67 21.93 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 126.719 2.007 . . . . 0.0 109.975 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -51.13 -28.81 26.47 Favored 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 122.886 2.391 . . . . 0.0 117.536 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.43 -18.14 63.01 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 120.585 1.539 . . . . 0.0 114.904 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -124.89 135.37 52.81 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.531 2.332 . . . . 0.0 112.997 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 t -158.59 108.25 2.01 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.041 -1.037 . . . . 0.0 109.778 165.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -119.52 149.49 41.82 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.043 1.737 . . . . 0.0 111.596 -166.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -66.46 84.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.224 0.609 . . . . 0.0 112.0 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 C--O 1.252 1.21 0 C-N-CA 127.118 2.167 . . . . 0.0 112.563 -177.834 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -95.81 132.78 40.7 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.03 1.732 . . . . 0.0 111.813 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 m -65.29 170.33 4.83 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -50.97 132.95 27.5 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.86 1.264 . . . . 0.0 111.918 167.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 67.55 53.09 0.74 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.643 1.977 . . . . 0.0 115.324 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.33 126.07 5.82 Favored Glycine 0 CA--C 1.543 1.819 0 C-N-CA 126.384 1.945 . . . . 0.0 111.945 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -74.1 60.77 0.8 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 119.517 1.658 . . . . 0.0 114.086 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.8 t -16.07 -59.62 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.928 3.291 . . . . 0.0 117.495 172.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.05 79.85 0.21 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.402 1.001 . . . . 0.0 112.992 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.5 60.58 0.47 Allowed Glycine 0 CA--C 1.543 1.8 0 C-N-CA 124.99 1.281 . . . . 0.0 111.421 163.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.6 mt -49.39 112.46 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 125.163 1.385 . . . . 0.0 113.804 -156.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.99 -53.19 0.79 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -150.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -50.54 154.07 1.43 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 121.634 0.73 . . . . 0.0 112.165 137.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 p -149.27 151.06 33.56 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.81 1.644 . . . . 0.0 111.141 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.76 -168.04 31.08 Favored Glycine 0 CA--C 1.549 2.159 0 C-N-CA 124.718 1.151 . . . . 0.0 113.572 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.16 113.78 1.74 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.228 3.285 . . . . 0.0 113.82 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -99.38 16.26 23.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -124.7 96.95 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.688 -1.258 . . . . 0.0 112.847 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.1 m -60.47 160.03 9.46 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.296 1.838 . . . . 0.0 115.683 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.6 165.21 5.16 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.112 1.365 . . . . 0.0 113.411 164.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.9 t -75.68 173.67 10.77 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 169.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.35 -63.06 0.16 Allowed Glycine 0 CA--C 1.539 1.581 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -159.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.9 p -62.95 168.92 3.61 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.577 1.551 . . . . 0.0 114.53 167.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -153.38 158.29 41.27 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.906 1.282 . . . . 0.0 112.525 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.8 t -63.46 75.81 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.757 1.223 . . . . 0.0 111.069 170.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.22 89.53 0.87 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.703 1.201 . . . . 0.0 111.892 -165.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.18 94.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 C-N-CA 126.215 1.806 . . . . 0.0 113.485 170.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -96.41 -44.03 7.38 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.416 1.486 . . . . 0.0 111.012 168.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -147.2 156.55 46.55 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 126.852 2.061 . . . . 0.0 112.347 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -40.52 -45.16 4.51 Favored 'Trans proline' 0 CA--C 1.554 1.514 0 C-N-CA 123.887 3.058 . . . . 0.0 115.748 159.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.01 -16.02 61.07 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 171.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -140.51 90.64 2.37 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.316 1.846 . . . . 0.0 112.675 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.4 t -109.31 124.59 51.18 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.237 -0.915 . . . . 0.0 111.063 148.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -138.27 141.58 39.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.728 1.211 . . . . 0.0 113.696 -168.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.3 79.67 0.06 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.678 1.591 . . . . 0.0 112.712 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.072 0.949 . . . . 0.0 112.408 165.219 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -80.37 144.27 32.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.048 1.339 . . . . 0.0 111.588 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -88.3 172.28 9.54 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -41.39 132.54 2.67 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 127.579 2.352 . . . . 0.0 113.191 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 67.1 -13.16 0.21 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.68 141.42 44.64 Favored Glycine 0 CA--C 1.55 2.234 0 O-C-N 120.063 -1.648 . . . . 0.0 112.911 167.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -75.48 108.37 8.24 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.999 -1.295 . . . . 0.0 113.318 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.6 t -74.6 -37.88 62.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.444 1.898 . . . . 0.0 112.94 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.23 158.84 28.44 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-O 123.07 1.372 . . . . 0.0 114.923 -173.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.67 46.71 0.02 OUTLIER Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.521 2.01 . . . . 0.0 110.342 -169.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.7 mt -50.8 117.89 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.836 1.254 . . . . 0.0 112.268 -158.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.54 -59.52 0.69 Allowed Glycine 0 CA--C 1.536 1.399 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -148.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.21 156.27 5.86 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-O 121.737 0.779 . . . . 0.0 112.264 145.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.6 p -138.68 147.98 43.43 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.251 1.82 . . . . 0.0 110.343 160.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.31 -161.85 32.0 Favored Glycine 0 CA--C 1.543 1.804 0 O-C-N 120.65 -1.281 . . . . 0.0 115.615 -175.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -71.16 79.09 1.42 Allowed 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.631 2.887 . . . . 0.0 113.605 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.2 p -71.18 25.82 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 -167.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 t -140.61 100.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 119.742 -1.849 . . . . 0.0 113.659 -173.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m -63.64 163.58 11.12 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.7 122.48 28.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.72 1.608 . . . . 0.0 113.093 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.9 t -44.34 135.21 4.69 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.9 1.28 . . . . 0.0 114.109 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.97 -40.97 2.28 Favored Glycine 0 CA--C 1.545 1.943 0 C-N-CA 124.209 0.909 . . . . 0.0 112.58 -154.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p -118.06 151.32 37.76 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.851 1.66 . . . . 0.0 114.264 175.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.8 m -109.58 142.95 39.96 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.02 2.528 . . . . 0.0 113.668 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.9 t -73.28 84.2 1.4 Allowed 'General case' 0 CA--C 1.552 1.021 0 O-C-N 121.101 -0.999 . . . . 0.0 111.099 167.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -57.79 178.28 0.09 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.59 49.95 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.479 1.133 . . . . 0.0 112.678 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.72 -44.49 96.09 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.563 1.545 . . . . 0.0 111.931 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -142.65 160.33 54.08 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.724 1.61 . . . . 0.0 110.065 159.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -45.05 -39.52 14.83 Favored 'Trans proline' 0 CA--C 1.555 1.53 0 C-N-CA 122.051 1.834 . . . . 0.0 113.203 161.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.91 -25.95 63.0 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -122.18 90.63 3.34 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.836 1.655 . . . . 0.0 111.948 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.0 t -116.23 107.28 14.66 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.973 0.892 . . . . 0.0 111.838 158.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -113.32 152.89 29.34 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.352 1.861 . . . . 0.0 111.552 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.27 84.97 0.15 Allowed 'General case' 0 CA--C 1.55 0.953 0 O-C-N 121.374 -0.829 . . . . 0.0 112.673 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 C--O 1.25 1.129 0 C-N-CA 128.81 2.844 . . . . 0.0 111.835 179.584 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -71.97 141.47 49.4 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.619 0.767 . . . . 0.0 111.987 166.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -91.55 155.69 18.2 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -38.16 132.03 1.07 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 127.181 2.192 . . . . 0.0 113.528 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 67.65 -27.52 0.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -170.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -42.58 119.91 2.26 Favored Glycine 0 CA--C 1.545 1.934 0 O-C-N 120.674 -1.267 . . . . 0.0 113.879 171.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -75.47 136.65 40.65 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.688 1.195 . . . . 0.0 111.959 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.0 p -144.67 28.36 1.3 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.369 1.067 . . . . 0.0 113.737 -166.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.05 69.97 0.03 OUTLIER Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.686 1.612 . . . . 0.0 114.981 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.25 86.17 0.4 Allowed Glycine 0 N--CA 1.471 0.996 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 152.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.6 mt -53.92 110.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 118.901 1.351 . . . . 0.0 111.987 -164.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.15 -48.59 0.86 Allowed Glycine 0 CA--C 1.544 1.89 0 C-N-CA 125.032 1.301 . . . . 0.0 110.401 -149.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.68 170.81 1.32 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.498 1.119 . . . . 0.0 112.718 153.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.2 p -152.27 147.61 26.57 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.425 -0.797 . . . . 0.0 111.957 158.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.55 175.89 25.39 Favored Glycine 0 CA--C 1.54 1.602 0 N-CA-C 115.319 0.888 . . . . 0.0 115.319 175.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.6 122.39 3.95 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.826 3.684 . . . . 0.0 114.595 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.3 p -83.32 -55.38 4.36 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.4 1.88 . . . . 0.0 113.117 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.2 t -66.0 111.36 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 C-N-CA 125.46 1.504 . . . . 0.0 114.102 -170.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.4 m -73.25 172.68 10.71 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.48 130.03 38.86 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 126.47 1.908 . . . . 0.0 114.087 172.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -52.14 113.78 1.13 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.244 1.018 . . . . 0.0 112.982 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.44 -45.23 1.03 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.034 1.302 . . . . 0.0 111.915 -163.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.4 p -127.41 -176.35 3.72 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 127.348 2.259 . . . . 0.0 111.827 170.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -148.06 155.44 41.49 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 119.358 -2.089 . . . . 0.0 112.344 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.7 t -69.46 77.32 0.4 Allowed 'General case' 0 CA--C 1.557 1.245 0 O-C-N 120.421 -1.424 . . . . 0.0 111.032 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 87.27 0.68 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.428 1.491 . . . . 0.0 113.624 -167.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.9 93.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.269 1.027 . . . . 0.0 113.757 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -93.5 -39.83 10.66 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.356 1.462 . . . . 0.0 111.408 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -150.39 163.67 23.38 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.934 1.694 . . . . 0.0 113.308 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.31 -14.66 35.66 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 123.357 2.705 . . . . 0.0 114.938 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.9 -11.91 27.82 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 125.974 1.71 . . . . 0.0 115.026 165.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -140.88 97.3 3.16 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.163 1.785 . . . . 0.0 112.767 -175.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -119.96 136.25 54.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.273 1.029 . . . . 0.0 110.702 145.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -146.44 146.14 30.47 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.216 1.406 . . . . 0.0 112.578 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.9 m -70.52 81.44 0.58 Allowed 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 176.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.8 mt . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.219 1.808 . . . . 0.0 115.359 177.681 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -72.21 141.73 49.01 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.879 0.872 . . . . 0.0 111.763 167.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.5 m -65.54 148.88 51.0 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -47.2 133.71 11.72 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.237 0.615 . . . . 0.0 111.545 157.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 63.06 53.57 2.3 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.759 1.224 . . . . 0.0 113.883 -169.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.08 117.76 2.67 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 124.923 1.249 . . . . 0.0 114.036 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -67.73 63.93 0.08 Allowed 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 125.538 1.535 . . . . 0.0 114.552 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.2 p -66.24 43.73 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 128.146 2.578 . . . . 0.0 115.689 174.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.68 78.93 0.03 OUTLIER Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.666 -1.271 . . . . 0.0 113.591 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.33 88.52 0.39 Allowed Glycine 0 CA--C 1.534 1.236 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 148.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.2 mt -50.63 108.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 119.746 1.773 . . . . 0.0 113.089 -163.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.28 -48.51 0.86 Allowed Glycine 0 CA--C 1.544 1.886 0 C-N-CA 125.612 1.577 . . . . 0.0 110.081 -152.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.57 166.07 0.14 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.156 0.982 . . . . 0.0 112.624 145.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.6 p -152.32 157.99 42.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.29 1.036 . . . . 0.0 111.468 156.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.39 -175.11 20.64 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -46.23 115.36 1.11 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 125.063 3.842 . . . . 0.0 115.024 -173.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.7 p -72.35 -65.94 0.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.008 1.723 . . . . 0.0 112.414 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -50.22 107.29 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 126.799 2.04 . . . . 0.0 114.31 -169.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.0 m -66.0 179.22 0.94 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 128.196 2.598 . . . . 0.0 117.119 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 129.28 37.52 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.685 1.594 . . . . 0.0 111.36 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -45.13 112.86 0.49 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.47 -44.78 1.37 Allowed Glycine 0 CA--C 1.549 2.162 0 C-N-CA 125.444 1.497 . . . . 0.0 113.68 -167.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 p -89.87 148.02 23.41 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 127.0 2.12 . . . . 0.0 113.198 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 m -124.56 142.26 51.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.324 1.85 . . . . 0.0 113.927 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -73.19 83.73 1.35 Allowed 'General case' 0 CA--C 1.554 1.109 0 O-C-N 120.357 -1.464 . . . . 0.0 111.257 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -12.81 8.59 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 -150.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.304 7.9 p 39.45 46.24 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 126.936 2.094 . . . . 0.0 115.5 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.07 -45.06 74.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.014 1.326 . . . . 0.0 111.801 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -136.61 157.11 75.76 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.111 1.364 . . . . 0.0 110.196 159.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.7 -16.94 16.34 Favored 'Trans proline' 0 CA--C 1.558 1.701 0 C-N-CA 122.318 2.012 . . . . 0.0 114.974 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.43 -18.23 25.77 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 127.165 2.186 . . . . 0.0 115.811 167.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -140.79 93.94 2.66 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.042 1.737 . . . . 0.0 112.606 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 t -122.35 91.64 3.55 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.052 1.741 . . . . 0.0 111.239 167.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.96 146.07 24.19 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.815 1.246 . . . . 0.0 113.735 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.9 m -66.07 95.13 0.26 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.328 -0.857 . . . . 0.0 111.929 156.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.9 mt . . . . . 0 C--O 1.257 1.462 0 CA-C-O 117.049 -1.453 . . . . 0.0 110.511 161.446 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.949 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -70.95 153.11 42.94 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 119.584 1.084 . . . . 0.0 112.156 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 m -74.58 161.36 29.8 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.59 1.556 . . . . 0.0 114.873 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -50.42 132.61 24.94 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.305 1.042 . . . . 0.0 110.696 159.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 63.39 65.57 0.75 Allowed 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -171.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.43 -89.54 0.03 OUTLIER Glycine 0 CA--C 1.555 2.557 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -84.84 170.96 12.63 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 129.607 3.163 . . . . 0.0 115.153 -6.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.97 11.44 13.41 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 128.053 2.541 . . . . 0.0 114.865 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.18 -164.29 10.78 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 126.487 1.994 . . . . 0.0 114.837 169.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.97 60.53 3.33 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.969 -0.724 . . . . 0.0 112.121 -164.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.3 mt -51.43 108.49 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 126.032 1.733 . . . . 0.0 111.745 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.38 -47.56 0.87 Allowed Glycine 0 CA--C 1.541 1.699 0 C-N-CA 124.705 1.145 . . . . 0.0 110.331 -147.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.33 164.42 0.96 Allowed 'General case' 0 CA--C 1.554 1.099 0 O-C-N 121.893 -0.769 . . . . 0.0 111.156 139.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.3 p -154.58 164.13 39.17 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.537 1.135 . . . . 0.0 111.972 164.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.19 179.22 19.01 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 116.052 1.181 . . . . 0.0 116.052 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -50.68 119.7 5.53 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 125.239 3.959 . . . . 0.0 116.648 -168.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.7 p -77.39 -39.53 46.91 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.626 1.57 . . . . 0.0 114.631 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.76 102.31 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 125.045 1.338 . . . . 0.0 114.393 -161.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -85.46 -177.92 6.57 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.18 146.2 55.27 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.73 1.612 . . . . 0.0 113.622 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.4 p -77.43 73.58 4.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.025 -1.047 . . . . 0.0 111.832 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.02 -50.71 0.04 OUTLIER Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.956 1.741 . . . . 0.0 110.764 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.2 p -74.08 177.44 5.71 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.564 1.146 . . . . 0.0 113.482 161.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.8 m -148.25 143.31 26.89 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.821 -1.174 . . . . 0.0 113.975 165.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.3 t -64.76 86.42 0.05 Allowed 'General case' 0 CA--C 1.558 1.278 0 O-C-N 120.414 -1.429 . . . . 0.0 111.954 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.12 161.15 11.45 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -160.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.09 134.54 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 O-C-N 120.629 -1.295 . . . . 0.0 111.253 164.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -152.68 -53.43 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.241 1.017 . . . . 0.0 111.866 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -158.04 164.09 22.46 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 124.772 1.229 . . . . 0.0 111.091 165.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -41.63 -42.3 5.99 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.808 3.006 . . . . 0.0 115.818 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.11 -4.67 18.21 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -143.65 118.1 9.7 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.751 1.621 . . . . 0.0 113.645 -170.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 t -135.48 95.59 3.29 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.38 -0.825 . . . . 0.0 110.996 153.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -109.8 150.12 28.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.893 1.277 . . . . 0.0 113.148 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.2 m -79.08 89.56 4.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.617 1.167 . . . . 0.0 113.064 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.258 1.513 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.98 163.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -69.57 136.25 51.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.938 1.695 . . . . 0.0 111.492 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -75.83 158.38 32.22 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -49.92 132.65 22.76 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.145 1.378 . . . . 0.0 111.619 167.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 64.5 42.44 5.01 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.03 129.15 6.43 Favored Glycine 0 CA--C 1.544 1.881 0 C-N-CA 125.844 1.688 . . . . 0.0 112.872 168.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -66.72 72.73 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.219 1.51 . . . . 0.0 114.589 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.7 t -31.31 -54.77 0.24 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 128.127 2.571 . . . . 0.0 116.012 171.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.74 45.69 0.5 Allowed Glycine 0 CA--C 1.539 1.566 0 N-CA-C 118.095 1.998 . . . . 0.0 118.095 -168.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.22 65.52 1.27 Allowed Glycine 0 CA--C 1.546 1.981 0 O-C-N 121.159 -1.2 . . . . 0.0 113.723 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.2 mt -44.1 114.27 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 118.984 1.392 . . . . 0.0 113.892 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.1 -54.62 0.78 Allowed Glycine 0 CA--C 1.537 1.425 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -154.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.82 160.72 4.34 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 122.071 0.939 . . . . 0.0 111.757 139.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.0 p -148.54 149.37 31.48 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.15 1.78 . . . . 0.0 111.138 163.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.07 -166.95 37.21 Favored Glycine 0 CA--C 1.546 2.007 0 O-C-N 120.96 -1.087 . . . . 0.0 114.949 -175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.73 80.97 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.894 3.062 . . . . 0.0 113.027 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.7 p -70.73 33.0 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 118.151 2.648 . . . . 0.0 118.151 -166.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 t -137.93 96.28 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 O-C-N 120.132 -1.605 . . . . 0.0 113.317 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.47 156.87 7.41 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.19 167.12 0.13 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.997 0.919 . . . . 0.0 112.71 153.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.8 t -82.75 -178.02 6.94 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.47 -66.07 1.02 Allowed Glycine 0 CA--C 1.539 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 111.898 -165.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.42 161.25 30.0 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.352 1.461 . . . . 0.0 114.069 170.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.7 p -128.94 151.12 50.02 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 130.936 3.694 . . . . 0.0 111.839 -168.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.6 t -74.42 74.94 1.91 Allowed 'General case' 0 CA--C 1.559 1.29 0 O-C-N 120.238 -1.538 . . . . 0.0 111.571 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -63.71 165.15 8.72 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -167.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 p -137.13 105.83 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 C-N-CA 125.534 1.533 . . . . 0.0 114.558 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.86 -50.33 6.1 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.451 1.5 . . . . 0.0 111.899 167.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.76 157.17 36.11 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 128.013 2.525 . . . . 0.0 108.85 171.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -50.07 -39.62 50.78 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 122.844 2.363 . . . . 0.0 115.107 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -50.96 -25.4 4.62 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -122.56 135.6 54.67 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.08 2.152 . . . . 0.0 113.342 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.74 111.18 1.15 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.229 -0.919 . . . . 0.0 113.427 165.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -122.71 151.75 41.25 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.47 1.908 . . . . 0.0 112.75 -169.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.5 m -61.79 88.88 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.9 0.48 . . . . 0.0 111.378 168.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.256 1.432 0 C-N-CA 128.456 2.702 . . . . 0.0 112.638 174.953 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -90.36 133.29 35.08 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 127.303 2.241 . . . . 0.0 111.276 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.1 p -75.81 166.67 23.18 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.938 1.695 . . . . 0.0 113.784 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -58.83 147.27 34.26 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 58.39 -11.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -161.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.06 122.67 24.32 Favored Glycine 0 CA--C 1.542 1.747 0 O-C-N 119.687 -1.883 . . . . 0.0 113.65 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -68.42 76.51 0.26 Allowed 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 118.946 1.373 . . . . 0.0 112.632 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.5 t -51.19 -31.2 19.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.037 1.735 . . . . 0.0 115.373 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.75 106.86 0.29 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 117.498 1.759 . . . . 0.0 117.498 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.45 85.43 0.34 Allowed Glycine 0 CA--C 1.534 1.237 0 O-C-N 120.895 -1.356 . . . . 0.0 109.961 154.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.3 mt -49.84 113.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 118.903 1.351 . . . . 0.0 113.052 -161.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.64 -45.94 1.1 Allowed Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.339 1.447 . . . . 0.0 110.6 -151.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.69 171.5 0.21 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 125.273 1.429 . . . . 0.0 112.714 153.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.8 p -153.63 174.47 14.44 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.693 1.197 . . . . 0.0 111.505 160.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 -175.29 19.55 Favored Glycine 0 CA--C 1.546 2.031 0 C-N-CA 124.233 0.92 . . . . 0.0 114.353 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.03 100.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 124.626 3.551 . . . . 0.0 116.804 -168.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -83.55 22.78 1.02 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.964 2.506 . . . . 0.0 114.2 -175.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -149.09 114.27 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 120.171 -1.581 . . . . 0.0 111.924 -173.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.0 m -70.14 167.13 18.45 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.93 140.29 38.09 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.662 1.585 . . . . 0.0 113.81 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 t -49.94 111.93 0.59 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.359 1.064 . . . . 0.0 113.55 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.94 -47.26 1.0 Allowed Glycine 0 CA--C 1.543 1.838 0 C-N-CA 125.34 1.448 . . . . 0.0 112.921 -164.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.63 149.61 40.41 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.294 2.237 . . . . 0.0 113.055 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.4 m -121.05 142.01 50.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.295 1.438 . . . . 0.0 112.749 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 t -57.52 88.85 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 126.31 1.844 . . . . 0.0 111.463 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -10.35 51.35 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -149.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.308 9.3 p 34.53 52.93 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 127.883 2.473 . . . . 0.0 116.663 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.0 -45.07 78.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.543 1.537 . . . . 0.0 112.413 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -152.28 169.77 9.03 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 125.49 1.516 . . . . 0.0 110.976 164.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -48.55 -33.11 22.77 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.257 2.638 . . . . 0.0 116.802 178.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.42 -10.76 48.13 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -137.68 101.5 4.49 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.456 1.502 . . . . 0.0 113.723 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 t -122.47 91.96 3.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.874 2.469 . . . . 0.0 110.505 158.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -92.65 152.4 19.57 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 120.503 -1.373 . . . . 0.0 112.588 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.1 m -78.21 78.13 4.69 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.697 -1.252 . . . . 0.0 110.989 162.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.188 -1.387 . . . . 0.0 112.485 161.671 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -79.24 145.06 33.79 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.953 1.301 . . . . 0.0 112.37 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.3 m -80.29 158.17 26.21 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.734 1.214 . . . . 0.0 113.82 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -38.59 132.55 1.14 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.875 1.67 . . . . 0.0 112.573 167.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 70.05 -23.12 0.16 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.69 137.72 45.46 Favored Glycine 0 CA--C 1.55 2.261 0 O-C-N 120.233 -1.542 . . . . 0.0 113.561 168.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -71.87 133.89 45.73 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 120.694 -1.474 . . . . 0.0 112.183 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.5 t -106.07 -33.34 7.91 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.73 2.012 . . . . 0.0 113.847 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.16 -166.45 23.07 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 120.664 -1.273 . . . . 0.0 115.769 -169.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.05 -98.2 0.97 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.147 1.832 . . . . 0.0 113.349 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.77 71.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 126.053 1.741 . . . . 0.0 114.604 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.19 41.68 2.18 Favored Glycine 0 CA--C 1.544 1.889 0 C-N-CA 125.611 1.576 . . . . 0.0 113.878 -173.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -80.94 132.27 35.4 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -150.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.2 p -96.1 -164.0 1.11 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.228 1.811 . . . . 0.0 113.389 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.06 -151.99 41.37 Favored Glycine 0 CA--C 1.551 2.329 0 O-C-N 119.67 -1.894 . . . . 0.0 115.863 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -71.64 62.02 2.93 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 123.993 3.128 . . . . 0.0 114.97 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.1 p -71.76 32.04 0.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -170.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -145.74 97.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 120.006 -1.684 . . . . 0.0 112.121 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.8 m -59.99 155.85 15.9 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.39 152.69 45.24 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.857 1.263 . . . . 0.0 112.622 162.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 t -62.3 171.37 1.89 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.21 -57.6 1.11 Allowed Glycine 0 CA--C 1.543 1.792 0 C-N-CA 124.172 0.891 . . . . 0.0 112.951 -164.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.7 p -76.52 145.95 38.76 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.1 m -99.09 142.28 30.79 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.806 2.043 . . . . 0.0 113.871 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.6 t -70.84 86.28 0.69 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.846 1.259 . . . . 0.0 110.82 163.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -64.08 177.39 0.81 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 117.875 2.546 . . . . 0.0 117.875 -165.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 p -140.37 50.75 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 122.515 1.15 . . . . 0.0 113.544 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -56.65 -44.6 81.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.328 1.851 . . . . 0.0 113.362 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -147.38 164.51 22.59 Favored Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 126.072 1.749 . . . . 0.0 110.02 162.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -43.37 -39.49 9.13 Favored 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 123.97 3.113 . . . . 0.0 116.969 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.17 -33.05 44.37 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -95.5 83.55 3.82 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.638 1.975 . . . . 0.0 113.523 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 t -105.16 104.93 14.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.643 0.777 . . . . 0.0 111.776 156.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -115.91 157.59 24.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.638 2.375 . . . . 0.0 112.16 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.9 m -71.26 79.83 0.72 Allowed 'General case' 0 CA--C 1.554 1.111 0 O-C-N 121.472 -0.767 . . . . 0.0 112.806 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.6 mt . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.432 1.893 . . . . 0.0 112.162 168.291 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -67.8 128.33 36.09 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.737 1.615 . . . . 0.0 111.572 174.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.3 m -72.12 161.96 30.14 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.953 1.301 . . . . 0.0 113.599 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -43.18 135.9 3.12 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.252 1.021 . . . . 0.0 113.115 172.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 69.83 -12.06 0.49 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.05 140.83 46.96 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.033 -1.667 . . . . 0.0 113.305 170.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.18 151.66 36.85 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.681 1.741 . . . . 0.0 112.875 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.7 t -127.62 -48.33 1.4 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.565 1.546 . . . . 0.0 113.062 -168.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.97 17.97 2.55 Favored Glycine 0 CA--C 1.548 2.106 0 N-CA-C 120.288 2.875 . . . . 0.0 120.288 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.11 68.69 2.82 Favored Glycine 0 CA--C 1.545 1.924 0 CA-C-N 120.756 2.278 . . . . 0.0 113.463 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.6 mt -46.3 128.66 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.664 1.185 . . . . 0.0 113.347 -173.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.13 -56.42 0.6 Allowed Glycine 0 N--CA 1.474 1.195 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -145.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.7 157.0 15.57 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.994 0.902 . . . . 0.0 112.586 150.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 p -140.8 137.48 33.36 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.694 1.598 . . . . 0.0 110.631 158.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.72 -173.04 46.0 Favored Glycine 0 CA--C 1.544 1.845 0 O-C-N 120.949 -1.095 . . . . 0.0 114.221 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -65.38 88.89 0.21 Allowed 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 123.414 2.743 . . . . 0.0 113.781 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 p -72.9 31.88 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -170.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.5 t -141.82 98.49 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 119.613 -1.93 . . . . 0.0 114.145 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m -65.85 157.26 30.97 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 96.47 0.47 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.178 1.391 . . . . 0.0 111.864 169.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 t -37.09 -13.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 119.913 3.301 . . . . 0.0 119.913 -166.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.07 -35.9 60.25 Favored Glycine 0 CA--C 1.547 2.032 0 CA-C-N 119.571 1.078 . . . . 0.0 113.685 160.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 p -111.12 173.43 6.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.846 2.058 . . . . 0.0 111.614 169.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 t -125.78 172.54 9.75 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.9 t -77.5 70.28 3.87 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.436 1.494 . . . . 0.0 110.973 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -57.64 167.61 1.04 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -169.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.83 117.06 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.035 1.334 . . . . 0.0 113.233 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -105.71 -53.32 2.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.562 1.545 . . . . 0.0 110.153 162.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.71 149.76 6.21 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.956 2.502 . . . . 0.0 110.426 176.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.82 17.76 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.587 0 C-N-CA 124.941 3.761 . . . . 0.0 118.458 -160.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.59 -27.94 12.8 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 126.087 1.755 . . . . 0.0 113.104 160.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -80.49 166.31 21.32 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.629 1.571 . . . . 0.0 112.467 161.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 t 153.63 81.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.032 2.533 . . . . 0.0 112.051 168.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -120.02 150.05 41.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.346 1.858 . . . . 0.0 112.585 -165.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.3 m -62.92 79.27 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.676 1.19 . . . . 0.0 113.309 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.258 1.538 0 C-N-CA 129.222 3.009 . . . . 0.0 112.267 178.233 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.26 136.12 39.65 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.755 1.222 . . . . 0.0 111.173 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -69.69 150.67 46.73 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.785 1.234 . . . . 0.0 113.929 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -42.88 133.93 3.48 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.939 1.695 . . . . 0.0 112.389 169.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 67.19 -13.73 0.2 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -171.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.02 126.69 33.88 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 120.202 -1.561 . . . . 0.0 113.628 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -75.76 132.18 40.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.039 0.936 . . . . 0.0 110.813 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.39 4.08 1.56 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -160.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.39 59.66 0.12 Allowed Glycine 0 CA--C 1.543 1.791 0 CA-C-N 118.771 0.714 . . . . 0.0 114.867 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.23 86.26 0.45 Allowed Glycine 0 N--CA 1.474 1.217 0 O-C-N 121.322 -1.105 . . . . 0.0 110.546 163.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.9 mt -54.19 109.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 118.81 1.305 . . . . 0.0 112.483 -162.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.87 -45.51 1.0 Allowed Glycine 0 CA--C 1.546 1.987 0 C-N-CA 125.364 1.459 . . . . 0.0 111.318 -151.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -177.43 0.49 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.305 1.442 . . . . 0.0 113.238 159.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.9 p -156.78 141.14 16.62 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.249 -0.907 . . . . 0.0 112.453 158.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.03 172.71 27.61 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 115.763 1.065 . . . . 0.0 115.763 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -45.88 117.83 2.02 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 125.065 3.843 . . . . 0.0 115.55 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.2 p -89.13 3.19 52.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.457 2.303 . . . . 0.0 115.782 -172.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 t -119.08 106.16 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.078 1.351 . . . . 0.0 112.697 -172.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.71 171.2 11.99 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 130.55 45.09 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.352 1.461 . . . . 0.0 113.634 167.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.3 t -55.06 117.47 3.49 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.138 -0.976 . . . . 0.0 112.025 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.15 -40.68 1.83 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.919 1.247 . . . . 0.0 113.008 -164.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.5 p -107.33 -178.87 3.76 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.875 1.27 . . . . 0.0 113.558 171.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -151.9 143.35 23.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.403 2.281 . . . . 0.0 111.673 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -67.3 82.33 0.14 Allowed 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.081 -1.637 . . . . 0.0 113.068 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -54.23 173.59 0.07 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.97 111.21 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.5 mt -98.81 -47.74 5.19 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.261 1.425 . . . . 0.0 112.32 166.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.21 161.84 29.6 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 126.785 2.034 . . . . 0.0 110.013 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.26 -9.31 6.33 Favored 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.118 1.879 . . . . 0.0 115.669 175.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.0 -18.93 23.8 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -120.66 107.58 12.97 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.841 1.656 . . . . 0.0 111.584 173.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.7 t -135.06 120.59 19.28 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.292 1.037 . . . . 0.0 112.333 156.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -136.7 145.15 44.39 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.149 2.179 . . . . 0.0 112.585 -164.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.3 m -64.67 84.13 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 120.64 -1.288 . . . . 0.0 114.123 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 C--O 1.252 1.19 0 C-N-CA 128.872 2.869 . . . . 0.0 113.167 173.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -102.36 138.62 39.05 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.426 1.49 . . . . 0.0 111.946 168.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 m -68.98 162.78 26.05 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.48 1.912 . . . . 0.0 114.958 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -47.63 137.66 8.97 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.598 1.159 . . . . 0.0 112.48 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 67.53 -15.49 0.18 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.957 2.103 . . . . 0.0 115.694 -168.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -50.27 132.07 29.57 Favored Glycine 0 CA--C 1.545 1.959 0 O-C-N 120.589 -1.319 . . . . 0.0 114.033 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.02 126.2 35.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.648 1.179 . . . . 0.0 112.196 -174.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.98 8.53 3.5 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -159.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.25 34.65 0.09 OUTLIER Glycine 0 CA--C 1.547 2.034 0 N-CA-C 117.642 1.817 . . . . 0.0 117.642 167.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.58 85.66 1.55 Allowed Glycine 0 CA--C 1.541 1.664 0 CA-C-N 119.028 1.414 . . . . 0.0 112.217 170.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.5 mt -53.9 118.2 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.988 1.315 . . . . 0.0 113.245 -164.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.18 -44.2 1.23 Allowed Glycine 0 CA--C 1.541 1.695 0 C-N-CA 125.238 1.399 . . . . 0.0 110.597 -153.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.42 173.71 3.86 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 160.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.1 p -157.98 85.07 0.88 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.969 -1.082 . . . . 0.0 112.429 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.4 167.83 33.04 Favored Glycine 0 CA--C 1.549 2.192 0 N-CA-C 116.426 1.331 . . . . 0.0 116.426 -169.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -63.61 113.42 2.12 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.977 3.785 . . . . 0.0 113.325 -170.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.5 p -72.26 -0.89 13.35 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -165.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 t -115.3 107.54 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 120.393 -1.442 . . . . 0.0 113.244 -167.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.7 m -66.24 168.36 8.79 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.07 151.37 47.01 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.964 1.305 . . . . 0.0 112.402 162.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -67.04 162.95 21.02 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.11 -56.88 4.8 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.811 1.196 . . . . 0.0 112.243 -168.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.405 ' HG1' ' C ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -86.59 162.9 17.75 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 127.672 2.389 . . . . 0.0 113.472 166.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 t -142.66 172.93 12.03 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.355 -1.466 . . . . 0.0 114.257 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 t -73.66 73.67 1.5 Allowed 'General case' 0 CA--C 1.555 1.166 0 O-C-N 120.58 -1.325 . . . . 0.0 113.269 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -66.4 93.3 0.22 Allowed 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.547 -1.346 . . . . 0.0 113.803 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.59 68.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 127.94 2.496 . . . . 0.0 115.408 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -62.46 -49.94 73.45 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 120.14 -1.6 . . . . 0.0 113.236 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -160.71 174.41 3.91 Favored Pre-proline 0 CA--C 1.569 1.675 0 O-C-N 120.641 -1.287 . . . . 0.0 114.448 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.41 -22.16 15.53 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.869 3.713 . . . . 0.0 118.189 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.1 -23.97 15.98 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.096 1.358 . . . . 0.0 113.508 170.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -120.72 93.63 4.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.992 1.717 . . . . 0.0 112.079 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 t -123.57 115.84 22.16 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.488 1.115 . . . . 0.0 109.747 150.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -148.04 147.13 29.25 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -158.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.5 m -67.55 78.79 0.18 Allowed 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.405 ' C ' ' HG1' ' A' ' 23' ' ' THR . 3.5 mm? . . . . . 0 C--O 1.259 1.6 0 C-N-CA 125.397 1.479 . . . . 0.0 112.815 167.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -85.13 145.69 27.5 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.256 1.822 . . . . 0.0 111.916 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.2 p -80.42 159.83 25.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.955 1.702 . . . . 0.0 114.929 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -40.9 135.19 1.76 Allowed 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 126.09 1.756 . . . . 0.0 112.803 168.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 65.37 -21.25 0.09 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -171.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -45.31 121.78 4.93 Favored Glycine 0 CA--C 1.546 2.021 0 O-C-N 120.097 -1.627 . . . . 0.0 112.544 163.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.54 100.85 5.43 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.905 -1.35 . . . . 0.0 112.715 -173.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -65.61 -36.66 84.37 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 125.384 1.473 . . . . 0.0 114.503 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.04 -142.35 6.42 Favored Glycine 0 CA--C 1.548 2.152 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.45 50.43 37.95 Favored Glycine 0 CA--C 1.543 1.833 0 O-C-N 120.633 -1.51 . . . . 0.0 112.776 -159.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -51.33 118.4 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 125.685 1.594 . . . . 0.0 112.774 -169.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.53 -53.26 0.81 Allowed Glycine 0 CA--C 1.537 1.443 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -145.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -52.22 152.56 3.25 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 122.133 -0.628 . . . . 0.0 111.603 137.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.6 p -150.93 134.59 16.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.752 1.621 . . . . 0.0 110.728 166.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.26 -168.41 41.41 Favored Glycine 0 CA--C 1.549 2.167 0 O-C-N 121.173 -0.954 . . . . 0.0 114.872 -173.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.82 75.1 0.07 OUTLIER 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 125.153 3.902 . . . . 0.0 115.961 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.0 p -60.71 32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 128.954 2.902 . . . . 0.0 118.291 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 t -141.45 97.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 O-C-N 119.504 -1.997 . . . . 0.0 112.702 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.43 169.43 7.47 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.41 106.82 14.59 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.878 2.071 . . . . 0.0 113.971 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -35.17 114.29 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.288 1.435 . . . . 0.0 113.996 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.55 -45.34 1.16 Allowed Glycine 0 CA--C 1.543 1.832 0 C-N-CA 124.368 0.985 . . . . 0.0 112.314 -151.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.97 153.65 47.35 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.403 2.281 . . . . 0.0 112.107 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.7 m -111.04 156.86 20.66 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.054 2.542 . . . . 0.0 113.29 -174.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.6 t -63.23 77.19 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 O-C-N 120.128 -1.608 . . . . 0.0 110.72 165.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -77.88 92.28 4.24 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.242 1.017 . . . . 0.0 111.9 -158.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -63.98 59.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 128.035 2.534 . . . . 0.0 115.497 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -58.77 -46.45 87.46 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.659 -1.901 . . . . 0.0 111.703 170.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -145.29 153.31 52.18 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.786 1.634 . . . . 0.0 112.09 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.24 -36.03 96.02 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.133 2.555 . . . . 0.0 113.254 169.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.79 -6.59 2.78 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 166.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -130.11 -158.02 0.86 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 129.303 3.041 . . . . 0.0 109.288 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t 136.53 76.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 130.059 3.344 . . . . 0.0 108.285 159.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -97.26 155.29 16.93 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.032 1.333 . . . . 0.0 112.789 -164.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.4 m -70.4 78.73 0.55 Allowed 'General case' 0 CA--C 1.549 0.916 0 O-C-N 120.892 -1.13 . . . . 0.0 112.962 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.0 mt . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 116.711 -1.614 . . . . 0.0 114.592 162.921 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -89.01 133.07 34.46 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.769 2.028 . . . . 0.0 110.463 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 m -70.14 160.55 31.86 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.863 1.265 . . . . 0.0 114.345 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -49.77 134.34 20.65 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.254 1.022 . . . . 0.0 111.648 170.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 65.87 -8.0 0.34 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.0 125.09 38.77 Favored Glycine 0 CA--C 1.541 1.678 0 O-C-N 120.093 -1.629 . . . . 0.0 112.678 170.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.76 107.39 0.69 Allowed 'General case' 0 CA--C 1.554 1.106 0 O-C-N 120.954 -1.321 . . . . 0.0 110.836 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.0 t -88.51 1.1 55.51 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.291 1.836 . . . . 0.0 113.589 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.5 121.84 0.67 Allowed Glycine 0 CA--C 1.539 1.584 0 O-C-N 120.846 -1.158 . . . . 0.0 114.442 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.81 69.27 0.28 Allowed Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 162.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.5 mm -41.67 116.72 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -159.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.01 -55.22 0.74 Allowed Glycine 0 CA--C 1.539 1.533 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -147.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -52.93 153.36 3.41 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.539 0.736 . . . . 0.0 112.713 144.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.3 p -151.58 150.92 30.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.755 2.022 . . . . 0.0 111.401 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.92 -167.81 32.25 Favored Glycine 0 CA--C 1.542 1.756 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.61 84.28 0.09 OUTLIER 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.255 3.303 . . . . 0.0 113.765 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -68.51 42.5 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 127.08 2.152 . . . . 0.0 115.945 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -146.16 102.61 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 119.959 -1.713 . . . . 0.0 113.175 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.4 m -60.58 158.05 13.16 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.76 151.69 33.35 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.986 1.314 . . . . 0.0 112.487 161.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.2 t -59.58 166.92 2.21 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.31 -59.49 0.26 Allowed Glycine 0 CA--C 1.546 2.011 0 C-N-CA 124.271 0.938 . . . . 0.0 113.469 -161.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.5 p -72.1 150.8 43.56 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.747 1.219 . . . . 0.0 114.189 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.2 p -125.45 143.95 50.76 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.839 -1.163 . . . . 0.0 113.371 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.8 t -67.6 74.12 0.16 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.435 1.494 . . . . 0.0 110.407 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -22.59 6.37 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 119.375 3.102 . . . . 0.0 119.375 -151.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.297 6.8 p 41.76 47.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.94 -45.33 90.69 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.687 1.595 . . . . 0.0 112.459 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -154.07 163.67 23.26 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 125.295 1.438 . . . . 0.0 110.9 168.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.35 -19.35 21.76 Favored 'Trans proline' 0 CA--C 1.556 1.594 0 C-N-CA 122.256 1.971 . . . . 0.0 116.831 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.47 -14.9 26.14 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 170.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -135.19 105.45 6.31 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.509 1.524 . . . . 0.0 113.299 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -121.15 96.65 5.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.03 2.532 . . . . 0.0 110.201 153.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -96.0 142.76 27.84 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.861 1.264 . . . . 0.0 111.772 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.3 m -68.66 87.88 0.34 Allowed 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.604 -1.31 . . . . 0.0 112.322 170.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.077 -1.439 . . . . 0.0 111.949 171.197 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -90.52 138.46 31.54 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.867 1.667 . . . . 0.0 112.069 171.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -66.87 173.9 3.3 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.781 1.633 . . . . 0.0 114.257 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.26 140.65 26.06 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.919 1.288 . . . . 0.0 112.475 167.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 63.78 42.57 6.07 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.86 130.74 9.23 Favored Glycine 0 CA--C 1.544 1.902 0 C-N-CA 126.001 1.763 . . . . 0.0 112.627 167.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -74.78 66.08 1.45 Allowed 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 119.639 1.72 . . . . 0.0 114.681 -172.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.8 t -31.09 -39.16 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 129.682 3.193 . . . . 0.0 117.613 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.38 83.6 0.12 Allowed Glycine 0 CA--C 1.537 1.41 0 O-C-N 121.233 -0.917 . . . . 0.0 115.339 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.91 63.98 0.27 Allowed Glycine 0 CA--C 1.543 1.784 0 C-N-CA 124.582 1.087 . . . . 0.0 112.525 167.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.3 7.6 tt -74.01 27.3 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 119.405 3.113 . . . . 0.0 119.405 -128.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.82 -38.63 76.2 Favored Glycine 0 CA--C 1.544 1.876 0 O-C-N 120.408 -1.433 . . . . 0.0 111.945 138.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -50.1 150.01 2.56 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.103 1.361 . . . . 0.0 113.279 159.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.1 p -142.13 154.69 45.07 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.322 1.449 . . . . 0.0 111.856 166.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 158.46 -167.8 34.63 Favored Glycine 0 CA--C 1.542 1.747 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -65.54 69.64 0.34 Allowed 'Trans proline' 0 CA--C 1.554 1.505 0 C-N-CA 124.824 3.683 . . . . 0.0 114.36 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.4 p -60.95 32.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -173.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.0 t -132.95 96.83 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 O-C-N 119.622 -1.924 . . . . 0.0 112.677 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.04 170.04 2.37 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 127.651 2.381 . . . . 0.0 117.163 -175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.7 120.0 29.7 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.953 1.701 . . . . 0.0 113.526 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 t -34.04 103.04 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.683 1.993 . . . . 0.0 115.43 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.23 -53.8 0.79 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.761 1.648 . . . . 0.0 110.715 -165.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.7 p -86.8 157.82 19.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.319 1.848 . . . . 0.0 112.955 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -142.85 165.2 28.03 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -73.15 74.48 1.26 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 128.245 2.618 . . . . 0.0 110.922 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -8.59 2.65 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 -154.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 14.9 p 30.49 63.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.0 mt -60.68 -34.76 74.82 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 120.474 -1.391 . . . . 0.0 113.06 167.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.21 159.16 5.19 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 127.802 2.441 . . . . 0.0 111.119 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -46.77 -34.02 14.98 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 124.061 3.174 . . . . 0.0 115.774 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.15 -27.39 66.39 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 172.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -144.07 104.91 4.19 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.583 1.553 . . . . 0.0 113.489 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 t -116.15 138.48 51.22 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.662 1.585 . . . . 0.0 111.837 146.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -138.44 148.81 44.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.562 1.945 . . . . 0.0 112.03 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.4 m -67.51 102.07 1.09 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.918 0.887 . . . . 0.0 111.783 168.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.894 2.078 . . . . 0.0 112.085 174.166 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -99.22 129.29 45.45 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.63 1.572 . . . . 0.0 112.365 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -53.69 154.82 3.5 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.966 1.706 . . . . 0.0 115.163 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -49.35 133.07 20.17 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.803 0.841 . . . . 0.0 111.337 164.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 73.08 -23.55 0.21 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.438 2.295 . . . . 0.0 115.73 -167.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.4 112.0 2.11 Favored Glycine 0 CA--C 1.545 1.958 0 O-C-N 120.505 -1.372 . . . . 0.0 113.823 171.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -76.86 123.95 27.0 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -166.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 71.8 m -62.9 -44.77 95.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.803 1.241 . . . . 0.0 114.015 173.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.89 -129.28 4.26 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.562 2.029 . . . . 0.0 112.683 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.47 54.5 19.36 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 121.686 -0.891 . . . . 0.0 110.874 -151.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -49.08 121.14 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.152 0.981 . . . . 0.0 113.021 -171.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.18 -50.39 0.89 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -142.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.94 163.05 0.54 Allowed 'General case' 0 CA--C 1.563 1.452 0 O-C-N 121.774 -0.839 . . . . 0.0 112.315 141.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.1 p -151.6 4.82 0.44 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.18 -134.07 8.22 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 116.794 1.477 . . . . 0.0 116.794 -171.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.91 138.42 16.6 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.624 2.883 . . . . 0.0 113.997 -167.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.4 p -105.68 -19.37 13.78 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.549 1.94 . . . . 0.0 115.217 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.36 96.65 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 O-C-N 120.174 -1.579 . . . . 0.0 114.03 -162.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.0 m -56.49 159.88 3.48 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.37 146.68 42.81 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.349 1.86 . . . . 0.0 113.777 167.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.0 t -59.79 111.74 1.57 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.765 1.226 . . . . 0.0 113.413 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.01 -55.18 0.52 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.1 1.809 . . . . 0.0 111.409 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 t -87.52 -176.58 5.64 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.673 1.589 . . . . 0.0 112.315 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -153.64 143.45 21.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.426 2.29 . . . . 0.0 110.672 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 t -58.08 81.17 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 127.582 2.353 . . . . 0.0 114.196 -171.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -74.48 83.99 1.99 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.505 1.922 . . . . 0.0 114.652 -164.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.91 76.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 C-N-CA 128.395 2.678 . . . . 0.0 115.608 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.7 -41.09 24.23 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.689 -1.257 . . . . 0.0 113.168 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -138.69 155.44 73.41 Favored Pre-proline 0 CA--C 1.553 1.093 0 O-C-N 120.756 -1.215 . . . . 0.0 112.765 173.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -38.58 -46.34 2.49 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.639 2.893 . . . . 0.0 115.027 165.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.91 -57.24 5.28 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -83.97 122.33 28.61 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.5 t -137.64 135.94 37.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.031 0.933 . . . . 0.0 111.43 149.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -129.4 147.5 51.23 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.253 1.421 . . . . 0.0 113.383 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.54 67.14 2.01 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 120.463 -1.398 . . . . 0.0 110.952 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 C--O 1.251 1.183 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.087 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -76.13 163.22 27.31 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 118.634 0.652 . . . . 0.0 110.855 153.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -87.1 -169.57 2.68 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -65.44 150.34 48.51 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.066 1.347 . . . . 0.0 111.184 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 61.1 16.07 6.81 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.37 126.07 7.95 Favored Glycine 0 CA--C 1.544 1.862 0 O-C-N 119.928 -1.732 . . . . 0.0 113.353 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -71.7 92.17 1.17 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.774 1.229 . . . . 0.0 111.616 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 p -103.78 12.62 34.37 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.682 2.393 . . . . 0.0 114.196 -169.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.04 68.83 0.07 OUTLIER Glycine 0 CA--C 1.544 1.894 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.82 88.08 0.47 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 162.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.1 mt -53.23 108.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 118.459 1.129 . . . . 0.0 112.838 -161.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.81 -42.28 1.27 Allowed Glycine 0 CA--C 1.544 1.885 0 C-N-CA 125.302 1.43 . . . . 0.0 111.228 -153.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -179.84 0.24 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.038 0.935 . . . . 0.0 112.905 155.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.2 p -151.24 139.37 20.16 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.045 -1.034 . . . . 0.0 111.894 157.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.78 173.85 24.08 Favored Glycine 0 CA--C 1.544 1.896 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.2 113.28 1.13 Allowed 'Trans proline' 0 CA--C 1.546 1.115 1 C-N-CA 125.329 4.019 . . . . 0.0 117.332 -168.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.4 p -82.74 20.73 1.1 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 128.706 2.802 . . . . 0.0 116.137 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.23 114.35 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 120.043 -1.661 . . . . 0.0 113.059 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.2 m -83.19 174.75 10.5 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 127.64 2.376 . . . . 0.0 116.643 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 117.86 9.81 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.645 1.578 . . . . 0.0 112.812 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -39.3 113.01 0.29 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.187 1.395 . . . . 0.0 114.283 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.8 -25.76 7.46 Favored Glycine 0 CA--C 1.545 1.955 0 C-N-CA 124.762 1.173 . . . . 0.0 114.319 -162.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.3 p -124.94 149.92 47.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.182 1.793 . . . . 0.0 114.398 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.1 m -115.74 137.39 52.13 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.795 2.838 . . . . 0.0 112.544 -173.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.84 84.03 0.31 Allowed 'General case' 0 CA--C 1.559 1.316 0 O-C-N 120.266 -1.521 . . . . 0.0 112.435 172.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -55.63 171.23 0.22 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 118.673 2.842 . . . . 0.0 118.673 -161.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.48 49.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.598 -1.314 . . . . 0.0 113.872 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.17 -50.62 67.42 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.711 1.604 . . . . 0.0 112.96 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -162.51 161.7 19.79 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 126.646 1.978 . . . . 0.0 110.118 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -56.81 -13.13 10.53 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.051 2.501 . . . . 0.0 117.323 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.53 -23.14 17.81 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 125.664 1.585 . . . . 0.0 114.831 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -115.0 97.4 6.2 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.64 1.576 . . . . 0.0 112.036 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.6 t -113.91 120.01 39.22 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.966 0.906 . . . . 0.0 110.774 148.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -130.26 146.3 51.85 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.909 1.684 . . . . 0.0 111.843 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.1 m -63.9 85.8 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.5 mt . . . . . 0 C--O 1.25 1.088 0 C-N-CA 127.931 2.492 . . . . 0.0 112.81 177.264 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 44.5 p . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 118.852 -0.594 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -63.01 168.6 3.91 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 119.749 1.159 . . . . 0.0 112.051 147.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -117.97 -173.98 2.55 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.413 1.485 . . . . 0.0 110.915 163.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -47.89 135.24 12.54 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.123 0.969 . . . . 0.0 112.653 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 75.45 1.58 3.67 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.642 2.377 . . . . 0.0 114.838 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.06 114.52 4.79 Favored Glycine 0 CA--C 1.541 1.703 0 O-C-N 118.094 -2.879 . . . . 0.0 116.326 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -53.94 139.75 33.02 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 118.473 1.137 . . . . 0.0 112.924 160.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 p -154.8 -13.89 0.12 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -163.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.46 72.67 0.11 Allowed Glycine 0 CA--C 1.542 1.774 0 N-CA-C 117.358 1.703 . . . . 0.0 117.358 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.27 114.64 0.62 Allowed Glycine 0 CA--C 1.543 1.789 0 C-N-CA 125.918 1.723 . . . . 0.0 111.571 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 mm -54.38 115.96 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 118.875 1.337 . . . . 0.0 112.987 -170.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.63 -48.49 0.94 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 125.592 1.568 . . . . 0.0 110.255 -154.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.16 168.48 6.71 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 121.786 -0.832 . . . . 0.0 112.16 158.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.5 p -153.35 148.76 27.12 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.123 -0.986 . . . . 0.0 111.926 152.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.87 -165.97 24.1 Favored Glycine 0 CA--C 1.544 1.897 0 C-N-CA 124.268 0.937 . . . . 0.0 115.246 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.43 156.37 21.97 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 124.153 3.235 . . . . 0.0 114.057 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 p -129.28 54.74 1.79 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.305 1.042 . . . . 0.0 113.383 -169.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.5 t -152.14 122.43 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 121.089 -1.007 . . . . 0.0 113.017 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.2 m -82.18 172.12 13.53 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.62 2.082 . . . . 0.0 116.62 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.81 117.05 23.03 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.709 1.604 . . . . 0.0 112.763 168.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 t -47.38 136.27 9.77 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.93 -65.18 0.25 Allowed Glycine 0 CA--C 1.541 1.675 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -151.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.8 p -88.64 161.0 17.12 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.539 1.135 . . . . 0.0 113.516 171.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 t -149.48 166.54 28.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.454 -1.404 . . . . 0.0 113.67 170.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 t -82.1 85.81 6.71 Favored 'General case' 0 CA--C 1.552 1.058 0 O-C-N 120.244 -1.535 . . . . 0.0 113.771 -166.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -88.38 90.73 8.52 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 122.353 1.073 . . . . 0.0 113.678 -163.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -70.9 81.46 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -176.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.44 -47.31 82.15 Favored 'General case' 0 CA--C 1.555 1.141 0 O-C-N 120.324 -1.485 . . . . 0.0 114.929 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.82 144.79 1.57 Allowed Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 125.503 1.521 . . . . 0.0 111.259 -169.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . 0.278 8.2 Cg_endo -48.92 -37.91 37.58 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 124.246 3.298 . . . . 0.0 119.176 -153.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.87 -40.14 95.84 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 120.323 1.42 . . . . 0.0 113.652 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -91.06 154.76 19.17 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.469 1.908 . . . . 0.0 113.36 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.4 t 158.79 112.94 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 128.687 2.795 . . . . 0.0 111.158 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -151.95 148.28 27.56 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -153.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 m -79.08 92.31 5.0 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.166 1.787 . . . . 0.0 112.004 168.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.271 -1.824 . . . . 0.0 111.767 165.845 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -79.02 142.54 36.49 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.271 1.828 . . . . 0.0 111.916 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -73.16 159.01 34.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.668 1.587 . . . . 0.0 115.193 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -40.03 136.86 1.07 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 126.069 1.747 . . . . 0.0 113.107 166.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 66.89 -11.11 0.27 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -174.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.12 152.17 20.0 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-N 120.433 1.47 . . . . 0.0 114.133 168.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -89.04 114.01 25.17 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 117.679 0.739 . . . . 0.0 112.031 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.4 t -92.59 -44.39 8.63 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 126.755 2.022 . . . . 0.0 115.57 -171.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.08 35.38 0.45 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 119.423 2.529 . . . . 0.0 119.423 -168.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.62 66.08 2.75 Favored Glycine 0 CA--C 1.545 1.948 0 CA-C-N 119.301 1.55 . . . . 0.0 113.447 175.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.4 mt -41.35 115.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.568 1.547 . . . . 0.0 113.825 -167.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.69 -54.27 0.79 Allowed Glycine 0 N--CA 1.476 1.324 0 N-CA-C 108.291 -1.923 . . . . 0.0 108.291 -151.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -55.91 156.69 4.97 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 121.498 0.666 . . . . 0.0 112.311 140.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.7 p -143.94 138.54 28.56 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.004 1.722 . . . . 0.0 111.115 162.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.26 -174.64 44.93 Favored Glycine 0 CA--C 1.55 2.223 0 N-CA-C 116.584 1.394 . . . . 0.0 116.584 -174.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -65.98 80.46 0.28 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 125.043 3.829 . . . . 0.0 114.202 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.3 p -63.79 33.15 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -167.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.0 t -139.02 93.79 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 O-C-N 119.566 -1.958 . . . . 0.0 114.182 -171.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.8 m -58.79 159.21 7.06 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.046 2.138 . . . . 0.0 115.991 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.33 158.56 11.53 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.116 1.366 . . . . 0.0 113.065 164.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.7 t -69.96 176.34 3.8 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.17 -58.25 2.33 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 121.023 -1.048 . . . . 0.0 112.828 -166.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.4 169.55 17.07 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 126.228 1.811 . . . . 0.0 113.201 168.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.1 t -134.95 170.1 16.39 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.847 2.459 . . . . 0.0 114.832 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.5 t -86.12 69.19 10.47 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 127.889 2.476 . . . . 0.0 112.194 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -54.26 160.75 1.53 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 118.974 2.953 . . . . 0.0 118.974 -161.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.11 59.4 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 127.41 2.284 . . . . 0.0 112.857 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.42 -55.03 6.91 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.304 -1.497 . . . . 0.0 112.695 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -157.32 152.67 21.93 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 126.719 2.007 . . . . 0.0 109.975 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -51.13 -28.81 26.47 Favored 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 122.886 2.391 . . . . 0.0 117.536 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.43 -18.14 63.01 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 120.585 1.539 . . . . 0.0 114.904 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -124.89 135.37 52.81 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.531 2.332 . . . . 0.0 112.997 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 t -158.59 108.25 2.01 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.041 -1.037 . . . . 0.0 109.778 165.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -119.52 149.49 41.82 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.043 1.737 . . . . 0.0 111.596 -166.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -66.46 84.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.224 0.609 . . . . 0.0 112.0 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 C--O 1.252 1.21 0 C-N-CA 127.118 2.167 . . . . 0.0 112.563 -177.834 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -95.81 132.78 40.7 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.03 1.732 . . . . 0.0 111.813 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 m -65.29 170.33 4.83 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -50.97 132.95 27.5 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.86 1.264 . . . . 0.0 111.918 167.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 67.55 53.09 0.74 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.643 1.977 . . . . 0.0 115.324 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.33 126.07 5.82 Favored Glycine 0 CA--C 1.543 1.819 0 C-N-CA 126.384 1.945 . . . . 0.0 111.945 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -74.1 60.77 0.8 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 119.517 1.658 . . . . 0.0 114.086 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.8 t -16.07 -59.62 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.928 3.291 . . . . 0.0 117.495 172.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.05 79.85 0.21 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.402 1.001 . . . . 0.0 112.992 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.5 60.58 0.47 Allowed Glycine 0 CA--C 1.543 1.8 0 C-N-CA 124.99 1.281 . . . . 0.0 111.421 163.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.6 mt -49.39 112.46 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 125.163 1.385 . . . . 0.0 113.804 -156.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.99 -53.19 0.79 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -150.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -50.54 154.07 1.43 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 121.634 0.73 . . . . 0.0 112.165 137.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 p -149.27 151.06 33.56 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.81 1.644 . . . . 0.0 111.141 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.76 -168.04 31.08 Favored Glycine 0 CA--C 1.549 2.159 0 C-N-CA 124.718 1.151 . . . . 0.0 113.572 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.16 113.78 1.74 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.228 3.285 . . . . 0.0 113.82 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -99.38 16.26 23.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -124.7 96.95 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.688 -1.258 . . . . 0.0 112.847 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.1 m -60.47 160.03 9.46 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.296 1.838 . . . . 0.0 115.683 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.6 165.21 5.16 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.112 1.365 . . . . 0.0 113.411 164.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.9 t -75.68 173.67 10.77 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 169.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.35 -63.06 0.16 Allowed Glycine 0 CA--C 1.539 1.581 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -159.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.9 p -62.95 168.92 3.61 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.577 1.551 . . . . 0.0 114.53 167.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -153.38 158.29 41.27 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.906 1.282 . . . . 0.0 112.525 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.8 t -63.46 75.81 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.757 1.223 . . . . 0.0 111.069 170.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.22 89.53 0.87 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.703 1.201 . . . . 0.0 111.892 -165.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.18 94.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 C-N-CA 126.215 1.806 . . . . 0.0 113.485 170.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -96.41 -44.03 7.38 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.416 1.486 . . . . 0.0 111.012 168.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -147.2 156.55 46.55 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 126.852 2.061 . . . . 0.0 112.347 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -40.52 -45.16 4.51 Favored 'Trans proline' 0 CA--C 1.554 1.514 0 C-N-CA 123.887 3.058 . . . . 0.0 115.748 159.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.01 -16.02 61.07 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 171.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -140.51 90.64 2.37 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.316 1.846 . . . . 0.0 112.675 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.4 t -109.31 124.59 51.18 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.237 -0.915 . . . . 0.0 111.063 148.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -138.27 141.58 39.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.728 1.211 . . . . 0.0 113.696 -168.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.3 79.67 0.06 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.678 1.591 . . . . 0.0 112.712 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.072 0.949 . . . . 0.0 112.408 165.219 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -80.37 144.27 32.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.048 1.339 . . . . 0.0 111.588 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -88.3 172.28 9.54 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -41.39 132.54 2.67 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 127.579 2.352 . . . . 0.0 113.191 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 67.1 -13.16 0.21 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.68 141.42 44.64 Favored Glycine 0 CA--C 1.55 2.234 0 O-C-N 120.063 -1.648 . . . . 0.0 112.911 167.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -75.48 108.37 8.24 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.999 -1.295 . . . . 0.0 113.318 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.6 t -74.6 -37.88 62.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.444 1.898 . . . . 0.0 112.94 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.23 158.84 28.44 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-O 123.07 1.372 . . . . 0.0 114.923 -173.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.67 46.71 0.02 OUTLIER Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.521 2.01 . . . . 0.0 110.342 -169.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.7 mt -50.8 117.89 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.836 1.254 . . . . 0.0 112.268 -158.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.54 -59.52 0.69 Allowed Glycine 0 CA--C 1.536 1.399 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -148.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.21 156.27 5.86 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-O 121.737 0.779 . . . . 0.0 112.264 145.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.6 p -138.68 147.98 43.43 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.251 1.82 . . . . 0.0 110.343 160.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.31 -161.85 32.0 Favored Glycine 0 CA--C 1.543 1.804 0 O-C-N 120.65 -1.281 . . . . 0.0 115.615 -175.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -71.16 79.09 1.42 Allowed 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.631 2.887 . . . . 0.0 113.605 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.2 p -71.18 25.82 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 -167.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 t -140.61 100.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 119.742 -1.849 . . . . 0.0 113.659 -173.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m -63.64 163.58 11.12 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.7 122.48 28.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.72 1.608 . . . . 0.0 113.093 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.9 t -44.34 135.21 4.69 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.9 1.28 . . . . 0.0 114.109 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.97 -40.97 2.28 Favored Glycine 0 CA--C 1.545 1.943 0 C-N-CA 124.209 0.909 . . . . 0.0 112.58 -154.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p -118.06 151.32 37.76 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.851 1.66 . . . . 0.0 114.264 175.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.8 m -109.58 142.95 39.96 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.02 2.528 . . . . 0.0 113.668 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.9 t -73.28 84.2 1.4 Allowed 'General case' 0 CA--C 1.552 1.021 0 O-C-N 121.101 -0.999 . . . . 0.0 111.099 167.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -57.79 178.28 0.09 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.59 49.95 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.479 1.133 . . . . 0.0 112.678 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.72 -44.49 96.09 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.563 1.545 . . . . 0.0 111.931 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -142.65 160.33 54.08 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.724 1.61 . . . . 0.0 110.065 159.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -45.05 -39.52 14.83 Favored 'Trans proline' 0 CA--C 1.555 1.53 0 C-N-CA 122.051 1.834 . . . . 0.0 113.203 161.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.91 -25.95 63.0 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -122.18 90.63 3.34 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.836 1.655 . . . . 0.0 111.948 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.0 t -116.23 107.28 14.66 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.973 0.892 . . . . 0.0 111.838 158.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -113.32 152.89 29.34 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.352 1.861 . . . . 0.0 111.552 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.27 84.97 0.15 Allowed 'General case' 0 CA--C 1.55 0.953 0 O-C-N 121.374 -0.829 . . . . 0.0 112.673 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 C--O 1.25 1.129 0 C-N-CA 128.81 2.844 . . . . 0.0 111.835 179.584 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -71.97 141.47 49.4 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.619 0.767 . . . . 0.0 111.987 166.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -91.55 155.69 18.2 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -38.16 132.03 1.07 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 127.181 2.192 . . . . 0.0 113.528 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 67.65 -27.52 0.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -170.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -42.58 119.91 2.26 Favored Glycine 0 CA--C 1.545 1.934 0 O-C-N 120.674 -1.267 . . . . 0.0 113.879 171.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -75.47 136.65 40.65 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.688 1.195 . . . . 0.0 111.959 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.0 p -144.67 28.36 1.3 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.369 1.067 . . . . 0.0 113.737 -166.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.05 69.97 0.03 OUTLIER Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.686 1.612 . . . . 0.0 114.981 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.25 86.17 0.4 Allowed Glycine 0 N--CA 1.471 0.996 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 152.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.6 mt -53.92 110.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 118.901 1.351 . . . . 0.0 111.987 -164.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.15 -48.59 0.86 Allowed Glycine 0 CA--C 1.544 1.89 0 C-N-CA 125.032 1.301 . . . . 0.0 110.401 -149.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.68 170.81 1.32 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.498 1.119 . . . . 0.0 112.718 153.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.2 p -152.27 147.61 26.57 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.425 -0.797 . . . . 0.0 111.957 158.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.55 175.89 25.39 Favored Glycine 0 CA--C 1.54 1.602 0 N-CA-C 115.319 0.888 . . . . 0.0 115.319 175.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.6 122.39 3.95 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.826 3.684 . . . . 0.0 114.595 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.3 p -83.32 -55.38 4.36 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.4 1.88 . . . . 0.0 113.117 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.2 t -66.0 111.36 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 C-N-CA 125.46 1.504 . . . . 0.0 114.102 -170.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.4 m -73.25 172.68 10.71 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.48 130.03 38.86 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 126.47 1.908 . . . . 0.0 114.087 172.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -52.14 113.78 1.13 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.244 1.018 . . . . 0.0 112.982 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.44 -45.23 1.03 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.034 1.302 . . . . 0.0 111.915 -163.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.4 p -127.41 -176.35 3.72 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 127.348 2.259 . . . . 0.0 111.827 170.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -148.06 155.44 41.49 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 119.358 -2.089 . . . . 0.0 112.344 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.7 t -69.46 77.32 0.4 Allowed 'General case' 0 CA--C 1.557 1.245 0 O-C-N 120.421 -1.424 . . . . 0.0 111.032 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 87.27 0.68 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.428 1.491 . . . . 0.0 113.624 -167.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.9 93.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.269 1.027 . . . . 0.0 113.757 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -93.5 -39.83 10.66 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.356 1.462 . . . . 0.0 111.408 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -150.39 163.67 23.38 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.934 1.694 . . . . 0.0 113.308 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.31 -14.66 35.66 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 123.357 2.705 . . . . 0.0 114.938 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.9 -11.91 27.82 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 125.974 1.71 . . . . 0.0 115.026 165.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -140.88 97.3 3.16 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.163 1.785 . . . . 0.0 112.767 -175.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -119.96 136.25 54.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.273 1.029 . . . . 0.0 110.702 145.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -146.44 146.14 30.47 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.216 1.406 . . . . 0.0 112.578 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.9 m -70.52 81.44 0.58 Allowed 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 176.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.8 mt . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.219 1.808 . . . . 0.0 115.359 177.681 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -72.21 141.73 49.01 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.879 0.872 . . . . 0.0 111.763 167.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.5 m -65.54 148.88 51.0 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -47.2 133.71 11.72 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.237 0.615 . . . . 0.0 111.545 157.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 63.06 53.57 2.3 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.759 1.224 . . . . 0.0 113.883 -169.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.08 117.76 2.67 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 124.923 1.249 . . . . 0.0 114.036 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -67.73 63.93 0.08 Allowed 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 125.538 1.535 . . . . 0.0 114.552 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.2 p -66.24 43.73 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 128.146 2.578 . . . . 0.0 115.689 174.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.68 78.93 0.03 OUTLIER Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.666 -1.271 . . . . 0.0 113.591 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.33 88.52 0.39 Allowed Glycine 0 CA--C 1.534 1.236 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 148.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.2 mt -50.63 108.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 119.746 1.773 . . . . 0.0 113.089 -163.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.28 -48.51 0.86 Allowed Glycine 0 CA--C 1.544 1.886 0 C-N-CA 125.612 1.577 . . . . 0.0 110.081 -152.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.57 166.07 0.14 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.156 0.982 . . . . 0.0 112.624 145.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.6 p -152.32 157.99 42.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.29 1.036 . . . . 0.0 111.468 156.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.39 -175.11 20.64 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -46.23 115.36 1.11 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 125.063 3.842 . . . . 0.0 115.024 -173.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.7 p -72.35 -65.94 0.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.008 1.723 . . . . 0.0 112.414 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -50.22 107.29 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 126.799 2.04 . . . . 0.0 114.31 -169.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.0 m -66.0 179.22 0.94 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 128.196 2.598 . . . . 0.0 117.119 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 129.28 37.52 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.685 1.594 . . . . 0.0 111.36 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -45.13 112.86 0.49 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.47 -44.78 1.37 Allowed Glycine 0 CA--C 1.549 2.162 0 C-N-CA 125.444 1.497 . . . . 0.0 113.68 -167.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 p -89.87 148.02 23.41 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 127.0 2.12 . . . . 0.0 113.198 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 m -124.56 142.26 51.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.324 1.85 . . . . 0.0 113.927 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -73.19 83.73 1.35 Allowed 'General case' 0 CA--C 1.554 1.109 0 O-C-N 120.357 -1.464 . . . . 0.0 111.257 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -12.81 8.59 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 -150.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.304 7.9 p 39.45 46.24 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 126.936 2.094 . . . . 0.0 115.5 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.07 -45.06 74.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.014 1.326 . . . . 0.0 111.801 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -136.61 157.11 75.76 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.111 1.364 . . . . 0.0 110.196 159.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.7 -16.94 16.34 Favored 'Trans proline' 0 CA--C 1.558 1.701 0 C-N-CA 122.318 2.012 . . . . 0.0 114.974 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.43 -18.23 25.77 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 127.165 2.186 . . . . 0.0 115.811 167.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -140.79 93.94 2.66 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.042 1.737 . . . . 0.0 112.606 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 t -122.35 91.64 3.55 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.052 1.741 . . . . 0.0 111.239 167.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.96 146.07 24.19 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.815 1.246 . . . . 0.0 113.735 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.9 m -66.07 95.13 0.26 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.328 -0.857 . . . . 0.0 111.929 156.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.9 mt . . . . . 0 C--O 1.257 1.462 0 CA-C-O 117.049 -1.453 . . . . 0.0 110.511 161.446 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.949 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -70.95 153.11 42.94 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 119.584 1.084 . . . . 0.0 112.156 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 m -74.58 161.36 29.8 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.59 1.556 . . . . 0.0 114.873 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -50.42 132.61 24.94 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.305 1.042 . . . . 0.0 110.696 159.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 63.39 65.57 0.75 Allowed 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -171.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.43 -89.54 0.03 OUTLIER Glycine 0 CA--C 1.555 2.557 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -84.84 170.96 12.63 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 129.607 3.163 . . . . 0.0 115.153 -6.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.97 11.44 13.41 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 128.053 2.541 . . . . 0.0 114.865 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.18 -164.29 10.78 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 126.487 1.994 . . . . 0.0 114.837 169.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.97 60.53 3.33 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.969 -0.724 . . . . 0.0 112.121 -164.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.3 mt -51.43 108.49 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 126.032 1.733 . . . . 0.0 111.745 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.38 -47.56 0.87 Allowed Glycine 0 CA--C 1.541 1.699 0 C-N-CA 124.705 1.145 . . . . 0.0 110.331 -147.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.33 164.42 0.96 Allowed 'General case' 0 CA--C 1.554 1.099 0 O-C-N 121.893 -0.769 . . . . 0.0 111.156 139.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.3 p -154.58 164.13 39.17 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.537 1.135 . . . . 0.0 111.972 164.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.19 179.22 19.01 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 116.052 1.181 . . . . 0.0 116.052 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -50.68 119.7 5.53 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 125.239 3.959 . . . . 0.0 116.648 -168.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.7 p -77.39 -39.53 46.91 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.626 1.57 . . . . 0.0 114.631 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.76 102.31 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 125.045 1.338 . . . . 0.0 114.393 -161.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -85.46 -177.92 6.57 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.18 146.2 55.27 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.73 1.612 . . . . 0.0 113.622 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.4 p -77.43 73.58 4.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.025 -1.047 . . . . 0.0 111.832 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.02 -50.71 0.04 OUTLIER Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.956 1.741 . . . . 0.0 110.764 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.2 p -74.08 177.44 5.71 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.564 1.146 . . . . 0.0 113.482 161.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.8 m -148.25 143.31 26.89 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.821 -1.174 . . . . 0.0 113.975 165.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.3 t -64.76 86.42 0.05 Allowed 'General case' 0 CA--C 1.558 1.278 0 O-C-N 120.414 -1.429 . . . . 0.0 111.954 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.12 161.15 11.45 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -160.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.09 134.54 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 O-C-N 120.629 -1.295 . . . . 0.0 111.253 164.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -152.68 -53.43 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.241 1.017 . . . . 0.0 111.866 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -158.04 164.09 22.46 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 124.772 1.229 . . . . 0.0 111.091 165.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -41.63 -42.3 5.99 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.808 3.006 . . . . 0.0 115.818 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.11 -4.67 18.21 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -143.65 118.1 9.7 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.751 1.621 . . . . 0.0 113.645 -170.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 t -135.48 95.59 3.29 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.38 -0.825 . . . . 0.0 110.996 153.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -109.8 150.12 28.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.893 1.277 . . . . 0.0 113.148 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.2 m -79.08 89.56 4.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.617 1.167 . . . . 0.0 113.064 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.258 1.513 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.98 163.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -69.57 136.25 51.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.938 1.695 . . . . 0.0 111.492 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -75.83 158.38 32.22 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -49.92 132.65 22.76 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.145 1.378 . . . . 0.0 111.619 167.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 64.5 42.44 5.01 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.03 129.15 6.43 Favored Glycine 0 CA--C 1.544 1.881 0 C-N-CA 125.844 1.688 . . . . 0.0 112.872 168.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -66.72 72.73 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.219 1.51 . . . . 0.0 114.589 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.7 t -31.31 -54.77 0.24 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 128.127 2.571 . . . . 0.0 116.012 171.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.74 45.69 0.5 Allowed Glycine 0 CA--C 1.539 1.566 0 N-CA-C 118.095 1.998 . . . . 0.0 118.095 -168.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.22 65.52 1.27 Allowed Glycine 0 CA--C 1.546 1.981 0 O-C-N 121.159 -1.2 . . . . 0.0 113.723 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.2 mt -44.1 114.27 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 118.984 1.392 . . . . 0.0 113.892 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.1 -54.62 0.78 Allowed Glycine 0 CA--C 1.537 1.425 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -154.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.82 160.72 4.34 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 122.071 0.939 . . . . 0.0 111.757 139.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.0 p -148.54 149.37 31.48 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.15 1.78 . . . . 0.0 111.138 163.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 163.07 -166.95 37.21 Favored Glycine 0 CA--C 1.546 2.007 0 O-C-N 120.96 -1.087 . . . . 0.0 114.949 -175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.73 80.97 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.894 3.062 . . . . 0.0 113.027 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.7 p -70.73 33.0 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 118.151 2.648 . . . . 0.0 118.151 -166.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 t -137.93 96.28 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 O-C-N 120.132 -1.605 . . . . 0.0 113.317 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.47 156.87 7.41 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.19 167.12 0.13 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.997 0.919 . . . . 0.0 112.71 153.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.8 t -82.75 -178.02 6.94 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.47 -66.07 1.02 Allowed Glycine 0 CA--C 1.539 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 111.898 -165.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.42 161.25 30.0 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.352 1.461 . . . . 0.0 114.069 170.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.7 p -128.94 151.12 50.02 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 130.936 3.694 . . . . 0.0 111.839 -168.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.6 t -74.42 74.94 1.91 Allowed 'General case' 0 CA--C 1.559 1.29 0 O-C-N 120.238 -1.538 . . . . 0.0 111.571 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -63.71 165.15 8.72 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -167.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 p -137.13 105.83 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 C-N-CA 125.534 1.533 . . . . 0.0 114.558 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.86 -50.33 6.1 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.451 1.5 . . . . 0.0 111.899 167.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.76 157.17 36.11 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 128.013 2.525 . . . . 0.0 108.85 171.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -50.07 -39.62 50.78 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 122.844 2.363 . . . . 0.0 115.107 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -50.96 -25.4 4.62 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -122.56 135.6 54.67 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.08 2.152 . . . . 0.0 113.342 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.74 111.18 1.15 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.229 -0.919 . . . . 0.0 113.427 165.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -122.71 151.75 41.25 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.47 1.908 . . . . 0.0 112.75 -169.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.5 m -61.79 88.88 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.9 0.48 . . . . 0.0 111.378 168.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.256 1.432 0 C-N-CA 128.456 2.702 . . . . 0.0 112.638 174.953 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -90.36 133.29 35.08 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 127.303 2.241 . . . . 0.0 111.276 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.1 p -75.81 166.67 23.18 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.938 1.695 . . . . 0.0 113.784 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -58.83 147.27 34.26 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 58.39 -11.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -161.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.06 122.67 24.32 Favored Glycine 0 CA--C 1.542 1.747 0 O-C-N 119.687 -1.883 . . . . 0.0 113.65 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -68.42 76.51 0.26 Allowed 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 118.946 1.373 . . . . 0.0 112.632 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.5 t -51.19 -31.2 19.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.037 1.735 . . . . 0.0 115.373 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.75 106.86 0.29 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 117.498 1.759 . . . . 0.0 117.498 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.45 85.43 0.34 Allowed Glycine 0 CA--C 1.534 1.237 0 O-C-N 120.895 -1.356 . . . . 0.0 109.961 154.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.3 mt -49.84 113.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 118.903 1.351 . . . . 0.0 113.052 -161.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.64 -45.94 1.1 Allowed Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.339 1.447 . . . . 0.0 110.6 -151.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.69 171.5 0.21 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 125.273 1.429 . . . . 0.0 112.714 153.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.8 p -153.63 174.47 14.44 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.693 1.197 . . . . 0.0 111.505 160.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 -175.29 19.55 Favored Glycine 0 CA--C 1.546 2.031 0 C-N-CA 124.233 0.92 . . . . 0.0 114.353 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.03 100.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 124.626 3.551 . . . . 0.0 116.804 -168.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -83.55 22.78 1.02 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.964 2.506 . . . . 0.0 114.2 -175.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -149.09 114.27 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 120.171 -1.581 . . . . 0.0 111.924 -173.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.0 m -70.14 167.13 18.45 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.93 140.29 38.09 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.662 1.585 . . . . 0.0 113.81 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 t -49.94 111.93 0.59 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.359 1.064 . . . . 0.0 113.55 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.94 -47.26 1.0 Allowed Glycine 0 CA--C 1.543 1.838 0 C-N-CA 125.34 1.448 . . . . 0.0 112.921 -164.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.63 149.61 40.41 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.294 2.237 . . . . 0.0 113.055 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.4 m -121.05 142.01 50.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.295 1.438 . . . . 0.0 112.749 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 t -57.52 88.85 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 126.31 1.844 . . . . 0.0 111.463 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -10.35 51.35 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -149.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.308 9.3 p 34.53 52.93 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 127.883 2.473 . . . . 0.0 116.663 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.0 -45.07 78.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.543 1.537 . . . . 0.0 112.413 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -152.28 169.77 9.03 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 125.49 1.516 . . . . 0.0 110.976 164.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -48.55 -33.11 22.77 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.257 2.638 . . . . 0.0 116.802 178.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.42 -10.76 48.13 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -137.68 101.5 4.49 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.456 1.502 . . . . 0.0 113.723 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 t -122.47 91.96 3.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.874 2.469 . . . . 0.0 110.505 158.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -92.65 152.4 19.57 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 120.503 -1.373 . . . . 0.0 112.588 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.1 m -78.21 78.13 4.69 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.697 -1.252 . . . . 0.0 110.989 162.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.188 -1.387 . . . . 0.0 112.485 161.671 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -79.24 145.06 33.79 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.953 1.301 . . . . 0.0 112.37 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.3 m -80.29 158.17 26.21 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.734 1.214 . . . . 0.0 113.82 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -38.59 132.55 1.14 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.875 1.67 . . . . 0.0 112.573 167.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 70.05 -23.12 0.16 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.69 137.72 45.46 Favored Glycine 0 CA--C 1.55 2.261 0 O-C-N 120.233 -1.542 . . . . 0.0 113.561 168.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -71.87 133.89 45.73 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 120.694 -1.474 . . . . 0.0 112.183 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.5 t -106.07 -33.34 7.91 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.73 2.012 . . . . 0.0 113.847 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.16 -166.45 23.07 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 120.664 -1.273 . . . . 0.0 115.769 -169.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.05 -98.2 0.97 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.147 1.832 . . . . 0.0 113.349 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.77 71.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 126.053 1.741 . . . . 0.0 114.604 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.19 41.68 2.18 Favored Glycine 0 CA--C 1.544 1.889 0 C-N-CA 125.611 1.576 . . . . 0.0 113.878 -173.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -80.94 132.27 35.4 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -150.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.2 p -96.1 -164.0 1.11 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.228 1.811 . . . . 0.0 113.389 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.06 -151.99 41.37 Favored Glycine 0 CA--C 1.551 2.329 0 O-C-N 119.67 -1.894 . . . . 0.0 115.863 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -71.64 62.02 2.93 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 123.993 3.128 . . . . 0.0 114.97 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.1 p -71.76 32.04 0.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -170.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -145.74 97.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 120.006 -1.684 . . . . 0.0 112.121 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.8 m -59.99 155.85 15.9 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.39 152.69 45.24 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.857 1.263 . . . . 0.0 112.622 162.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 t -62.3 171.37 1.89 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.21 -57.6 1.11 Allowed Glycine 0 CA--C 1.543 1.792 0 C-N-CA 124.172 0.891 . . . . 0.0 112.951 -164.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.7 p -76.52 145.95 38.76 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.1 m -99.09 142.28 30.79 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.806 2.043 . . . . 0.0 113.871 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.6 t -70.84 86.28 0.69 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.846 1.259 . . . . 0.0 110.82 163.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.436 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 23.5 mm-40 -64.08 177.39 0.81 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 117.875 2.546 . . . . 0.0 117.875 -165.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 p -140.37 50.75 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 122.515 1.15 . . . . 0.0 113.544 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -56.65 -44.6 81.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.328 1.851 . . . . 0.0 113.362 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -147.38 164.51 22.59 Favored Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 126.072 1.749 . . . . 0.0 110.02 162.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -43.37 -39.49 9.13 Favored 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 123.97 3.113 . . . . 0.0 116.969 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.17 -33.05 44.37 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -95.5 83.55 3.82 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.638 1.975 . . . . 0.0 113.523 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 t -105.16 104.93 14.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.643 0.777 . . . . 0.0 111.776 156.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -115.91 157.59 24.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.638 2.375 . . . . 0.0 112.16 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.9 m -71.26 79.83 0.72 Allowed 'General case' 0 CA--C 1.554 1.111 0 O-C-N 121.472 -0.767 . . . . 0.0 112.806 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.436 ' HB2' ' HG3' ' A' ' 26' ' ' GLN . 76.6 mt . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.432 1.893 . . . . 0.0 112.162 168.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -67.8 128.33 36.09 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.737 1.615 . . . . 0.0 111.572 174.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.3 m -72.12 161.96 30.14 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.953 1.301 . . . . 0.0 113.599 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -43.18 135.9 3.12 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.252 1.021 . . . . 0.0 113.115 172.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 69.83 -12.06 0.49 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.05 140.83 46.96 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.033 -1.667 . . . . 0.0 113.305 170.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.18 151.66 36.85 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.681 1.741 . . . . 0.0 112.875 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.7 t -127.62 -48.33 1.4 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.565 1.546 . . . . 0.0 113.062 -168.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.97 17.97 2.55 Favored Glycine 0 CA--C 1.548 2.106 0 N-CA-C 120.288 2.875 . . . . 0.0 120.288 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.11 68.69 2.82 Favored Glycine 0 CA--C 1.545 1.924 0 CA-C-N 120.756 2.278 . . . . 0.0 113.463 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.6 mt -46.3 128.66 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.664 1.185 . . . . 0.0 113.347 -173.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.13 -56.42 0.6 Allowed Glycine 0 N--CA 1.474 1.195 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -145.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.7 157.0 15.57 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.994 0.902 . . . . 0.0 112.586 150.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 p -140.8 137.48 33.36 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.694 1.598 . . . . 0.0 110.631 158.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.72 -173.04 46.0 Favored Glycine 0 CA--C 1.544 1.845 0 O-C-N 120.949 -1.095 . . . . 0.0 114.221 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -65.38 88.89 0.21 Allowed 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 123.414 2.743 . . . . 0.0 113.781 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 p -72.9 31.88 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -170.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.5 t -141.82 98.49 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 119.613 -1.93 . . . . 0.0 114.145 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m -65.85 157.26 30.97 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 96.47 0.47 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.178 1.391 . . . . 0.0 111.864 169.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 t -37.09 -13.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 119.913 3.301 . . . . 0.0 119.913 -166.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.07 -35.9 60.25 Favored Glycine 0 CA--C 1.547 2.032 0 CA-C-N 119.571 1.078 . . . . 0.0 113.685 160.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 p -111.12 173.43 6.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.846 2.058 . . . . 0.0 111.614 169.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 t -125.78 172.54 9.75 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.9 t -77.5 70.28 3.87 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.436 1.494 . . . . 0.0 110.973 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -57.64 167.61 1.04 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -169.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.83 117.06 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.035 1.334 . . . . 0.0 113.233 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -105.71 -53.32 2.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.562 1.545 . . . . 0.0 110.153 162.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.71 149.76 6.21 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.956 2.502 . . . . 0.0 110.426 176.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.82 17.76 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.587 0 C-N-CA 124.941 3.761 . . . . 0.0 118.458 -160.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.59 -27.94 12.8 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 126.087 1.755 . . . . 0.0 113.104 160.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -80.49 166.31 21.32 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.629 1.571 . . . . 0.0 112.467 161.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 t 153.63 81.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.032 2.533 . . . . 0.0 112.051 168.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -120.02 150.05 41.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.346 1.858 . . . . 0.0 112.585 -165.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.3 m -62.92 79.27 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.676 1.19 . . . . 0.0 113.309 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.258 1.538 0 C-N-CA 129.222 3.009 . . . . 0.0 112.267 178.233 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.26 136.12 39.65 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.755 1.222 . . . . 0.0 111.173 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -69.69 150.67 46.73 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.785 1.234 . . . . 0.0 113.929 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -42.88 133.93 3.48 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.939 1.695 . . . . 0.0 112.389 169.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 67.19 -13.73 0.2 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -171.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.02 126.69 33.88 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 120.202 -1.561 . . . . 0.0 113.628 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -75.76 132.18 40.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.039 0.936 . . . . 0.0 110.813 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.39 4.08 1.56 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -160.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.39 59.66 0.12 Allowed Glycine 0 CA--C 1.543 1.791 0 CA-C-N 118.771 0.714 . . . . 0.0 114.867 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.23 86.26 0.45 Allowed Glycine 0 N--CA 1.474 1.217 0 O-C-N 121.322 -1.105 . . . . 0.0 110.546 163.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.9 mt -54.19 109.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 118.81 1.305 . . . . 0.0 112.483 -162.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.87 -45.51 1.0 Allowed Glycine 0 CA--C 1.546 1.987 0 C-N-CA 125.364 1.459 . . . . 0.0 111.318 -151.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -177.43 0.49 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.305 1.442 . . . . 0.0 113.238 159.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.9 p -156.78 141.14 16.62 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.249 -0.907 . . . . 0.0 112.453 158.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.03 172.71 27.61 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 115.763 1.065 . . . . 0.0 115.763 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -45.88 117.83 2.02 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 125.065 3.843 . . . . 0.0 115.55 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.2 p -89.13 3.19 52.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.457 2.303 . . . . 0.0 115.782 -172.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 t -119.08 106.16 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.078 1.351 . . . . 0.0 112.697 -172.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.71 171.2 11.99 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 130.55 45.09 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.352 1.461 . . . . 0.0 113.634 167.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.3 t -55.06 117.47 3.49 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.138 -0.976 . . . . 0.0 112.025 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.15 -40.68 1.83 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.919 1.247 . . . . 0.0 113.008 -164.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.5 p -107.33 -178.87 3.76 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.875 1.27 . . . . 0.0 113.558 171.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -151.9 143.35 23.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.403 2.281 . . . . 0.0 111.673 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -67.3 82.33 0.14 Allowed 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.081 -1.637 . . . . 0.0 113.068 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -54.23 173.59 0.07 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.97 111.21 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.5 mt -98.81 -47.74 5.19 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.261 1.425 . . . . 0.0 112.32 166.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.21 161.84 29.6 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 126.785 2.034 . . . . 0.0 110.013 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.26 -9.31 6.33 Favored 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.118 1.879 . . . . 0.0 115.669 175.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.0 -18.93 23.8 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -120.66 107.58 12.97 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.841 1.656 . . . . 0.0 111.584 173.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.7 t -135.06 120.59 19.28 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.292 1.037 . . . . 0.0 112.333 156.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -136.7 145.15 44.39 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.149 2.179 . . . . 0.0 112.585 -164.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.3 m -64.67 84.13 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 120.64 -1.288 . . . . 0.0 114.123 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 C--O 1.252 1.19 0 C-N-CA 128.872 2.869 . . . . 0.0 113.167 173.95 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -102.36 138.62 39.05 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.426 1.49 . . . . 0.0 111.946 168.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 m -68.98 162.78 26.05 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.48 1.912 . . . . 0.0 114.958 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -47.63 137.66 8.97 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.598 1.159 . . . . 0.0 112.48 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 67.53 -15.49 0.18 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.957 2.103 . . . . 0.0 115.694 -168.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -50.27 132.07 29.57 Favored Glycine 0 CA--C 1.545 1.959 0 O-C-N 120.589 -1.319 . . . . 0.0 114.033 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.02 126.2 35.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.648 1.179 . . . . 0.0 112.196 -174.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.98 8.53 3.5 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -159.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.25 34.65 0.09 OUTLIER Glycine 0 CA--C 1.547 2.034 0 N-CA-C 117.642 1.817 . . . . 0.0 117.642 167.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.58 85.66 1.55 Allowed Glycine 0 CA--C 1.541 1.664 0 CA-C-N 119.028 1.414 . . . . 0.0 112.217 170.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.5 mt -53.9 118.2 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.988 1.315 . . . . 0.0 113.245 -164.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.18 -44.2 1.23 Allowed Glycine 0 CA--C 1.541 1.695 0 C-N-CA 125.238 1.399 . . . . 0.0 110.597 -153.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.42 173.71 3.86 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 160.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.1 p -157.98 85.07 0.88 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.969 -1.082 . . . . 0.0 112.429 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.4 167.83 33.04 Favored Glycine 0 CA--C 1.549 2.192 0 N-CA-C 116.426 1.331 . . . . 0.0 116.426 -169.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -63.61 113.42 2.12 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.977 3.785 . . . . 0.0 113.325 -170.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.5 p -72.26 -0.89 13.35 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -165.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 t -115.3 107.54 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 120.393 -1.442 . . . . 0.0 113.244 -167.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.7 m -66.24 168.36 8.79 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.07 151.37 47.01 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.964 1.305 . . . . 0.0 112.402 162.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -67.04 162.95 21.02 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.11 -56.88 4.8 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.811 1.196 . . . . 0.0 112.243 -168.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.59 162.9 17.75 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 127.672 2.389 . . . . 0.0 113.472 166.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 t -142.66 172.93 12.03 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.355 -1.466 . . . . 0.0 114.257 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 t -73.66 73.67 1.5 Allowed 'General case' 0 CA--C 1.555 1.166 0 O-C-N 120.58 -1.325 . . . . 0.0 113.269 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -66.4 93.3 0.22 Allowed 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.547 -1.346 . . . . 0.0 113.803 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.59 68.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 127.94 2.496 . . . . 0.0 115.408 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -62.46 -49.94 73.45 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 120.14 -1.6 . . . . 0.0 113.236 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -160.71 174.41 3.91 Favored Pre-proline 0 CA--C 1.569 1.675 0 O-C-N 120.641 -1.287 . . . . 0.0 114.448 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.41 -22.16 15.53 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.869 3.713 . . . . 0.0 118.189 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.1 -23.97 15.98 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.096 1.358 . . . . 0.0 113.508 170.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -120.72 93.63 4.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.992 1.717 . . . . 0.0 112.079 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 t -123.57 115.84 22.16 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.488 1.115 . . . . 0.0 109.747 150.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -148.04 147.13 29.25 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -158.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.5 m -67.55 78.79 0.18 Allowed 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.259 1.6 0 C-N-CA 125.397 1.479 . . . . 0.0 112.815 167.916 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -85.13 145.69 27.5 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.256 1.822 . . . . 0.0 111.916 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.2 p -80.42 159.83 25.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.955 1.702 . . . . 0.0 114.929 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -40.9 135.19 1.76 Allowed 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 126.09 1.756 . . . . 0.0 112.803 168.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 65.37 -21.25 0.09 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -171.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -45.31 121.78 4.93 Favored Glycine 0 CA--C 1.546 2.021 0 O-C-N 120.097 -1.627 . . . . 0.0 112.544 163.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.54 100.85 5.43 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.905 -1.35 . . . . 0.0 112.715 -173.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -65.61 -36.66 84.37 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 125.384 1.473 . . . . 0.0 114.503 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.04 -142.35 6.42 Favored Glycine 0 CA--C 1.548 2.152 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.45 50.43 37.95 Favored Glycine 0 CA--C 1.543 1.833 0 O-C-N 120.633 -1.51 . . . . 0.0 112.776 -159.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -51.33 118.4 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 125.685 1.594 . . . . 0.0 112.774 -169.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.53 -53.26 0.81 Allowed Glycine 0 CA--C 1.537 1.443 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -145.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -52.22 152.56 3.25 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 122.133 -0.628 . . . . 0.0 111.603 137.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.6 p -150.93 134.59 16.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.752 1.621 . . . . 0.0 110.728 166.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.26 -168.41 41.41 Favored Glycine 0 CA--C 1.549 2.167 0 O-C-N 121.173 -0.954 . . . . 0.0 114.872 -173.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.82 75.1 0.07 OUTLIER 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 125.153 3.902 . . . . 0.0 115.961 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.0 p -60.71 32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 128.954 2.902 . . . . 0.0 118.291 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 t -141.45 97.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 O-C-N 119.504 -1.997 . . . . 0.0 112.702 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.43 169.43 7.47 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.41 106.82 14.59 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.878 2.071 . . . . 0.0 113.971 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -35.17 114.29 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.288 1.435 . . . . 0.0 113.996 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.55 -45.34 1.16 Allowed Glycine 0 CA--C 1.543 1.832 0 C-N-CA 124.368 0.985 . . . . 0.0 112.314 -151.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.97 153.65 47.35 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.403 2.281 . . . . 0.0 112.107 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.7 m -111.04 156.86 20.66 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.054 2.542 . . . . 0.0 113.29 -174.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.6 t -63.23 77.19 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 O-C-N 120.128 -1.608 . . . . 0.0 110.72 165.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -77.88 92.28 4.24 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.242 1.017 . . . . 0.0 111.9 -158.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -63.98 59.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 128.035 2.534 . . . . 0.0 115.497 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -58.77 -46.45 87.46 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.659 -1.901 . . . . 0.0 111.703 170.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -145.29 153.31 52.18 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.786 1.634 . . . . 0.0 112.09 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.24 -36.03 96.02 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.133 2.555 . . . . 0.0 113.254 169.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.79 -6.59 2.78 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 166.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -130.11 -158.02 0.86 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 129.303 3.041 . . . . 0.0 109.288 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t 136.53 76.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 130.059 3.344 . . . . 0.0 108.285 159.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -97.26 155.29 16.93 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.032 1.333 . . . . 0.0 112.789 -164.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.4 m -70.4 78.73 0.55 Allowed 'General case' 0 CA--C 1.549 0.916 0 O-C-N 120.892 -1.13 . . . . 0.0 112.962 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.0 mt . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 116.711 -1.614 . . . . 0.0 114.592 162.921 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -89.01 133.07 34.46 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.769 2.028 . . . . 0.0 110.463 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 m -70.14 160.55 31.86 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.863 1.265 . . . . 0.0 114.345 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -49.77 134.34 20.65 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.254 1.022 . . . . 0.0 111.648 170.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 65.87 -8.0 0.34 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.0 125.09 38.77 Favored Glycine 0 CA--C 1.541 1.678 0 O-C-N 120.093 -1.629 . . . . 0.0 112.678 170.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.76 107.39 0.69 Allowed 'General case' 0 CA--C 1.554 1.106 0 O-C-N 120.954 -1.321 . . . . 0.0 110.836 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.0 t -88.51 1.1 55.51 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.291 1.836 . . . . 0.0 113.589 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.5 121.84 0.67 Allowed Glycine 0 CA--C 1.539 1.584 0 O-C-N 120.846 -1.158 . . . . 0.0 114.442 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.81 69.27 0.28 Allowed Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 162.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.5 mm -41.67 116.72 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -159.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.01 -55.22 0.74 Allowed Glycine 0 CA--C 1.539 1.533 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -147.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -52.93 153.36 3.41 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.539 0.736 . . . . 0.0 112.713 144.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.3 p -151.58 150.92 30.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.755 2.022 . . . . 0.0 111.401 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.92 -167.81 32.25 Favored Glycine 0 CA--C 1.542 1.756 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.61 84.28 0.09 OUTLIER 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.255 3.303 . . . . 0.0 113.765 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -68.51 42.5 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 127.08 2.152 . . . . 0.0 115.945 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -146.16 102.61 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 119.959 -1.713 . . . . 0.0 113.175 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.4 m -60.58 158.05 13.16 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.76 151.69 33.35 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.986 1.314 . . . . 0.0 112.487 161.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.2 t -59.58 166.92 2.21 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.31 -59.49 0.26 Allowed Glycine 0 CA--C 1.546 2.011 0 C-N-CA 124.271 0.938 . . . . 0.0 113.469 -161.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.5 p -72.1 150.8 43.56 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.747 1.219 . . . . 0.0 114.189 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.2 p -125.45 143.95 50.76 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.839 -1.163 . . . . 0.0 113.371 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.8 t -67.6 74.12 0.16 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.435 1.494 . . . . 0.0 110.407 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -22.59 6.37 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 119.375 3.102 . . . . 0.0 119.375 -151.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.297 6.8 p 41.76 47.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.94 -45.33 90.69 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.687 1.595 . . . . 0.0 112.459 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -154.07 163.67 23.26 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 125.295 1.438 . . . . 0.0 110.9 168.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.35 -19.35 21.76 Favored 'Trans proline' 0 CA--C 1.556 1.594 0 C-N-CA 122.256 1.971 . . . . 0.0 116.831 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.47 -14.9 26.14 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 170.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -135.19 105.45 6.31 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.509 1.524 . . . . 0.0 113.299 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -121.15 96.65 5.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.03 2.532 . . . . 0.0 110.201 153.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -96.0 142.76 27.84 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.861 1.264 . . . . 0.0 111.772 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.3 m -68.66 87.88 0.34 Allowed 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.604 -1.31 . . . . 0.0 112.322 170.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.077 -1.439 . . . . 0.0 111.949 171.197 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -90.52 138.46 31.54 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.867 1.667 . . . . 0.0 112.069 171.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -66.87 173.9 3.3 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.781 1.633 . . . . 0.0 114.257 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.26 140.65 26.06 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.919 1.288 . . . . 0.0 112.475 167.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 63.78 42.57 6.07 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.86 130.74 9.23 Favored Glycine 0 CA--C 1.544 1.902 0 C-N-CA 126.001 1.763 . . . . 0.0 112.627 167.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -74.78 66.08 1.45 Allowed 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 119.639 1.72 . . . . 0.0 114.681 -172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.8 t -31.09 -39.16 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 129.682 3.193 . . . . 0.0 117.613 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.38 83.6 0.12 Allowed Glycine 0 CA--C 1.537 1.41 0 O-C-N 121.233 -0.917 . . . . 0.0 115.339 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.91 63.98 0.27 Allowed Glycine 0 CA--C 1.543 1.784 0 C-N-CA 124.582 1.087 . . . . 0.0 112.525 167.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.3 7.6 tt -74.01 27.3 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 119.405 3.113 . . . . 0.0 119.405 -128.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.82 -38.63 76.2 Favored Glycine 0 CA--C 1.544 1.876 0 O-C-N 120.408 -1.433 . . . . 0.0 111.945 138.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -50.1 150.01 2.56 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.103 1.361 . . . . 0.0 113.279 159.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.1 p -142.13 154.69 45.07 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.322 1.449 . . . . 0.0 111.856 166.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 17' ' ' THR . . . 158.46 -167.8 34.63 Favored Glycine 0 CA--C 1.542 1.747 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -65.54 69.64 0.34 Allowed 'Trans proline' 0 CA--C 1.554 1.505 0 C-N-CA 124.824 3.683 . . . . 0.0 114.36 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 15' ' ' GLY . 33.4 p -60.95 32.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -173.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.0 t -132.95 96.83 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 O-C-N 119.622 -1.924 . . . . 0.0 112.677 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.04 170.04 2.37 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 127.651 2.381 . . . . 0.0 117.163 -175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.7 120.0 29.7 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.953 1.701 . . . . 0.0 113.526 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 t -34.04 103.04 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.683 1.993 . . . . 0.0 115.43 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.23 -53.8 0.79 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.761 1.648 . . . . 0.0 110.715 -165.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.7 p -86.8 157.82 19.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.319 1.848 . . . . 0.0 112.955 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -142.85 165.2 28.03 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -73.15 74.48 1.26 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 128.245 2.618 . . . . 0.0 110.922 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -8.59 2.65 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 -154.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 14.9 p 30.49 63.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.0 mt -60.68 -34.76 74.82 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 120.474 -1.391 . . . . 0.0 113.06 167.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -171.21 159.16 5.19 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 127.802 2.441 . . . . 0.0 111.119 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -46.77 -34.02 14.98 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 124.061 3.174 . . . . 0.0 115.774 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.15 -27.39 66.39 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 172.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -144.07 104.91 4.19 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.583 1.553 . . . . 0.0 113.489 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 t -116.15 138.48 51.22 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.662 1.585 . . . . 0.0 111.837 146.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -138.44 148.81 44.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.562 1.945 . . . . 0.0 112.03 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.4 m -67.51 102.07 1.09 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.918 0.887 . . . . 0.0 111.783 168.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.894 2.078 . . . . 0.0 112.085 174.166 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -99.22 129.29 45.45 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.63 1.572 . . . . 0.0 112.365 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -53.69 154.82 3.5 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.966 1.706 . . . . 0.0 115.163 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -49.35 133.07 20.17 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.803 0.841 . . . . 0.0 111.337 164.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 73.08 -23.55 0.21 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.438 2.295 . . . . 0.0 115.73 -167.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.4 112.0 2.11 Favored Glycine 0 CA--C 1.545 1.958 0 O-C-N 120.505 -1.372 . . . . 0.0 113.823 171.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -76.86 123.95 27.0 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -166.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 71.8 m -62.9 -44.77 95.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.803 1.241 . . . . 0.0 114.015 173.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.89 -129.28 4.26 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.562 2.029 . . . . 0.0 112.683 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.47 54.5 19.36 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 121.686 -0.891 . . . . 0.0 110.874 -151.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -49.08 121.14 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.152 0.981 . . . . 0.0 113.021 -171.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.18 -50.39 0.89 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -142.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.94 163.05 0.54 Allowed 'General case' 0 CA--C 1.563 1.452 0 O-C-N 121.774 -0.839 . . . . 0.0 112.315 141.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.1 p -151.6 4.82 0.44 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.18 -134.07 8.22 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 116.794 1.477 . . . . 0.0 116.794 -171.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.91 138.42 16.6 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.624 2.883 . . . . 0.0 113.997 -167.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.4 p -105.68 -19.37 13.78 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.549 1.94 . . . . 0.0 115.217 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.36 96.65 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 O-C-N 120.174 -1.579 . . . . 0.0 114.03 -162.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.0 m -56.49 159.88 3.48 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.37 146.68 42.81 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.349 1.86 . . . . 0.0 113.777 167.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.0 t -59.79 111.74 1.57 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.765 1.226 . . . . 0.0 113.413 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.01 -55.18 0.52 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.1 1.809 . . . . 0.0 111.409 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 t -87.52 -176.58 5.64 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.673 1.589 . . . . 0.0 112.315 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -153.64 143.45 21.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.426 2.29 . . . . 0.0 110.672 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 t -58.08 81.17 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 127.582 2.353 . . . . 0.0 114.196 -171.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -74.48 83.99 1.99 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.505 1.922 . . . . 0.0 114.652 -164.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.91 76.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 C-N-CA 128.395 2.678 . . . . 0.0 115.608 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.7 -41.09 24.23 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.689 -1.257 . . . . 0.0 113.168 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -138.69 155.44 73.41 Favored Pre-proline 0 CA--C 1.553 1.093 0 O-C-N 120.756 -1.215 . . . . 0.0 112.765 173.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -38.58 -46.34 2.49 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.639 2.893 . . . . 0.0 115.027 165.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.91 -57.24 5.28 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -83.97 122.33 28.61 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.5 t -137.64 135.94 37.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.031 0.933 . . . . 0.0 111.43 149.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -129.4 147.5 51.23 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.253 1.421 . . . . 0.0 113.383 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.54 67.14 2.01 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 120.463 -1.398 . . . . 0.0 110.952 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 C--O 1.251 1.183 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.087 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -76.13 163.22 27.31 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 118.634 0.652 . . . . 0.0 110.855 153.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -87.1 -169.57 2.68 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -65.44 150.34 48.51 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.066 1.347 . . . . 0.0 111.184 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 61.1 16.07 6.81 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.37 126.07 7.95 Favored Glycine 0 CA--C 1.544 1.862 0 O-C-N 119.928 -1.732 . . . . 0.0 113.353 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -71.7 92.17 1.17 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.774 1.229 . . . . 0.0 111.616 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 p -103.78 12.62 34.37 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.682 2.393 . . . . 0.0 114.196 -169.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.04 68.83 0.07 OUTLIER Glycine 0 CA--C 1.544 1.894 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.82 88.08 0.47 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 162.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.1 mt -53.23 108.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 118.459 1.129 . . . . 0.0 112.838 -161.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.81 -42.28 1.27 Allowed Glycine 0 CA--C 1.544 1.885 0 C-N-CA 125.302 1.43 . . . . 0.0 111.228 -153.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -179.84 0.24 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.038 0.935 . . . . 0.0 112.905 155.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.2 p -151.24 139.37 20.16 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.045 -1.034 . . . . 0.0 111.894 157.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.78 173.85 24.08 Favored Glycine 0 CA--C 1.544 1.896 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.2 113.28 1.13 Allowed 'Trans proline' 0 CA--C 1.546 1.115 1 C-N-CA 125.329 4.019 . . . . 0.0 117.332 -168.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.4 p -82.74 20.73 1.1 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 128.706 2.802 . . . . 0.0 116.137 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.23 114.35 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 120.043 -1.661 . . . . 0.0 113.059 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.2 m -83.19 174.75 10.5 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 127.64 2.376 . . . . 0.0 116.643 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 117.86 9.81 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.645 1.578 . . . . 0.0 112.812 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -39.3 113.01 0.29 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.187 1.395 . . . . 0.0 114.283 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.8 -25.76 7.46 Favored Glycine 0 CA--C 1.545 1.955 0 C-N-CA 124.762 1.173 . . . . 0.0 114.319 -162.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.3 p -124.94 149.92 47.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.182 1.793 . . . . 0.0 114.398 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.1 m -115.74 137.39 52.13 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.795 2.838 . . . . 0.0 112.544 -173.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.84 84.03 0.31 Allowed 'General case' 0 CA--C 1.559 1.316 0 O-C-N 120.266 -1.521 . . . . 0.0 112.435 172.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -55.63 171.23 0.22 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 118.673 2.842 . . . . 0.0 118.673 -161.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.48 49.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.598 -1.314 . . . . 0.0 113.872 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.17 -50.62 67.42 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.711 1.604 . . . . 0.0 112.96 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -162.51 161.7 19.79 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 126.646 1.978 . . . . 0.0 110.118 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -56.81 -13.13 10.53 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.051 2.501 . . . . 0.0 117.323 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.53 -23.14 17.81 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 125.664 1.585 . . . . 0.0 114.831 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -115.0 97.4 6.2 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.64 1.576 . . . . 0.0 112.036 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.6 t -113.91 120.01 39.22 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.966 0.906 . . . . 0.0 110.774 148.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -130.26 146.3 51.85 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.909 1.684 . . . . 0.0 111.843 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.1 m -63.9 85.8 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 36' ' ' LEU . 40.5 mt . . . . . 0 C--O 1.25 1.088 0 C-N-CA 127.931 2.492 . . . . 0.0 112.81 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 44.5 p . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 118.852 -0.594 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -63.01 168.6 3.91 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 119.749 1.159 . . . . 0.0 112.051 147.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -117.97 -173.98 2.55 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.413 1.485 . . . . 0.0 110.915 163.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -47.89 135.24 12.54 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.123 0.969 . . . . 0.0 112.653 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 75.45 1.58 3.67 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.642 2.377 . . . . 0.0 114.838 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.06 114.52 4.79 Favored Glycine 0 CA--C 1.541 1.703 0 O-C-N 118.094 -2.879 . . . . 0.0 116.326 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -53.94 139.75 33.02 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 118.473 1.137 . . . . 0.0 112.924 160.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 p -154.8 -13.89 0.12 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -163.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.46 72.67 0.11 Allowed Glycine 0 CA--C 1.542 1.774 0 N-CA-C 117.358 1.703 . . . . 0.0 117.358 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.27 114.64 0.62 Allowed Glycine 0 CA--C 1.543 1.789 0 C-N-CA 125.918 1.723 . . . . 0.0 111.571 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 mm -54.38 115.96 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 118.875 1.337 . . . . 0.0 112.987 -170.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.63 -48.49 0.94 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 125.592 1.568 . . . . 0.0 110.255 -154.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.16 168.48 6.71 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 121.786 -0.832 . . . . 0.0 112.16 158.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.5 p -153.35 148.76 27.12 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.123 -0.986 . . . . 0.0 111.926 152.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.87 -165.97 24.1 Favored Glycine 0 CA--C 1.544 1.897 0 C-N-CA 124.268 0.937 . . . . 0.0 115.246 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.43 156.37 21.97 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 124.153 3.235 . . . . 0.0 114.057 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 p -129.28 54.74 1.79 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.305 1.042 . . . . 0.0 113.383 -169.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.5 t -152.14 122.43 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 121.089 -1.007 . . . . 0.0 113.017 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.2 m -82.18 172.12 13.53 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.62 2.082 . . . . 0.0 116.62 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.81 117.05 23.03 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.709 1.604 . . . . 0.0 112.763 168.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 t -47.38 136.27 9.77 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.93 -65.18 0.25 Allowed Glycine 0 CA--C 1.541 1.675 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -151.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.8 p -88.64 161.0 17.12 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.539 1.135 . . . . 0.0 113.516 171.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 t -149.48 166.54 28.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.454 -1.404 . . . . 0.0 113.67 170.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 t -82.1 85.81 6.71 Favored 'General case' 0 CA--C 1.552 1.058 0 O-C-N 120.244 -1.535 . . . . 0.0 113.771 -166.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -88.38 90.73 8.52 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 122.353 1.073 . . . . 0.0 113.678 -163.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -70.9 81.46 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -176.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.44 -47.31 82.15 Favored 'General case' 0 CA--C 1.555 1.141 0 O-C-N 120.324 -1.485 . . . . 0.0 114.929 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.82 144.79 1.57 Allowed Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 125.503 1.521 . . . . 0.0 111.259 -169.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . 0.278 8.2 Cg_endo -48.92 -37.91 37.58 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 124.246 3.298 . . . . 0.0 119.176 -153.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.87 -40.14 95.84 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 120.323 1.42 . . . . 0.0 113.652 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -91.06 154.76 19.17 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.469 1.908 . . . . 0.0 113.36 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.4 t 158.79 112.94 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 128.687 2.795 . . . . 0.0 111.158 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -151.95 148.28 27.56 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -153.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 m -79.08 92.31 5.0 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.166 1.787 . . . . 0.0 112.004 168.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.271 -1.824 . . . . 0.0 111.767 165.845 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -79.02 142.54 36.49 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.271 1.828 . . . . 0.0 111.916 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -73.16 159.01 34.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.668 1.587 . . . . 0.0 115.193 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -40.03 136.86 1.07 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 126.069 1.747 . . . . 0.0 113.107 166.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 66.89 -11.11 0.27 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -174.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.12 152.17 20.0 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-N 120.433 1.47 . . . . 0.0 114.133 168.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -89.04 114.01 25.17 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 117.679 0.739 . . . . 0.0 112.031 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.4 t -92.59 -44.39 8.63 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 126.755 2.022 . . . . 0.0 115.57 -171.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.08 35.38 0.45 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 119.423 2.529 . . . . 0.0 119.423 -168.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.62 66.08 2.75 Favored Glycine 0 CA--C 1.545 1.948 0 CA-C-N 119.301 1.55 . . . . 0.0 113.447 175.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.4 mt -41.35 115.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.568 1.547 . . . . 0.0 113.825 -167.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.69 -54.27 0.79 Allowed Glycine 0 N--CA 1.476 1.324 0 N-CA-C 108.291 -1.923 . . . . 0.0 108.291 -151.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -55.91 156.69 4.97 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 121.498 0.666 . . . . 0.0 112.311 140.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.7 p -143.94 138.54 28.56 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.004 1.722 . . . . 0.0 111.115 162.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.26 -174.64 44.93 Favored Glycine 0 CA--C 1.55 2.223 0 N-CA-C 116.584 1.394 . . . . 0.0 116.584 -174.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -65.98 80.46 0.28 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 125.043 3.829 . . . . 0.0 114.202 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.3 p -63.79 33.15 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -167.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.0 t -139.02 93.79 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 O-C-N 119.566 -1.958 . . . . 0.0 114.182 -171.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.8 m -58.79 159.21 7.06 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.046 2.138 . . . . 0.0 115.991 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.33 158.56 11.53 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.116 1.366 . . . . 0.0 113.065 164.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.7 t -69.96 176.34 3.8 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.17 -58.25 2.33 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 121.023 -1.048 . . . . 0.0 112.828 -166.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.4 169.55 17.07 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 126.228 1.811 . . . . 0.0 113.201 168.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.1 t -134.95 170.1 16.39 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.847 2.459 . . . . 0.0 114.832 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.5 t -86.12 69.19 10.47 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 127.889 2.476 . . . . 0.0 112.194 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -54.26 160.75 1.53 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 118.974 2.953 . . . . 0.0 118.974 -161.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.11 59.4 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 127.41 2.284 . . . . 0.0 112.857 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.42 -55.03 6.91 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.304 -1.497 . . . . 0.0 112.695 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -157.32 152.67 21.93 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 126.719 2.007 . . . . 0.0 109.975 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -51.13 -28.81 26.47 Favored 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 122.886 2.391 . . . . 0.0 117.536 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.43 -18.14 63.01 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 120.585 1.539 . . . . 0.0 114.904 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -124.89 135.37 52.81 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.531 2.332 . . . . 0.0 112.997 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 t -158.59 108.25 2.01 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.041 -1.037 . . . . 0.0 109.778 165.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -119.52 149.49 41.82 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.043 1.737 . . . . 0.0 111.596 -166.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -66.46 84.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.224 0.609 . . . . 0.0 112.0 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 C--O 1.252 1.21 0 C-N-CA 127.118 2.167 . . . . 0.0 112.563 -177.834 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -95.81 132.78 40.7 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.03 1.732 . . . . 0.0 111.813 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 m -65.29 170.33 4.83 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -50.97 132.95 27.5 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.86 1.264 . . . . 0.0 111.918 167.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 67.55 53.09 0.74 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.643 1.977 . . . . 0.0 115.324 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.33 126.07 5.82 Favored Glycine 0 CA--C 1.543 1.819 0 C-N-CA 126.384 1.945 . . . . 0.0 111.945 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -74.1 60.77 0.8 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 119.517 1.658 . . . . 0.0 114.086 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.8 t -16.07 -59.62 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.928 3.291 . . . . 0.0 117.495 172.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.05 79.85 0.21 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.402 1.001 . . . . 0.0 112.992 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.5 60.58 0.47 Allowed Glycine 0 CA--C 1.543 1.8 0 C-N-CA 124.99 1.281 . . . . 0.0 111.421 163.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.6 mt -49.39 112.46 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 125.163 1.385 . . . . 0.0 113.804 -156.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.99 -53.19 0.79 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -150.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -50.54 154.07 1.43 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 121.634 0.73 . . . . 0.0 112.165 137.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 p -149.27 151.06 33.56 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.81 1.644 . . . . 0.0 111.141 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.76 -168.04 31.08 Favored Glycine 0 CA--C 1.549 2.159 0 C-N-CA 124.718 1.151 . . . . 0.0 113.572 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.16 113.78 1.74 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.228 3.285 . . . . 0.0 113.82 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -99.38 16.26 23.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -124.7 96.95 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.688 -1.258 . . . . 0.0 112.847 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.1 m -60.47 160.03 9.46 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.296 1.838 . . . . 0.0 115.683 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.6 165.21 5.16 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.112 1.365 . . . . 0.0 113.411 164.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.9 t -75.68 173.67 10.77 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 169.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.35 -63.06 0.16 Allowed Glycine 0 CA--C 1.539 1.581 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -159.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.9 p -62.95 168.92 3.61 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.577 1.551 . . . . 0.0 114.53 167.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -153.38 158.29 41.27 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.906 1.282 . . . . 0.0 112.525 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.8 t -63.46 75.81 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.757 1.223 . . . . 0.0 111.069 170.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.22 89.53 0.87 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.703 1.201 . . . . 0.0 111.892 -165.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.18 94.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 C-N-CA 126.215 1.806 . . . . 0.0 113.485 170.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -96.41 -44.03 7.38 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.416 1.486 . . . . 0.0 111.012 168.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -147.2 156.55 46.55 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 126.852 2.061 . . . . 0.0 112.347 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -40.52 -45.16 4.51 Favored 'Trans proline' 0 CA--C 1.554 1.514 0 C-N-CA 123.887 3.058 . . . . 0.0 115.748 159.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.01 -16.02 61.07 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 171.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -140.51 90.64 2.37 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.316 1.846 . . . . 0.0 112.675 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.4 t -109.31 124.59 51.18 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.237 -0.915 . . . . 0.0 111.063 148.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -138.27 141.58 39.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.728 1.211 . . . . 0.0 113.696 -168.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.3 79.67 0.06 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.678 1.591 . . . . 0.0 112.712 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.072 0.949 . . . . 0.0 112.408 165.219 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -80.37 144.27 32.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.048 1.339 . . . . 0.0 111.588 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -88.3 172.28 9.54 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -41.39 132.54 2.67 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 127.579 2.352 . . . . 0.0 113.191 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 67.1 -13.16 0.21 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.68 141.42 44.64 Favored Glycine 0 CA--C 1.55 2.234 0 O-C-N 120.063 -1.648 . . . . 0.0 112.911 167.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -75.48 108.37 8.24 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.999 -1.295 . . . . 0.0 113.318 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.6 t -74.6 -37.88 62.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.444 1.898 . . . . 0.0 112.94 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.23 158.84 28.44 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-O 123.07 1.372 . . . . 0.0 114.923 -173.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.67 46.71 0.02 OUTLIER Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.521 2.01 . . . . 0.0 110.342 -169.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.7 mt -50.8 117.89 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.836 1.254 . . . . 0.0 112.268 -158.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.54 -59.52 0.69 Allowed Glycine 0 CA--C 1.536 1.399 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -148.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.21 156.27 5.86 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-O 121.737 0.779 . . . . 0.0 112.264 145.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.6 p -138.68 147.98 43.43 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.251 1.82 . . . . 0.0 110.343 160.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.31 -161.85 32.0 Favored Glycine 0 CA--C 1.543 1.804 0 O-C-N 120.65 -1.281 . . . . 0.0 115.615 -175.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -71.16 79.09 1.42 Allowed 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.631 2.887 . . . . 0.0 113.605 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.2 p -71.18 25.82 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 -167.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 t -140.61 100.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 119.742 -1.849 . . . . 0.0 113.659 -173.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m -63.64 163.58 11.12 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.7 122.48 28.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.72 1.608 . . . . 0.0 113.093 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.9 t -44.34 135.21 4.69 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.9 1.28 . . . . 0.0 114.109 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.97 -40.97 2.28 Favored Glycine 0 CA--C 1.545 1.943 0 C-N-CA 124.209 0.909 . . . . 0.0 112.58 -154.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p -118.06 151.32 37.76 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.851 1.66 . . . . 0.0 114.264 175.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.8 m -109.58 142.95 39.96 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.02 2.528 . . . . 0.0 113.668 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.9 t -73.28 84.2 1.4 Allowed 'General case' 0 CA--C 1.552 1.021 0 O-C-N 121.101 -0.999 . . . . 0.0 111.099 167.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -57.79 178.28 0.09 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.59 49.95 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.479 1.133 . . . . 0.0 112.678 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.72 -44.49 96.09 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.563 1.545 . . . . 0.0 111.931 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -142.65 160.33 54.08 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.724 1.61 . . . . 0.0 110.065 159.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -45.05 -39.52 14.83 Favored 'Trans proline' 0 CA--C 1.555 1.53 0 C-N-CA 122.051 1.834 . . . . 0.0 113.203 161.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.91 -25.95 63.0 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -122.18 90.63 3.34 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.836 1.655 . . . . 0.0 111.948 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.0 t -116.23 107.28 14.66 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.973 0.892 . . . . 0.0 111.838 158.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -113.32 152.89 29.34 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.352 1.861 . . . . 0.0 111.552 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.27 84.97 0.15 Allowed 'General case' 0 CA--C 1.55 0.953 0 O-C-N 121.374 -0.829 . . . . 0.0 112.673 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 C--O 1.25 1.129 0 C-N-CA 128.81 2.844 . . . . 0.0 111.835 179.584 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -71.97 141.47 49.4 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.619 0.767 . . . . 0.0 111.987 166.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -91.55 155.69 18.2 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -38.16 132.03 1.07 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 127.181 2.192 . . . . 0.0 113.528 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 67.65 -27.52 0.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -170.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -42.58 119.91 2.26 Favored Glycine 0 CA--C 1.545 1.934 0 O-C-N 120.674 -1.267 . . . . 0.0 113.879 171.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -75.47 136.65 40.65 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.688 1.195 . . . . 0.0 111.959 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.0 p -144.67 28.36 1.3 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.369 1.067 . . . . 0.0 113.737 -166.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.05 69.97 0.03 OUTLIER Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.686 1.612 . . . . 0.0 114.981 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.25 86.17 0.4 Allowed Glycine 0 N--CA 1.471 0.996 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 152.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.6 mt -53.92 110.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 118.901 1.351 . . . . 0.0 111.987 -164.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.15 -48.59 0.86 Allowed Glycine 0 CA--C 1.544 1.89 0 C-N-CA 125.032 1.301 . . . . 0.0 110.401 -149.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.68 170.81 1.32 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.498 1.119 . . . . 0.0 112.718 153.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.2 p -152.27 147.61 26.57 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.425 -0.797 . . . . 0.0 111.957 158.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.55 175.89 25.39 Favored Glycine 0 CA--C 1.54 1.602 0 N-CA-C 115.319 0.888 . . . . 0.0 115.319 175.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.6 122.39 3.95 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.826 3.684 . . . . 0.0 114.595 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.3 p -83.32 -55.38 4.36 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.4 1.88 . . . . 0.0 113.117 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.2 t -66.0 111.36 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 C-N-CA 125.46 1.504 . . . . 0.0 114.102 -170.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.4 m -73.25 172.68 10.71 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.48 130.03 38.86 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 126.47 1.908 . . . . 0.0 114.087 172.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -52.14 113.78 1.13 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.244 1.018 . . . . 0.0 112.982 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.44 -45.23 1.03 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.034 1.302 . . . . 0.0 111.915 -163.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.4 p -127.41 -176.35 3.72 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 127.348 2.259 . . . . 0.0 111.827 170.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -148.06 155.44 41.49 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 119.358 -2.089 . . . . 0.0 112.344 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.7 t -69.46 77.32 0.4 Allowed 'General case' 0 CA--C 1.557 1.245 0 O-C-N 120.421 -1.424 . . . . 0.0 111.032 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -70.7 87.27 0.68 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.428 1.491 . . . . 0.0 113.624 -167.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.9 93.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.269 1.027 . . . . 0.0 113.757 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -93.5 -39.83 10.66 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.356 1.462 . . . . 0.0 111.408 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -150.39 163.67 23.38 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.934 1.694 . . . . 0.0 113.308 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.31 -14.66 35.66 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 123.357 2.705 . . . . 0.0 114.938 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.9 -11.91 27.82 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 125.974 1.71 . . . . 0.0 115.026 165.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -140.88 97.3 3.16 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.163 1.785 . . . . 0.0 112.767 -175.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -119.96 136.25 54.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.273 1.029 . . . . 0.0 110.702 145.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -146.44 146.14 30.47 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.216 1.406 . . . . 0.0 112.578 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.9 m -70.52 81.44 0.58 Allowed 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 176.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.8 mt . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.219 1.808 . . . . 0.0 115.359 177.681 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -72.21 141.73 49.01 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.879 0.872 . . . . 0.0 111.763 167.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.5 m -65.54 148.88 51.0 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -47.2 133.71 11.72 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.237 0.615 . . . . 0.0 111.545 157.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 63.06 53.57 2.3 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.759 1.224 . . . . 0.0 113.883 -169.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.08 117.76 2.67 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 124.923 1.249 . . . . 0.0 114.036 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -67.73 63.93 0.08 Allowed 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 125.538 1.535 . . . . 0.0 114.552 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.2 p -66.24 43.73 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 128.146 2.578 . . . . 0.0 115.689 174.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.68 78.93 0.03 OUTLIER Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.666 -1.271 . . . . 0.0 113.591 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.33 88.52 0.39 Allowed Glycine 0 CA--C 1.534 1.236 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 148.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.2 mt -50.63 108.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 119.746 1.773 . . . . 0.0 113.089 -163.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.28 -48.51 0.86 Allowed Glycine 0 CA--C 1.544 1.886 0 C-N-CA 125.612 1.577 . . . . 0.0 110.081 -152.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.57 166.07 0.14 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.156 0.982 . . . . 0.0 112.624 145.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.6 p -152.32 157.99 42.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.29 1.036 . . . . 0.0 111.468 156.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.39 -175.11 20.64 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -46.23 115.36 1.11 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 125.063 3.842 . . . . 0.0 115.024 -173.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.7 p -72.35 -65.94 0.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.008 1.723 . . . . 0.0 112.414 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -50.22 107.29 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 126.799 2.04 . . . . 0.0 114.31 -169.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.0 m -66.0 179.22 0.94 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 128.196 2.598 . . . . 0.0 117.119 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 129.28 37.52 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.685 1.594 . . . . 0.0 111.36 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -45.13 112.86 0.49 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.47 -44.78 1.37 Allowed Glycine 0 CA--C 1.549 2.162 0 C-N-CA 125.444 1.497 . . . . 0.0 113.68 -167.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 p -89.87 148.02 23.41 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 127.0 2.12 . . . . 0.0 113.198 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 m -124.56 142.26 51.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.324 1.85 . . . . 0.0 113.927 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -73.19 83.73 1.35 Allowed 'General case' 0 CA--C 1.554 1.109 0 O-C-N 120.357 -1.464 . . . . 0.0 111.257 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -12.81 8.59 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 -150.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.304 7.9 p 39.45 46.24 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 126.936 2.094 . . . . 0.0 115.5 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.07 -45.06 74.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.014 1.326 . . . . 0.0 111.801 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -136.61 157.11 75.76 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.111 1.364 . . . . 0.0 110.196 159.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.7 -16.94 16.34 Favored 'Trans proline' 0 CA--C 1.558 1.701 0 C-N-CA 122.318 2.012 . . . . 0.0 114.974 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.43 -18.23 25.77 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 127.165 2.186 . . . . 0.0 115.811 167.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -140.79 93.94 2.66 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.042 1.737 . . . . 0.0 112.606 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 t -122.35 91.64 3.55 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.052 1.741 . . . . 0.0 111.239 167.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.96 146.07 24.19 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.815 1.246 . . . . 0.0 113.735 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.9 m -66.07 95.13 0.26 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.328 -0.857 . . . . 0.0 111.929 156.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.9 mt . . . . . 0 C--O 1.257 1.462 0 CA-C-O 117.049 -1.453 . . . . 0.0 110.511 161.446 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.949 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -70.95 153.11 42.94 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 119.584 1.084 . . . . 0.0 112.156 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 m -74.58 161.36 29.8 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.59 1.556 . . . . 0.0 114.873 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -50.42 132.61 24.94 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.305 1.042 . . . . 0.0 110.696 159.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 63.39 65.57 0.75 Allowed 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -171.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.43 -89.54 0.03 OUTLIER Glycine 0 CA--C 1.555 2.557 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -84.84 170.96 12.63 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 129.607 3.163 . . . . 0.0 115.153 -6.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.97 11.44 13.41 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 128.053 2.541 . . . . 0.0 114.865 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.18 -164.29 10.78 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 126.487 1.994 . . . . 0.0 114.837 169.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.97 60.53 3.33 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.969 -0.724 . . . . 0.0 112.121 -164.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.3 mt -51.43 108.49 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 126.032 1.733 . . . . 0.0 111.745 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.38 -47.56 0.87 Allowed Glycine 0 CA--C 1.541 1.699 0 C-N-CA 124.705 1.145 . . . . 0.0 110.331 -147.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.33 164.42 0.96 Allowed 'General case' 0 CA--C 1.554 1.099 0 O-C-N 121.893 -0.769 . . . . 0.0 111.156 139.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.3 p -154.58 164.13 39.17 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.537 1.135 . . . . 0.0 111.972 164.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.19 179.22 19.01 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 116.052 1.181 . . . . 0.0 116.052 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -50.68 119.7 5.53 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 125.239 3.959 . . . . 0.0 116.648 -168.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.7 p -77.39 -39.53 46.91 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.626 1.57 . . . . 0.0 114.631 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.76 102.31 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 125.045 1.338 . . . . 0.0 114.393 -161.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -85.46 -177.92 6.57 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.18 146.2 55.27 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.73 1.612 . . . . 0.0 113.622 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.4 p -77.43 73.58 4.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.025 -1.047 . . . . 0.0 111.832 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.02 -50.71 0.04 OUTLIER Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.956 1.741 . . . . 0.0 110.764 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.2 p -74.08 177.44 5.71 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.564 1.146 . . . . 0.0 113.482 161.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.8 m -148.25 143.31 26.89 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.821 -1.174 . . . . 0.0 113.975 165.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.3 t -64.76 86.42 0.05 Allowed 'General case' 0 CA--C 1.558 1.278 0 O-C-N 120.414 -1.429 . . . . 0.0 111.954 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.12 161.15 11.45 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -160.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.09 134.54 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 O-C-N 120.629 -1.295 . . . . 0.0 111.253 164.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -152.68 -53.43 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.241 1.017 . . . . 0.0 111.866 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -158.04 164.09 22.46 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 124.772 1.229 . . . . 0.0 111.091 165.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -41.63 -42.3 5.99 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.808 3.006 . . . . 0.0 115.818 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.11 -4.67 18.21 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -143.65 118.1 9.7 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.751 1.621 . . . . 0.0 113.645 -170.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 t -135.48 95.59 3.29 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.38 -0.825 . . . . 0.0 110.996 153.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -109.8 150.12 28.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.893 1.277 . . . . 0.0 113.148 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.2 m -79.08 89.56 4.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.617 1.167 . . . . 0.0 113.064 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.258 1.513 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.98 163.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -69.57 136.25 51.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.938 1.695 . . . . 0.0 111.492 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -75.83 158.38 32.22 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -49.92 132.65 22.76 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.145 1.378 . . . . 0.0 111.619 167.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 64.5 42.44 5.01 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.03 129.15 6.43 Favored Glycine 0 CA--C 1.544 1.881 0 C-N-CA 125.844 1.688 . . . . 0.0 112.872 168.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -66.72 72.73 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.219 1.51 . . . . 0.0 114.589 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.7 t -31.31 -54.77 0.24 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 128.127 2.571 . . . . 0.0 116.012 171.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.74 45.69 0.5 Allowed Glycine 0 CA--C 1.539 1.566 0 N-CA-C 118.095 1.998 . . . . 0.0 118.095 -168.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.22 65.52 1.27 Allowed Glycine 0 CA--C 1.546 1.981 0 O-C-N 121.159 -1.2 . . . . 0.0 113.723 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.2 mt -44.1 114.27 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 118.984 1.392 . . . . 0.0 113.892 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.1 -54.62 0.78 Allowed Glycine 0 CA--C 1.537 1.425 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -154.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.82 160.72 4.34 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 122.071 0.939 . . . . 0.0 111.757 139.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.0 p -148.54 149.37 31.48 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.15 1.78 . . . . 0.0 111.138 163.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 17' ' ' THR . . . 163.07 -166.95 37.21 Favored Glycine 0 CA--C 1.546 2.007 0 O-C-N 120.96 -1.087 . . . . 0.0 114.949 -175.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.73 80.97 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.894 3.062 . . . . 0.0 113.027 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 15' ' ' GLY . 25.7 p -70.73 33.0 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 118.151 2.648 . . . . 0.0 118.151 -166.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 t -137.93 96.28 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 O-C-N 120.132 -1.605 . . . . 0.0 113.317 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.47 156.87 7.41 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.19 167.12 0.13 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.997 0.919 . . . . 0.0 112.71 153.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.8 t -82.75 -178.02 6.94 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.47 -66.07 1.02 Allowed Glycine 0 CA--C 1.539 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 111.898 -165.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.42 161.25 30.0 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.352 1.461 . . . . 0.0 114.069 170.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.7 p -128.94 151.12 50.02 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 130.936 3.694 . . . . 0.0 111.839 -168.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.6 t -74.42 74.94 1.91 Allowed 'General case' 0 CA--C 1.559 1.29 0 O-C-N 120.238 -1.538 . . . . 0.0 111.571 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -63.71 165.15 8.72 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -167.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 p -137.13 105.83 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 C-N-CA 125.534 1.533 . . . . 0.0 114.558 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.86 -50.33 6.1 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.451 1.5 . . . . 0.0 111.899 167.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.76 157.17 36.11 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 128.013 2.525 . . . . 0.0 108.85 171.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -50.07 -39.62 50.78 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 122.844 2.363 . . . . 0.0 115.107 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -50.96 -25.4 4.62 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -122.56 135.6 54.67 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.08 2.152 . . . . 0.0 113.342 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.74 111.18 1.15 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.229 -0.919 . . . . 0.0 113.427 165.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -122.71 151.75 41.25 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.47 1.908 . . . . 0.0 112.75 -169.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.5 m -61.79 88.88 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.9 0.48 . . . . 0.0 111.378 168.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.256 1.432 0 C-N-CA 128.456 2.702 . . . . 0.0 112.638 174.953 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -90.36 133.29 35.08 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 127.303 2.241 . . . . 0.0 111.276 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.1 p -75.81 166.67 23.18 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.938 1.695 . . . . 0.0 113.784 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -58.83 147.27 34.26 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 58.39 -11.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -161.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.06 122.67 24.32 Favored Glycine 0 CA--C 1.542 1.747 0 O-C-N 119.687 -1.883 . . . . 0.0 113.65 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -68.42 76.51 0.26 Allowed 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 118.946 1.373 . . . . 0.0 112.632 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . 52.5 t -51.19 -31.2 19.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.037 1.735 . . . . 0.0 115.373 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.75 106.86 0.29 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 117.498 1.759 . . . . 0.0 117.498 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.45 85.43 0.34 Allowed Glycine 0 CA--C 1.534 1.237 0 O-C-N 120.895 -1.356 . . . . 0.0 109.961 154.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.3 mt -49.84 113.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 118.903 1.351 . . . . 0.0 113.052 -161.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.64 -45.94 1.1 Allowed Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.339 1.447 . . . . 0.0 110.6 -151.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.69 171.5 0.21 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 125.273 1.429 . . . . 0.0 112.714 153.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.8 p -153.63 174.47 14.44 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.693 1.197 . . . . 0.0 111.505 160.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 -175.29 19.55 Favored Glycine 0 CA--C 1.546 2.031 0 C-N-CA 124.233 0.92 . . . . 0.0 114.353 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.03 100.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 124.626 3.551 . . . . 0.0 116.804 -168.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -83.55 22.78 1.02 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.964 2.506 . . . . 0.0 114.2 -175.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -149.09 114.27 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 120.171 -1.581 . . . . 0.0 111.924 -173.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.0 m -70.14 167.13 18.45 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.93 140.29 38.09 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.662 1.585 . . . . 0.0 113.81 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 t -49.94 111.93 0.59 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.359 1.064 . . . . 0.0 113.55 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.94 -47.26 1.0 Allowed Glycine 0 CA--C 1.543 1.838 0 C-N-CA 125.34 1.448 . . . . 0.0 112.921 -164.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.63 149.61 40.41 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.294 2.237 . . . . 0.0 113.055 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.4 m -121.05 142.01 50.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.295 1.438 . . . . 0.0 112.749 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 t -57.52 88.85 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 126.31 1.844 . . . . 0.0 111.463 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -10.35 51.35 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -149.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.308 9.3 p 34.53 52.93 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 127.883 2.473 . . . . 0.0 116.663 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.0 -45.07 78.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.543 1.537 . . . . 0.0 112.413 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -152.28 169.77 9.03 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 125.49 1.516 . . . . 0.0 110.976 164.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -48.55 -33.11 22.77 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.257 2.638 . . . . 0.0 116.802 178.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.42 -10.76 48.13 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -137.68 101.5 4.49 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.456 1.502 . . . . 0.0 113.723 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 t -122.47 91.96 3.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.874 2.469 . . . . 0.0 110.505 158.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -92.65 152.4 19.57 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 120.503 -1.373 . . . . 0.0 112.588 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 76.1 m -78.21 78.13 4.69 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.697 -1.252 . . . . 0.0 110.989 162.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.188 -1.387 . . . . 0.0 112.485 161.671 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -79.24 145.06 33.79 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.953 1.301 . . . . 0.0 112.37 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.3 m -80.29 158.17 26.21 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.734 1.214 . . . . 0.0 113.82 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -38.59 132.55 1.14 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.875 1.67 . . . . 0.0 112.573 167.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 70.05 -23.12 0.16 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.69 137.72 45.46 Favored Glycine 0 CA--C 1.55 2.261 0 O-C-N 120.233 -1.542 . . . . 0.0 113.561 168.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -71.87 133.89 45.73 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 120.694 -1.474 . . . . 0.0 112.183 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.5 t -106.07 -33.34 7.91 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.73 2.012 . . . . 0.0 113.847 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.16 -166.45 23.07 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 120.664 -1.273 . . . . 0.0 115.769 -169.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.05 -98.2 0.97 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.147 1.832 . . . . 0.0 113.349 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.77 71.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 126.053 1.741 . . . . 0.0 114.604 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.19 41.68 2.18 Favored Glycine 0 CA--C 1.544 1.889 0 C-N-CA 125.611 1.576 . . . . 0.0 113.878 -173.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -80.94 132.27 35.4 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -150.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.2 p -96.1 -164.0 1.11 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.228 1.811 . . . . 0.0 113.389 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.06 -151.99 41.37 Favored Glycine 0 CA--C 1.551 2.329 0 O-C-N 119.67 -1.894 . . . . 0.0 115.863 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -71.64 62.02 2.93 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 123.993 3.128 . . . . 0.0 114.97 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.1 p -71.76 32.04 0.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -170.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -145.74 97.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 120.006 -1.684 . . . . 0.0 112.121 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.8 m -59.99 155.85 15.9 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.39 152.69 45.24 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.857 1.263 . . . . 0.0 112.622 162.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 t -62.3 171.37 1.89 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.21 -57.6 1.11 Allowed Glycine 0 CA--C 1.543 1.792 0 C-N-CA 124.172 0.891 . . . . 0.0 112.951 -164.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.7 p -76.52 145.95 38.76 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.1 m -99.09 142.28 30.79 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.806 2.043 . . . . 0.0 113.871 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.6 t -70.84 86.28 0.69 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.846 1.259 . . . . 0.0 110.82 163.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.436 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 23.5 mm-40 -64.08 177.39 0.81 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 117.875 2.546 . . . . 0.0 117.875 -165.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 p -140.37 50.75 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 122.515 1.15 . . . . 0.0 113.544 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -56.65 -44.6 81.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.328 1.851 . . . . 0.0 113.362 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -147.38 164.51 22.59 Favored Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 126.072 1.749 . . . . 0.0 110.02 162.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -43.37 -39.49 9.13 Favored 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 123.97 3.113 . . . . 0.0 116.969 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.17 -33.05 44.37 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -95.5 83.55 3.82 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.638 1.975 . . . . 0.0 113.523 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 t -105.16 104.93 14.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.643 0.777 . . . . 0.0 111.776 156.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -115.91 157.59 24.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.638 2.375 . . . . 0.0 112.16 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.9 m -71.26 79.83 0.72 Allowed 'General case' 0 CA--C 1.554 1.111 0 O-C-N 121.472 -0.767 . . . . 0.0 112.806 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.436 ' HB2' ' HG3' ' A' ' 26' ' ' GLN . 76.6 mt . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.432 1.893 . . . . 0.0 112.162 168.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -67.8 128.33 36.09 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.737 1.615 . . . . 0.0 111.572 174.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.3 m -72.12 161.96 30.14 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.953 1.301 . . . . 0.0 113.599 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -43.18 135.9 3.12 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.252 1.021 . . . . 0.0 113.115 172.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 69.83 -12.06 0.49 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.05 140.83 46.96 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.033 -1.667 . . . . 0.0 113.305 170.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.18 151.66 36.85 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.681 1.741 . . . . 0.0 112.875 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.7 t -127.62 -48.33 1.4 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.565 1.546 . . . . 0.0 113.062 -168.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.97 17.97 2.55 Favored Glycine 0 CA--C 1.548 2.106 0 N-CA-C 120.288 2.875 . . . . 0.0 120.288 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.11 68.69 2.82 Favored Glycine 0 CA--C 1.545 1.924 0 CA-C-N 120.756 2.278 . . . . 0.0 113.463 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.6 mt -46.3 128.66 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.664 1.185 . . . . 0.0 113.347 -173.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.13 -56.42 0.6 Allowed Glycine 0 N--CA 1.474 1.195 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -145.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.7 157.0 15.57 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.994 0.902 . . . . 0.0 112.586 150.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 p -140.8 137.48 33.36 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.694 1.598 . . . . 0.0 110.631 158.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.72 -173.04 46.0 Favored Glycine 0 CA--C 1.544 1.845 0 O-C-N 120.949 -1.095 . . . . 0.0 114.221 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -65.38 88.89 0.21 Allowed 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 123.414 2.743 . . . . 0.0 113.781 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 p -72.9 31.88 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -170.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.5 t -141.82 98.49 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 119.613 -1.93 . . . . 0.0 114.145 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m -65.85 157.26 30.97 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 96.47 0.47 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.178 1.391 . . . . 0.0 111.864 169.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 t -37.09 -13.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 119.913 3.301 . . . . 0.0 119.913 -166.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.07 -35.9 60.25 Favored Glycine 0 CA--C 1.547 2.032 0 CA-C-N 119.571 1.078 . . . . 0.0 113.685 160.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 p -111.12 173.43 6.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.846 2.058 . . . . 0.0 111.614 169.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 t -125.78 172.54 9.75 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.9 t -77.5 70.28 3.87 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.436 1.494 . . . . 0.0 110.973 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -57.64 167.61 1.04 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -169.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.83 117.06 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.035 1.334 . . . . 0.0 113.233 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -105.71 -53.32 2.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.562 1.545 . . . . 0.0 110.153 162.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.71 149.76 6.21 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.956 2.502 . . . . 0.0 110.426 176.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.82 17.76 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.587 0 C-N-CA 124.941 3.761 . . . . 0.0 118.458 -160.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.59 -27.94 12.8 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 126.087 1.755 . . . . 0.0 113.104 160.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -80.49 166.31 21.32 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.629 1.571 . . . . 0.0 112.467 161.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 t 153.63 81.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.032 2.533 . . . . 0.0 112.051 168.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -120.02 150.05 41.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.346 1.858 . . . . 0.0 112.585 -165.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.3 m -62.92 79.27 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.676 1.19 . . . . 0.0 113.309 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.258 1.538 0 C-N-CA 129.222 3.009 . . . . 0.0 112.267 178.233 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.26 136.12 39.65 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.755 1.222 . . . . 0.0 111.173 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -69.69 150.67 46.73 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.785 1.234 . . . . 0.0 113.929 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -42.88 133.93 3.48 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.939 1.695 . . . . 0.0 112.389 169.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 67.19 -13.73 0.2 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -171.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.02 126.69 33.88 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 120.202 -1.561 . . . . 0.0 113.628 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -75.76 132.18 40.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.039 0.936 . . . . 0.0 110.813 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.39 4.08 1.56 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -160.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.39 59.66 0.12 Allowed Glycine 0 CA--C 1.543 1.791 0 CA-C-N 118.771 0.714 . . . . 0.0 114.867 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.23 86.26 0.45 Allowed Glycine 0 N--CA 1.474 1.217 0 O-C-N 121.322 -1.105 . . . . 0.0 110.546 163.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.9 mt -54.19 109.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 118.81 1.305 . . . . 0.0 112.483 -162.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.87 -45.51 1.0 Allowed Glycine 0 CA--C 1.546 1.987 0 C-N-CA 125.364 1.459 . . . . 0.0 111.318 -151.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -177.43 0.49 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.305 1.442 . . . . 0.0 113.238 159.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.9 p -156.78 141.14 16.62 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.249 -0.907 . . . . 0.0 112.453 158.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.03 172.71 27.61 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 115.763 1.065 . . . . 0.0 115.763 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -45.88 117.83 2.02 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 125.065 3.843 . . . . 0.0 115.55 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.2 p -89.13 3.19 52.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.457 2.303 . . . . 0.0 115.782 -172.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 t -119.08 106.16 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.078 1.351 . . . . 0.0 112.697 -172.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.71 171.2 11.99 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 130.55 45.09 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.352 1.461 . . . . 0.0 113.634 167.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.3 t -55.06 117.47 3.49 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.138 -0.976 . . . . 0.0 112.025 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.15 -40.68 1.83 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.919 1.247 . . . . 0.0 113.008 -164.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.5 p -107.33 -178.87 3.76 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.875 1.27 . . . . 0.0 113.558 171.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -151.9 143.35 23.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.403 2.281 . . . . 0.0 111.673 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -67.3 82.33 0.14 Allowed 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.081 -1.637 . . . . 0.0 113.068 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -54.23 173.59 0.07 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.97 111.21 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.5 mt -98.81 -47.74 5.19 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.261 1.425 . . . . 0.0 112.32 166.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.21 161.84 29.6 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 126.785 2.034 . . . . 0.0 110.013 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.26 -9.31 6.33 Favored 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.118 1.879 . . . . 0.0 115.669 175.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.0 -18.93 23.8 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -120.66 107.58 12.97 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.841 1.656 . . . . 0.0 111.584 173.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.7 t -135.06 120.59 19.28 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.292 1.037 . . . . 0.0 112.333 156.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -136.7 145.15 44.39 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.149 2.179 . . . . 0.0 112.585 -164.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.3 m -64.67 84.13 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 120.64 -1.288 . . . . 0.0 114.123 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 C--O 1.252 1.19 0 C-N-CA 128.872 2.869 . . . . 0.0 113.167 173.95 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -102.36 138.62 39.05 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.426 1.49 . . . . 0.0 111.946 168.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 m -68.98 162.78 26.05 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.48 1.912 . . . . 0.0 114.958 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -47.63 137.66 8.97 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.598 1.159 . . . . 0.0 112.48 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 67.53 -15.49 0.18 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.957 2.103 . . . . 0.0 115.694 -168.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -50.27 132.07 29.57 Favored Glycine 0 CA--C 1.545 1.959 0 O-C-N 120.589 -1.319 . . . . 0.0 114.033 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.02 126.2 35.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.648 1.179 . . . . 0.0 112.196 -174.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.98 8.53 3.5 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -159.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.25 34.65 0.09 OUTLIER Glycine 0 CA--C 1.547 2.034 0 N-CA-C 117.642 1.817 . . . . 0.0 117.642 167.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.58 85.66 1.55 Allowed Glycine 0 CA--C 1.541 1.664 0 CA-C-N 119.028 1.414 . . . . 0.0 112.217 170.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.5 mt -53.9 118.2 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.988 1.315 . . . . 0.0 113.245 -164.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.18 -44.2 1.23 Allowed Glycine 0 CA--C 1.541 1.695 0 C-N-CA 125.238 1.399 . . . . 0.0 110.597 -153.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.42 173.71 3.86 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 160.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.1 p -157.98 85.07 0.88 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.969 -1.082 . . . . 0.0 112.429 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.4 167.83 33.04 Favored Glycine 0 CA--C 1.549 2.192 0 N-CA-C 116.426 1.331 . . . . 0.0 116.426 -169.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -63.61 113.42 2.12 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.977 3.785 . . . . 0.0 113.325 -170.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.5 p -72.26 -0.89 13.35 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -165.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 t -115.3 107.54 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 120.393 -1.442 . . . . 0.0 113.244 -167.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.7 m -66.24 168.36 8.79 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.07 151.37 47.01 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.964 1.305 . . . . 0.0 112.402 162.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -67.04 162.95 21.02 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.11 -56.88 4.8 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.811 1.196 . . . . 0.0 112.243 -168.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.59 162.9 17.75 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 127.672 2.389 . . . . 0.0 113.472 166.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 t -142.66 172.93 12.03 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.355 -1.466 . . . . 0.0 114.257 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 t -73.66 73.67 1.5 Allowed 'General case' 0 CA--C 1.555 1.166 0 O-C-N 120.58 -1.325 . . . . 0.0 113.269 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -66.4 93.3 0.22 Allowed 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.547 -1.346 . . . . 0.0 113.803 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.59 68.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 127.94 2.496 . . . . 0.0 115.408 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -62.46 -49.94 73.45 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 120.14 -1.6 . . . . 0.0 113.236 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -160.71 174.41 3.91 Favored Pre-proline 0 CA--C 1.569 1.675 0 O-C-N 120.641 -1.287 . . . . 0.0 114.448 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.41 -22.16 15.53 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.869 3.713 . . . . 0.0 118.189 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.1 -23.97 15.98 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.096 1.358 . . . . 0.0 113.508 170.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -120.72 93.63 4.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.992 1.717 . . . . 0.0 112.079 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 t -123.57 115.84 22.16 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.488 1.115 . . . . 0.0 109.747 150.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -148.04 147.13 29.25 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -158.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.5 m -67.55 78.79 0.18 Allowed 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.259 1.6 0 C-N-CA 125.397 1.479 . . . . 0.0 112.815 167.916 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -85.13 145.69 27.5 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.256 1.822 . . . . 0.0 111.916 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.2 p -80.42 159.83 25.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.955 1.702 . . . . 0.0 114.929 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -40.9 135.19 1.76 Allowed 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 126.09 1.756 . . . . 0.0 112.803 168.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 65.37 -21.25 0.09 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -171.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -45.31 121.78 4.93 Favored Glycine 0 CA--C 1.546 2.021 0 O-C-N 120.097 -1.627 . . . . 0.0 112.544 163.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.54 100.85 5.43 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.905 -1.35 . . . . 0.0 112.715 -173.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -65.61 -36.66 84.37 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 125.384 1.473 . . . . 0.0 114.503 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.04 -142.35 6.42 Favored Glycine 0 CA--C 1.548 2.152 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.45 50.43 37.95 Favored Glycine 0 CA--C 1.543 1.833 0 O-C-N 120.633 -1.51 . . . . 0.0 112.776 -159.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -51.33 118.4 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 125.685 1.594 . . . . 0.0 112.774 -169.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.53 -53.26 0.81 Allowed Glycine 0 CA--C 1.537 1.443 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -145.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -52.22 152.56 3.25 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 122.133 -0.628 . . . . 0.0 111.603 137.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.6 p -150.93 134.59 16.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.752 1.621 . . . . 0.0 110.728 166.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.26 -168.41 41.41 Favored Glycine 0 CA--C 1.549 2.167 0 O-C-N 121.173 -0.954 . . . . 0.0 114.872 -173.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.82 75.1 0.07 OUTLIER 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 125.153 3.902 . . . . 0.0 115.961 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.0 p -60.71 32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 128.954 2.902 . . . . 0.0 118.291 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 t -141.45 97.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 O-C-N 119.504 -1.997 . . . . 0.0 112.702 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.43 169.43 7.47 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.41 106.82 14.59 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.878 2.071 . . . . 0.0 113.971 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -35.17 114.29 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.288 1.435 . . . . 0.0 113.996 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.55 -45.34 1.16 Allowed Glycine 0 CA--C 1.543 1.832 0 C-N-CA 124.368 0.985 . . . . 0.0 112.314 -151.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.97 153.65 47.35 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.403 2.281 . . . . 0.0 112.107 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.7 m -111.04 156.86 20.66 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.054 2.542 . . . . 0.0 113.29 -174.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.6 t -63.23 77.19 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 O-C-N 120.128 -1.608 . . . . 0.0 110.72 165.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -77.88 92.28 4.24 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.242 1.017 . . . . 0.0 111.9 -158.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -63.98 59.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 128.035 2.534 . . . . 0.0 115.497 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -58.77 -46.45 87.46 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.659 -1.901 . . . . 0.0 111.703 170.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -145.29 153.31 52.18 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.786 1.634 . . . . 0.0 112.09 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.24 -36.03 96.02 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.133 2.555 . . . . 0.0 113.254 169.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.79 -6.59 2.78 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 166.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -130.11 -158.02 0.86 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 129.303 3.041 . . . . 0.0 109.288 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t 136.53 76.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 130.059 3.344 . . . . 0.0 108.285 159.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -97.26 155.29 16.93 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.032 1.333 . . . . 0.0 112.789 -164.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.4 m -70.4 78.73 0.55 Allowed 'General case' 0 CA--C 1.549 0.916 0 O-C-N 120.892 -1.13 . . . . 0.0 112.962 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.0 mt . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 116.711 -1.614 . . . . 0.0 114.592 162.921 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -89.01 133.07 34.46 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.769 2.028 . . . . 0.0 110.463 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 m -70.14 160.55 31.86 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.863 1.265 . . . . 0.0 114.345 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -49.77 134.34 20.65 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.254 1.022 . . . . 0.0 111.648 170.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 65.87 -8.0 0.34 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.0 125.09 38.77 Favored Glycine 0 CA--C 1.541 1.678 0 O-C-N 120.093 -1.629 . . . . 0.0 112.678 170.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.76 107.39 0.69 Allowed 'General case' 0 CA--C 1.554 1.106 0 O-C-N 120.954 -1.321 . . . . 0.0 110.836 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.0 t -88.51 1.1 55.51 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.291 1.836 . . . . 0.0 113.589 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.5 121.84 0.67 Allowed Glycine 0 CA--C 1.539 1.584 0 O-C-N 120.846 -1.158 . . . . 0.0 114.442 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.81 69.27 0.28 Allowed Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 162.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.5 mm -41.67 116.72 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -159.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.01 -55.22 0.74 Allowed Glycine 0 CA--C 1.539 1.533 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -147.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -52.93 153.36 3.41 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.539 0.736 . . . . 0.0 112.713 144.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.3 p -151.58 150.92 30.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.755 2.022 . . . . 0.0 111.401 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.92 -167.81 32.25 Favored Glycine 0 CA--C 1.542 1.756 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.61 84.28 0.09 OUTLIER 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.255 3.303 . . . . 0.0 113.765 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -68.51 42.5 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 127.08 2.152 . . . . 0.0 115.945 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -146.16 102.61 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 119.959 -1.713 . . . . 0.0 113.175 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.4 m -60.58 158.05 13.16 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.76 151.69 33.35 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.986 1.314 . . . . 0.0 112.487 161.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.2 t -59.58 166.92 2.21 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.31 -59.49 0.26 Allowed Glycine 0 CA--C 1.546 2.011 0 C-N-CA 124.271 0.938 . . . . 0.0 113.469 -161.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.5 p -72.1 150.8 43.56 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.747 1.219 . . . . 0.0 114.189 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.2 p -125.45 143.95 50.76 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.839 -1.163 . . . . 0.0 113.371 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.8 t -67.6 74.12 0.16 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.435 1.494 . . . . 0.0 110.407 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -22.59 6.37 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 119.375 3.102 . . . . 0.0 119.375 -151.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.297 6.8 p 41.76 47.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.94 -45.33 90.69 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.687 1.595 . . . . 0.0 112.459 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -154.07 163.67 23.26 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 125.295 1.438 . . . . 0.0 110.9 168.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.35 -19.35 21.76 Favored 'Trans proline' 0 CA--C 1.556 1.594 0 C-N-CA 122.256 1.971 . . . . 0.0 116.831 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.47 -14.9 26.14 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 170.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -135.19 105.45 6.31 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.509 1.524 . . . . 0.0 113.299 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -121.15 96.65 5.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.03 2.532 . . . . 0.0 110.201 153.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -96.0 142.76 27.84 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.861 1.264 . . . . 0.0 111.772 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.3 m -68.66 87.88 0.34 Allowed 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.604 -1.31 . . . . 0.0 112.322 170.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.077 -1.439 . . . . 0.0 111.949 171.197 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -90.52 138.46 31.54 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.867 1.667 . . . . 0.0 112.069 171.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -66.87 173.9 3.3 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.781 1.633 . . . . 0.0 114.257 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.26 140.65 26.06 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.919 1.288 . . . . 0.0 112.475 167.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 63.78 42.57 6.07 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.86 130.74 9.23 Favored Glycine 0 CA--C 1.544 1.902 0 C-N-CA 126.001 1.763 . . . . 0.0 112.627 167.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -74.78 66.08 1.45 Allowed 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 119.639 1.72 . . . . 0.0 114.681 -172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.8 t -31.09 -39.16 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 129.682 3.193 . . . . 0.0 117.613 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.38 83.6 0.12 Allowed Glycine 0 CA--C 1.537 1.41 0 O-C-N 121.233 -0.917 . . . . 0.0 115.339 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.91 63.98 0.27 Allowed Glycine 0 CA--C 1.543 1.784 0 C-N-CA 124.582 1.087 . . . . 0.0 112.525 167.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.3 7.6 tt -74.01 27.3 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 119.405 3.113 . . . . 0.0 119.405 -128.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.82 -38.63 76.2 Favored Glycine 0 CA--C 1.544 1.876 0 O-C-N 120.408 -1.433 . . . . 0.0 111.945 138.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -50.1 150.01 2.56 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.103 1.361 . . . . 0.0 113.279 159.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.1 p -142.13 154.69 45.07 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.322 1.449 . . . . 0.0 111.856 166.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 17' ' ' THR . . . 158.46 -167.8 34.63 Favored Glycine 0 CA--C 1.542 1.747 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -65.54 69.64 0.34 Allowed 'Trans proline' 0 CA--C 1.554 1.505 0 C-N-CA 124.824 3.683 . . . . 0.0 114.36 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 15' ' ' GLY . 33.4 p -60.95 32.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -173.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.0 t -132.95 96.83 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 O-C-N 119.622 -1.924 . . . . 0.0 112.677 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.04 170.04 2.37 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 127.651 2.381 . . . . 0.0 117.163 -175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.7 120.0 29.7 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.953 1.701 . . . . 0.0 113.526 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 t -34.04 103.04 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.683 1.993 . . . . 0.0 115.43 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.23 -53.8 0.79 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.761 1.648 . . . . 0.0 110.715 -165.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.7 p -86.8 157.82 19.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.319 1.848 . . . . 0.0 112.955 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -142.85 165.2 28.03 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -73.15 74.48 1.26 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 128.245 2.618 . . . . 0.0 110.922 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -8.59 2.65 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 -154.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 14.9 p 30.49 63.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.0 mt -60.68 -34.76 74.82 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 120.474 -1.391 . . . . 0.0 113.06 167.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -171.21 159.16 5.19 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 127.802 2.441 . . . . 0.0 111.119 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -46.77 -34.02 14.98 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 124.061 3.174 . . . . 0.0 115.774 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.15 -27.39 66.39 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 172.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -144.07 104.91 4.19 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.583 1.553 . . . . 0.0 113.489 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 t -116.15 138.48 51.22 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.662 1.585 . . . . 0.0 111.837 146.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -138.44 148.81 44.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.562 1.945 . . . . 0.0 112.03 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.4 m -67.51 102.07 1.09 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.918 0.887 . . . . 0.0 111.783 168.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.894 2.078 . . . . 0.0 112.085 174.166 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -99.22 129.29 45.45 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.63 1.572 . . . . 0.0 112.365 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -53.69 154.82 3.5 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.966 1.706 . . . . 0.0 115.163 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -49.35 133.07 20.17 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.803 0.841 . . . . 0.0 111.337 164.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 73.08 -23.55 0.21 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.438 2.295 . . . . 0.0 115.73 -167.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.4 112.0 2.11 Favored Glycine 0 CA--C 1.545 1.958 0 O-C-N 120.505 -1.372 . . . . 0.0 113.823 171.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -76.86 123.95 27.0 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -166.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 71.8 m -62.9 -44.77 95.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.803 1.241 . . . . 0.0 114.015 173.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.89 -129.28 4.26 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.562 2.029 . . . . 0.0 112.683 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.47 54.5 19.36 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 121.686 -0.891 . . . . 0.0 110.874 -151.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -49.08 121.14 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.152 0.981 . . . . 0.0 113.021 -171.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.18 -50.39 0.89 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -142.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.94 163.05 0.54 Allowed 'General case' 0 CA--C 1.563 1.452 0 O-C-N 121.774 -0.839 . . . . 0.0 112.315 141.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.1 p -151.6 4.82 0.44 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.18 -134.07 8.22 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 116.794 1.477 . . . . 0.0 116.794 -171.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.91 138.42 16.6 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.624 2.883 . . . . 0.0 113.997 -167.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.4 p -105.68 -19.37 13.78 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.549 1.94 . . . . 0.0 115.217 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.36 96.65 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 O-C-N 120.174 -1.579 . . . . 0.0 114.03 -162.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.0 m -56.49 159.88 3.48 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.37 146.68 42.81 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.349 1.86 . . . . 0.0 113.777 167.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.0 t -59.79 111.74 1.57 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.765 1.226 . . . . 0.0 113.413 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.01 -55.18 0.52 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.1 1.809 . . . . 0.0 111.409 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 t -87.52 -176.58 5.64 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.673 1.589 . . . . 0.0 112.315 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -153.64 143.45 21.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.426 2.29 . . . . 0.0 110.672 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 t -58.08 81.17 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 127.582 2.353 . . . . 0.0 114.196 -171.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -74.48 83.99 1.99 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.505 1.922 . . . . 0.0 114.652 -164.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.91 76.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 C-N-CA 128.395 2.678 . . . . 0.0 115.608 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.7 -41.09 24.23 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.689 -1.257 . . . . 0.0 113.168 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -138.69 155.44 73.41 Favored Pre-proline 0 CA--C 1.553 1.093 0 O-C-N 120.756 -1.215 . . . . 0.0 112.765 173.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -38.58 -46.34 2.49 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.639 2.893 . . . . 0.0 115.027 165.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.91 -57.24 5.28 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -83.97 122.33 28.61 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.5 t -137.64 135.94 37.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.031 0.933 . . . . 0.0 111.43 149.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -129.4 147.5 51.23 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.253 1.421 . . . . 0.0 113.383 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.54 67.14 2.01 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 120.463 -1.398 . . . . 0.0 110.952 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 C--O 1.251 1.183 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.087 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -76.13 163.22 27.31 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 118.634 0.652 . . . . 0.0 110.855 153.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -87.1 -169.57 2.68 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -65.44 150.34 48.51 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.066 1.347 . . . . 0.0 111.184 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 61.1 16.07 6.81 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.37 126.07 7.95 Favored Glycine 0 CA--C 1.544 1.862 0 O-C-N 119.928 -1.732 . . . . 0.0 113.353 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -71.7 92.17 1.17 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.774 1.229 . . . . 0.0 111.616 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 p -103.78 12.62 34.37 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.682 2.393 . . . . 0.0 114.196 -169.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.04 68.83 0.07 OUTLIER Glycine 0 CA--C 1.544 1.894 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.82 88.08 0.47 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 162.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.1 mt -53.23 108.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 118.459 1.129 . . . . 0.0 112.838 -161.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.81 -42.28 1.27 Allowed Glycine 0 CA--C 1.544 1.885 0 C-N-CA 125.302 1.43 . . . . 0.0 111.228 -153.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -179.84 0.24 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.038 0.935 . . . . 0.0 112.905 155.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.2 p -151.24 139.37 20.16 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.045 -1.034 . . . . 0.0 111.894 157.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.78 173.85 24.08 Favored Glycine 0 CA--C 1.544 1.896 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.2 113.28 1.13 Allowed 'Trans proline' 0 CA--C 1.546 1.115 1 C-N-CA 125.329 4.019 . . . . 0.0 117.332 -168.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.4 p -82.74 20.73 1.1 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 128.706 2.802 . . . . 0.0 116.137 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.23 114.35 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 120.043 -1.661 . . . . 0.0 113.059 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.2 m -83.19 174.75 10.5 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 127.64 2.376 . . . . 0.0 116.643 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 117.86 9.81 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.645 1.578 . . . . 0.0 112.812 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -39.3 113.01 0.29 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.187 1.395 . . . . 0.0 114.283 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.8 -25.76 7.46 Favored Glycine 0 CA--C 1.545 1.955 0 C-N-CA 124.762 1.173 . . . . 0.0 114.319 -162.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.3 p -124.94 149.92 47.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.182 1.793 . . . . 0.0 114.398 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.1 m -115.74 137.39 52.13 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.795 2.838 . . . . 0.0 112.544 -173.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.84 84.03 0.31 Allowed 'General case' 0 CA--C 1.559 1.316 0 O-C-N 120.266 -1.521 . . . . 0.0 112.435 172.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -55.63 171.23 0.22 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 118.673 2.842 . . . . 0.0 118.673 -161.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.48 49.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.598 -1.314 . . . . 0.0 113.872 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.17 -50.62 67.42 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.711 1.604 . . . . 0.0 112.96 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -162.51 161.7 19.79 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 126.646 1.978 . . . . 0.0 110.118 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -56.81 -13.13 10.53 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.051 2.501 . . . . 0.0 117.323 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.53 -23.14 17.81 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 125.664 1.585 . . . . 0.0 114.831 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -115.0 97.4 6.2 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.64 1.576 . . . . 0.0 112.036 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.6 t -113.91 120.01 39.22 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.966 0.906 . . . . 0.0 110.774 148.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -130.26 146.3 51.85 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.909 1.684 . . . . 0.0 111.843 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.1 m -63.9 85.8 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 36' ' ' LEU . 40.5 mt . . . . . 0 C--O 1.25 1.088 0 C-N-CA 127.931 2.492 . . . . 0.0 112.81 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 44.5 p . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 118.852 -0.594 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -63.01 168.6 3.91 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 119.749 1.159 . . . . 0.0 112.051 147.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -117.97 -173.98 2.55 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.413 1.485 . . . . 0.0 110.915 163.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -47.89 135.24 12.54 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.123 0.969 . . . . 0.0 112.653 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 75.45 1.58 3.67 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.642 2.377 . . . . 0.0 114.838 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.06 114.52 4.79 Favored Glycine 0 CA--C 1.541 1.703 0 O-C-N 118.094 -2.879 . . . . 0.0 116.326 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -53.94 139.75 33.02 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 118.473 1.137 . . . . 0.0 112.924 160.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 p -154.8 -13.89 0.12 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -163.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.46 72.67 0.11 Allowed Glycine 0 CA--C 1.542 1.774 0 N-CA-C 117.358 1.703 . . . . 0.0 117.358 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.27 114.64 0.62 Allowed Glycine 0 CA--C 1.543 1.789 0 C-N-CA 125.918 1.723 . . . . 0.0 111.571 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 mm -54.38 115.96 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 118.875 1.337 . . . . 0.0 112.987 -170.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.63 -48.49 0.94 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 125.592 1.568 . . . . 0.0 110.255 -154.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.16 168.48 6.71 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 121.786 -0.832 . . . . 0.0 112.16 158.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.5 p -153.35 148.76 27.12 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.123 -0.986 . . . . 0.0 111.926 152.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.87 -165.97 24.1 Favored Glycine 0 CA--C 1.544 1.897 0 C-N-CA 124.268 0.937 . . . . 0.0 115.246 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.43 156.37 21.97 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 124.153 3.235 . . . . 0.0 114.057 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 p -129.28 54.74 1.79 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.305 1.042 . . . . 0.0 113.383 -169.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.5 t -152.14 122.43 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 121.089 -1.007 . . . . 0.0 113.017 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.2 m -82.18 172.12 13.53 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.62 2.082 . . . . 0.0 116.62 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.81 117.05 23.03 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.709 1.604 . . . . 0.0 112.763 168.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 t -47.38 136.27 9.77 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.93 -65.18 0.25 Allowed Glycine 0 CA--C 1.541 1.675 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -151.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.8 p -88.64 161.0 17.12 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.539 1.135 . . . . 0.0 113.516 171.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 t -149.48 166.54 28.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.454 -1.404 . . . . 0.0 113.67 170.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 t -82.1 85.81 6.71 Favored 'General case' 0 CA--C 1.552 1.058 0 O-C-N 120.244 -1.535 . . . . 0.0 113.771 -166.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -88.38 90.73 8.52 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 122.353 1.073 . . . . 0.0 113.678 -163.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -70.9 81.46 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -176.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.44 -47.31 82.15 Favored 'General case' 0 CA--C 1.555 1.141 0 O-C-N 120.324 -1.485 . . . . 0.0 114.929 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.82 144.79 1.57 Allowed Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 125.503 1.521 . . . . 0.0 111.259 -169.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . 0.278 8.2 Cg_endo -48.92 -37.91 37.58 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 124.246 3.298 . . . . 0.0 119.176 -153.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.87 -40.14 95.84 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 120.323 1.42 . . . . 0.0 113.652 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -91.06 154.76 19.17 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.469 1.908 . . . . 0.0 113.36 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.4 t 158.79 112.94 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 128.687 2.795 . . . . 0.0 111.158 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -151.95 148.28 27.56 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -153.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 m -79.08 92.31 5.0 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.166 1.787 . . . . 0.0 112.004 168.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.271 -1.824 . . . . 0.0 111.767 165.845 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -79.02 142.54 36.49 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.271 1.828 . . . . 0.0 111.916 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -73.16 159.01 34.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.668 1.587 . . . . 0.0 115.193 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -40.03 136.86 1.07 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 126.069 1.747 . . . . 0.0 113.107 166.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 66.89 -11.11 0.27 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -174.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.12 152.17 20.0 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-N 120.433 1.47 . . . . 0.0 114.133 168.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -89.04 114.01 25.17 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 117.679 0.739 . . . . 0.0 112.031 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.4 t -92.59 -44.39 8.63 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 126.755 2.022 . . . . 0.0 115.57 -171.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.08 35.38 0.45 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 119.423 2.529 . . . . 0.0 119.423 -168.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.62 66.08 2.75 Favored Glycine 0 CA--C 1.545 1.948 0 CA-C-N 119.301 1.55 . . . . 0.0 113.447 175.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.4 mt -41.35 115.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.568 1.547 . . . . 0.0 113.825 -167.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.69 -54.27 0.79 Allowed Glycine 0 N--CA 1.476 1.324 0 N-CA-C 108.291 -1.923 . . . . 0.0 108.291 -151.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -55.91 156.69 4.97 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 121.498 0.666 . . . . 0.0 112.311 140.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.7 p -143.94 138.54 28.56 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.004 1.722 . . . . 0.0 111.115 162.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.26 -174.64 44.93 Favored Glycine 0 CA--C 1.55 2.223 0 N-CA-C 116.584 1.394 . . . . 0.0 116.584 -174.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -65.98 80.46 0.28 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 125.043 3.829 . . . . 0.0 114.202 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.3 p -63.79 33.15 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -167.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.0 t -139.02 93.79 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 O-C-N 119.566 -1.958 . . . . 0.0 114.182 -171.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.8 m -58.79 159.21 7.06 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.046 2.138 . . . . 0.0 115.991 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.33 158.56 11.53 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.116 1.366 . . . . 0.0 113.065 164.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.7 t -69.96 176.34 3.8 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.17 -58.25 2.33 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 121.023 -1.048 . . . . 0.0 112.828 -166.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.4 169.55 17.07 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 126.228 1.811 . . . . 0.0 113.201 168.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.1 t -134.95 170.1 16.39 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.847 2.459 . . . . 0.0 114.832 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.5 t -86.12 69.19 10.47 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 127.889 2.476 . . . . 0.0 112.194 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -54.26 160.75 1.53 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 118.974 2.953 . . . . 0.0 118.974 -161.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.11 59.4 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 127.41 2.284 . . . . 0.0 112.857 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.42 -55.03 6.91 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.304 -1.497 . . . . 0.0 112.695 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -157.32 152.67 21.93 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 126.719 2.007 . . . . 0.0 109.975 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -51.13 -28.81 26.47 Favored 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 122.886 2.391 . . . . 0.0 117.536 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.43 -18.14 63.01 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 120.585 1.539 . . . . 0.0 114.904 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -124.89 135.37 52.81 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.531 2.332 . . . . 0.0 112.997 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 t -158.59 108.25 2.01 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.041 -1.037 . . . . 0.0 109.778 165.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -119.52 149.49 41.82 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.043 1.737 . . . . 0.0 111.596 -166.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -66.46 84.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.224 0.609 . . . . 0.0 112.0 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 C--O 1.252 1.21 0 C-N-CA 127.118 2.167 . . . . 0.0 112.563 -177.834 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -95.81 132.78 40.7 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.03 1.732 . . . . 0.0 111.813 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 m -65.29 170.33 4.83 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -50.97 132.95 27.5 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.86 1.264 . . . . 0.0 111.918 167.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 67.55 53.09 0.74 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.643 1.977 . . . . 0.0 115.324 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.33 126.07 5.82 Favored Glycine 0 CA--C 1.543 1.819 0 C-N-CA 126.384 1.945 . . . . 0.0 111.945 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -74.1 60.77 0.8 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 119.517 1.658 . . . . 0.0 114.086 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.8 t -16.07 -59.62 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.928 3.291 . . . . 0.0 117.495 172.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.05 79.85 0.21 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.402 1.001 . . . . 0.0 112.992 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.5 60.58 0.47 Allowed Glycine 0 CA--C 1.543 1.8 0 C-N-CA 124.99 1.281 . . . . 0.0 111.421 163.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.6 mt -49.39 112.46 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 125.163 1.385 . . . . 0.0 113.804 -156.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.99 -53.19 0.79 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -150.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -50.54 154.07 1.43 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 121.634 0.73 . . . . 0.0 112.165 137.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 p -149.27 151.06 33.56 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.81 1.644 . . . . 0.0 111.141 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.76 -168.04 31.08 Favored Glycine 0 CA--C 1.549 2.159 0 C-N-CA 124.718 1.151 . . . . 0.0 113.572 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.16 113.78 1.74 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.228 3.285 . . . . 0.0 113.82 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -99.38 16.26 23.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -124.7 96.95 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.688 -1.258 . . . . 0.0 112.847 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.1 m -60.47 160.03 9.46 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.296 1.838 . . . . 0.0 115.683 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.6 165.21 5.16 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.112 1.365 . . . . 0.0 113.411 164.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.9 t -75.68 173.67 10.77 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 169.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.35 -63.06 0.16 Allowed Glycine 0 CA--C 1.539 1.581 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -159.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.9 p -62.95 168.92 3.61 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.577 1.551 . . . . 0.0 114.53 167.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -153.38 158.29 41.27 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.906 1.282 . . . . 0.0 112.525 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.8 t -63.46 75.81 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.757 1.223 . . . . 0.0 111.069 170.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.22 89.53 0.87 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.703 1.201 . . . . 0.0 111.892 -165.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.18 94.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 C-N-CA 126.215 1.806 . . . . 0.0 113.485 170.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -96.41 -44.03 7.38 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.416 1.486 . . . . 0.0 111.012 168.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -147.2 156.55 46.55 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 126.852 2.061 . . . . 0.0 112.347 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -40.52 -45.16 4.51 Favored 'Trans proline' 0 CA--C 1.554 1.514 0 C-N-CA 123.887 3.058 . . . . 0.0 115.748 159.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.01 -16.02 61.07 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 171.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -140.51 90.64 2.37 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.316 1.846 . . . . 0.0 112.675 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.4 t -109.31 124.59 51.18 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.237 -0.915 . . . . 0.0 111.063 148.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -138.27 141.58 39.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.728 1.211 . . . . 0.0 113.696 -168.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.3 79.67 0.06 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.678 1.591 . . . . 0.0 112.712 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.072 0.949 . . . . 0.0 112.408 165.219 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -80.37 144.27 32.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.048 1.339 . . . . 0.0 111.588 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -88.3 172.28 9.54 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -41.39 132.54 2.67 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 127.579 2.352 . . . . 0.0 113.191 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 67.1 -13.16 0.21 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.68 141.42 44.64 Favored Glycine 0 CA--C 1.55 2.234 0 O-C-N 120.063 -1.648 . . . . 0.0 112.911 167.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -75.48 108.37 8.24 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.999 -1.295 . . . . 0.0 113.318 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.6 t -74.6 -37.88 62.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.444 1.898 . . . . 0.0 112.94 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.23 158.84 28.44 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-O 123.07 1.372 . . . . 0.0 114.923 -173.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.67 46.71 0.02 OUTLIER Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.521 2.01 . . . . 0.0 110.342 -169.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.7 mt -50.8 117.89 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.836 1.254 . . . . 0.0 112.268 -158.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.54 -59.52 0.69 Allowed Glycine 0 CA--C 1.536 1.399 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -148.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.21 156.27 5.86 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-O 121.737 0.779 . . . . 0.0 112.264 145.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.6 p -138.68 147.98 43.43 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.251 1.82 . . . . 0.0 110.343 160.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.31 -161.85 32.0 Favored Glycine 0 CA--C 1.543 1.804 0 O-C-N 120.65 -1.281 . . . . 0.0 115.615 -175.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -71.16 79.09 1.42 Allowed 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.631 2.887 . . . . 0.0 113.605 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.2 p -71.18 25.82 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 -167.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 t -140.61 100.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 119.742 -1.849 . . . . 0.0 113.659 -173.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m -63.64 163.58 11.12 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.7 122.48 28.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.72 1.608 . . . . 0.0 113.093 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.9 t -44.34 135.21 4.69 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.9 1.28 . . . . 0.0 114.109 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.97 -40.97 2.28 Favored Glycine 0 CA--C 1.545 1.943 0 C-N-CA 124.209 0.909 . . . . 0.0 112.58 -154.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p -118.06 151.32 37.76 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.851 1.66 . . . . 0.0 114.264 175.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.8 m -109.58 142.95 39.96 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.02 2.528 . . . . 0.0 113.668 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.9 t -73.28 84.2 1.4 Allowed 'General case' 0 CA--C 1.552 1.021 0 O-C-N 121.101 -0.999 . . . . 0.0 111.099 167.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -57.79 178.28 0.09 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.59 49.95 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.479 1.133 . . . . 0.0 112.678 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.72 -44.49 96.09 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.563 1.545 . . . . 0.0 111.931 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -142.65 160.33 54.08 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.724 1.61 . . . . 0.0 110.065 159.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -45.05 -39.52 14.83 Favored 'Trans proline' 0 CA--C 1.555 1.53 0 C-N-CA 122.051 1.834 . . . . 0.0 113.203 161.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.91 -25.95 63.0 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -122.18 90.63 3.34 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.836 1.655 . . . . 0.0 111.948 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.0 t -116.23 107.28 14.66 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.973 0.892 . . . . 0.0 111.838 158.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -113.32 152.89 29.34 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.352 1.861 . . . . 0.0 111.552 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.27 84.97 0.15 Allowed 'General case' 0 CA--C 1.55 0.953 0 O-C-N 121.374 -0.829 . . . . 0.0 112.673 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 C--O 1.25 1.129 0 C-N-CA 128.81 2.844 . . . . 0.0 111.835 179.584 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -71.97 141.47 49.4 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.619 0.767 . . . . 0.0 111.987 166.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -91.55 155.69 18.2 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -38.16 132.03 1.07 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 127.181 2.192 . . . . 0.0 113.528 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 67.65 -27.52 0.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -170.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -42.58 119.91 2.26 Favored Glycine 0 CA--C 1.545 1.934 0 O-C-N 120.674 -1.267 . . . . 0.0 113.879 171.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -75.47 136.65 40.65 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.688 1.195 . . . . 0.0 111.959 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.0 p -144.67 28.36 1.3 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.369 1.067 . . . . 0.0 113.737 -166.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.05 69.97 0.03 OUTLIER Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.686 1.612 . . . . 0.0 114.981 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.25 86.17 0.4 Allowed Glycine 0 N--CA 1.471 0.996 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 152.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.6 mt -53.92 110.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 118.901 1.351 . . . . 0.0 111.987 -164.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.15 -48.59 0.86 Allowed Glycine 0 CA--C 1.544 1.89 0 C-N-CA 125.032 1.301 . . . . 0.0 110.401 -149.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.68 170.81 1.32 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.498 1.119 . . . . 0.0 112.718 153.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.2 p -152.27 147.61 26.57 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.425 -0.797 . . . . 0.0 111.957 158.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.55 175.89 25.39 Favored Glycine 0 CA--C 1.54 1.602 0 N-CA-C 115.319 0.888 . . . . 0.0 115.319 175.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.6 122.39 3.95 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.826 3.684 . . . . 0.0 114.595 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.3 p -83.32 -55.38 4.36 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.4 1.88 . . . . 0.0 113.117 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.2 t -66.0 111.36 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 C-N-CA 125.46 1.504 . . . . 0.0 114.102 -170.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.4 m -73.25 172.68 10.71 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.48 130.03 38.86 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 126.47 1.908 . . . . 0.0 114.087 172.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -52.14 113.78 1.13 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.244 1.018 . . . . 0.0 112.982 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.44 -45.23 1.03 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.034 1.302 . . . . 0.0 111.915 -163.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.4 p -127.41 -176.35 3.72 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 127.348 2.259 . . . . 0.0 111.827 170.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -148.06 155.44 41.49 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 119.358 -2.089 . . . . 0.0 112.344 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.7 t -69.46 77.32 0.4 Allowed 'General case' 0 CA--C 1.557 1.245 0 O-C-N 120.421 -1.424 . . . . 0.0 111.032 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -70.7 87.27 0.68 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.428 1.491 . . . . 0.0 113.624 -167.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.9 93.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.269 1.027 . . . . 0.0 113.757 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -93.5 -39.83 10.66 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.356 1.462 . . . . 0.0 111.408 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -150.39 163.67 23.38 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.934 1.694 . . . . 0.0 113.308 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.31 -14.66 35.66 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 123.357 2.705 . . . . 0.0 114.938 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.9 -11.91 27.82 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 125.974 1.71 . . . . 0.0 115.026 165.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -140.88 97.3 3.16 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.163 1.785 . . . . 0.0 112.767 -175.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -119.96 136.25 54.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.273 1.029 . . . . 0.0 110.702 145.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -146.44 146.14 30.47 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.216 1.406 . . . . 0.0 112.578 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.9 m -70.52 81.44 0.58 Allowed 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 176.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.8 mt . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.219 1.808 . . . . 0.0 115.359 177.681 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -72.21 141.73 49.01 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.879 0.872 . . . . 0.0 111.763 167.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.5 m -65.54 148.88 51.0 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -47.2 133.71 11.72 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.237 0.615 . . . . 0.0 111.545 157.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 63.06 53.57 2.3 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.759 1.224 . . . . 0.0 113.883 -169.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.08 117.76 2.67 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 124.923 1.249 . . . . 0.0 114.036 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -67.73 63.93 0.08 Allowed 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 125.538 1.535 . . . . 0.0 114.552 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.2 p -66.24 43.73 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 128.146 2.578 . . . . 0.0 115.689 174.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.68 78.93 0.03 OUTLIER Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.666 -1.271 . . . . 0.0 113.591 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.33 88.52 0.39 Allowed Glycine 0 CA--C 1.534 1.236 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 148.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.2 mt -50.63 108.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 119.746 1.773 . . . . 0.0 113.089 -163.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.28 -48.51 0.86 Allowed Glycine 0 CA--C 1.544 1.886 0 C-N-CA 125.612 1.577 . . . . 0.0 110.081 -152.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.57 166.07 0.14 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.156 0.982 . . . . 0.0 112.624 145.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.6 p -152.32 157.99 42.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.29 1.036 . . . . 0.0 111.468 156.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.39 -175.11 20.64 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -46.23 115.36 1.11 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 125.063 3.842 . . . . 0.0 115.024 -173.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.7 p -72.35 -65.94 0.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.008 1.723 . . . . 0.0 112.414 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -50.22 107.29 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 126.799 2.04 . . . . 0.0 114.31 -169.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.0 m -66.0 179.22 0.94 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 128.196 2.598 . . . . 0.0 117.119 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 129.28 37.52 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.685 1.594 . . . . 0.0 111.36 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -45.13 112.86 0.49 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.47 -44.78 1.37 Allowed Glycine 0 CA--C 1.549 2.162 0 C-N-CA 125.444 1.497 . . . . 0.0 113.68 -167.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 p -89.87 148.02 23.41 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 127.0 2.12 . . . . 0.0 113.198 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 m -124.56 142.26 51.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.324 1.85 . . . . 0.0 113.927 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -73.19 83.73 1.35 Allowed 'General case' 0 CA--C 1.554 1.109 0 O-C-N 120.357 -1.464 . . . . 0.0 111.257 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -12.81 8.59 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 -150.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.304 7.9 p 39.45 46.24 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 126.936 2.094 . . . . 0.0 115.5 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.07 -45.06 74.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.014 1.326 . . . . 0.0 111.801 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -136.61 157.11 75.76 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.111 1.364 . . . . 0.0 110.196 159.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.7 -16.94 16.34 Favored 'Trans proline' 0 CA--C 1.558 1.701 0 C-N-CA 122.318 2.012 . . . . 0.0 114.974 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.43 -18.23 25.77 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 127.165 2.186 . . . . 0.0 115.811 167.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -140.79 93.94 2.66 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.042 1.737 . . . . 0.0 112.606 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 t -122.35 91.64 3.55 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.052 1.741 . . . . 0.0 111.239 167.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.96 146.07 24.19 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.815 1.246 . . . . 0.0 113.735 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.9 m -66.07 95.13 0.26 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.328 -0.857 . . . . 0.0 111.929 156.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.9 mt . . . . . 0 C--O 1.257 1.462 0 CA-C-O 117.049 -1.453 . . . . 0.0 110.511 161.446 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.949 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -70.95 153.11 42.94 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 119.584 1.084 . . . . 0.0 112.156 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 m -74.58 161.36 29.8 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.59 1.556 . . . . 0.0 114.873 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -50.42 132.61 24.94 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.305 1.042 . . . . 0.0 110.696 159.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 63.39 65.57 0.75 Allowed 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -171.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.43 -89.54 0.03 OUTLIER Glycine 0 CA--C 1.555 2.557 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -84.84 170.96 12.63 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 129.607 3.163 . . . . 0.0 115.153 -6.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.97 11.44 13.41 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 128.053 2.541 . . . . 0.0 114.865 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.18 -164.29 10.78 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 126.487 1.994 . . . . 0.0 114.837 169.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.97 60.53 3.33 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.969 -0.724 . . . . 0.0 112.121 -164.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.3 mt -51.43 108.49 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 126.032 1.733 . . . . 0.0 111.745 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.38 -47.56 0.87 Allowed Glycine 0 CA--C 1.541 1.699 0 C-N-CA 124.705 1.145 . . . . 0.0 110.331 -147.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.33 164.42 0.96 Allowed 'General case' 0 CA--C 1.554 1.099 0 O-C-N 121.893 -0.769 . . . . 0.0 111.156 139.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.3 p -154.58 164.13 39.17 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.537 1.135 . . . . 0.0 111.972 164.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.19 179.22 19.01 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 116.052 1.181 . . . . 0.0 116.052 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -50.68 119.7 5.53 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 125.239 3.959 . . . . 0.0 116.648 -168.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.7 p -77.39 -39.53 46.91 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.626 1.57 . . . . 0.0 114.631 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.76 102.31 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 125.045 1.338 . . . . 0.0 114.393 -161.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -85.46 -177.92 6.57 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.18 146.2 55.27 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.73 1.612 . . . . 0.0 113.622 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.4 p -77.43 73.58 4.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.025 -1.047 . . . . 0.0 111.832 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.02 -50.71 0.04 OUTLIER Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.956 1.741 . . . . 0.0 110.764 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.2 p -74.08 177.44 5.71 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.564 1.146 . . . . 0.0 113.482 161.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.8 m -148.25 143.31 26.89 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.821 -1.174 . . . . 0.0 113.975 165.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.3 t -64.76 86.42 0.05 Allowed 'General case' 0 CA--C 1.558 1.278 0 O-C-N 120.414 -1.429 . . . . 0.0 111.954 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.12 161.15 11.45 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -160.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.09 134.54 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 O-C-N 120.629 -1.295 . . . . 0.0 111.253 164.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -152.68 -53.43 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.241 1.017 . . . . 0.0 111.866 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -158.04 164.09 22.46 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 124.772 1.229 . . . . 0.0 111.091 165.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -41.63 -42.3 5.99 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.808 3.006 . . . . 0.0 115.818 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.11 -4.67 18.21 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -143.65 118.1 9.7 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.751 1.621 . . . . 0.0 113.645 -170.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 t -135.48 95.59 3.29 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.38 -0.825 . . . . 0.0 110.996 153.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -109.8 150.12 28.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.893 1.277 . . . . 0.0 113.148 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.2 m -79.08 89.56 4.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.617 1.167 . . . . 0.0 113.064 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.258 1.513 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.98 163.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -69.57 136.25 51.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.938 1.695 . . . . 0.0 111.492 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -75.83 158.38 32.22 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -49.92 132.65 22.76 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.145 1.378 . . . . 0.0 111.619 167.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 64.5 42.44 5.01 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.03 129.15 6.43 Favored Glycine 0 CA--C 1.544 1.881 0 C-N-CA 125.844 1.688 . . . . 0.0 112.872 168.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -66.72 72.73 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.219 1.51 . . . . 0.0 114.589 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.7 t -31.31 -54.77 0.24 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 128.127 2.571 . . . . 0.0 116.012 171.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.74 45.69 0.5 Allowed Glycine 0 CA--C 1.539 1.566 0 N-CA-C 118.095 1.998 . . . . 0.0 118.095 -168.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.22 65.52 1.27 Allowed Glycine 0 CA--C 1.546 1.981 0 O-C-N 121.159 -1.2 . . . . 0.0 113.723 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.2 mt -44.1 114.27 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 118.984 1.392 . . . . 0.0 113.892 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.1 -54.62 0.78 Allowed Glycine 0 CA--C 1.537 1.425 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -154.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.82 160.72 4.34 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 122.071 0.939 . . . . 0.0 111.757 139.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.0 p -148.54 149.37 31.48 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.15 1.78 . . . . 0.0 111.138 163.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 17' ' ' THR . . . 163.07 -166.95 37.21 Favored Glycine 0 CA--C 1.546 2.007 0 O-C-N 120.96 -1.087 . . . . 0.0 114.949 -175.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.73 80.97 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.894 3.062 . . . . 0.0 113.027 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 15' ' ' GLY . 25.7 p -70.73 33.0 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 118.151 2.648 . . . . 0.0 118.151 -166.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 t -137.93 96.28 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 O-C-N 120.132 -1.605 . . . . 0.0 113.317 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.47 156.87 7.41 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.19 167.12 0.13 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.997 0.919 . . . . 0.0 112.71 153.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.8 t -82.75 -178.02 6.94 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.47 -66.07 1.02 Allowed Glycine 0 CA--C 1.539 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 111.898 -165.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.42 161.25 30.0 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.352 1.461 . . . . 0.0 114.069 170.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.7 p -128.94 151.12 50.02 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 130.936 3.694 . . . . 0.0 111.839 -168.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.6 t -74.42 74.94 1.91 Allowed 'General case' 0 CA--C 1.559 1.29 0 O-C-N 120.238 -1.538 . . . . 0.0 111.571 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -63.71 165.15 8.72 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -167.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 p -137.13 105.83 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 C-N-CA 125.534 1.533 . . . . 0.0 114.558 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.86 -50.33 6.1 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.451 1.5 . . . . 0.0 111.899 167.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.76 157.17 36.11 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 128.013 2.525 . . . . 0.0 108.85 171.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -50.07 -39.62 50.78 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 122.844 2.363 . . . . 0.0 115.107 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -50.96 -25.4 4.62 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -122.56 135.6 54.67 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.08 2.152 . . . . 0.0 113.342 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.74 111.18 1.15 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.229 -0.919 . . . . 0.0 113.427 165.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -122.71 151.75 41.25 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.47 1.908 . . . . 0.0 112.75 -169.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.5 m -61.79 88.88 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.9 0.48 . . . . 0.0 111.378 168.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.256 1.432 0 C-N-CA 128.456 2.702 . . . . 0.0 112.638 174.953 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -90.36 133.29 35.08 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 127.303 2.241 . . . . 0.0 111.276 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.1 p -75.81 166.67 23.18 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.938 1.695 . . . . 0.0 113.784 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -58.83 147.27 34.26 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 58.39 -11.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -161.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.06 122.67 24.32 Favored Glycine 0 CA--C 1.542 1.747 0 O-C-N 119.687 -1.883 . . . . 0.0 113.65 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -68.42 76.51 0.26 Allowed 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 118.946 1.373 . . . . 0.0 112.632 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . 52.5 t -51.19 -31.2 19.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.037 1.735 . . . . 0.0 115.373 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.75 106.86 0.29 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 117.498 1.759 . . . . 0.0 117.498 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.45 85.43 0.34 Allowed Glycine 0 CA--C 1.534 1.237 0 O-C-N 120.895 -1.356 . . . . 0.0 109.961 154.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.3 mt -49.84 113.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 118.903 1.351 . . . . 0.0 113.052 -161.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.64 -45.94 1.1 Allowed Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.339 1.447 . . . . 0.0 110.6 -151.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.69 171.5 0.21 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 125.273 1.429 . . . . 0.0 112.714 153.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.8 p -153.63 174.47 14.44 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.693 1.197 . . . . 0.0 111.505 160.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 -175.29 19.55 Favored Glycine 0 CA--C 1.546 2.031 0 C-N-CA 124.233 0.92 . . . . 0.0 114.353 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.03 100.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 124.626 3.551 . . . . 0.0 116.804 -168.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -83.55 22.78 1.02 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.964 2.506 . . . . 0.0 114.2 -175.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -149.09 114.27 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 120.171 -1.581 . . . . 0.0 111.924 -173.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.0 m -70.14 167.13 18.45 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.93 140.29 38.09 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.662 1.585 . . . . 0.0 113.81 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 t -49.94 111.93 0.59 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.359 1.064 . . . . 0.0 113.55 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.94 -47.26 1.0 Allowed Glycine 0 CA--C 1.543 1.838 0 C-N-CA 125.34 1.448 . . . . 0.0 112.921 -164.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.63 149.61 40.41 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.294 2.237 . . . . 0.0 113.055 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.4 m -121.05 142.01 50.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.295 1.438 . . . . 0.0 112.749 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 t -57.52 88.85 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 126.31 1.844 . . . . 0.0 111.463 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -10.35 51.35 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -149.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.308 9.3 p 34.53 52.93 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 127.883 2.473 . . . . 0.0 116.663 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.0 -45.07 78.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.543 1.537 . . . . 0.0 112.413 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -152.28 169.77 9.03 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 125.49 1.516 . . . . 0.0 110.976 164.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -48.55 -33.11 22.77 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.257 2.638 . . . . 0.0 116.802 178.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.42 -10.76 48.13 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -137.68 101.5 4.49 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.456 1.502 . . . . 0.0 113.723 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 t -122.47 91.96 3.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.874 2.469 . . . . 0.0 110.505 158.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -92.65 152.4 19.57 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 120.503 -1.373 . . . . 0.0 112.588 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 76.1 m -78.21 78.13 4.69 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.697 -1.252 . . . . 0.0 110.989 162.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.188 -1.387 . . . . 0.0 112.485 161.671 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -79.24 145.06 33.79 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.953 1.301 . . . . 0.0 112.37 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.3 m -80.29 158.17 26.21 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.734 1.214 . . . . 0.0 113.82 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -38.59 132.55 1.14 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.875 1.67 . . . . 0.0 112.573 167.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 70.05 -23.12 0.16 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.69 137.72 45.46 Favored Glycine 0 CA--C 1.55 2.261 0 O-C-N 120.233 -1.542 . . . . 0.0 113.561 168.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -71.87 133.89 45.73 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 120.694 -1.474 . . . . 0.0 112.183 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.5 t -106.07 -33.34 7.91 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.73 2.012 . . . . 0.0 113.847 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.16 -166.45 23.07 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 120.664 -1.273 . . . . 0.0 115.769 -169.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.05 -98.2 0.97 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.147 1.832 . . . . 0.0 113.349 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.77 71.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 126.053 1.741 . . . . 0.0 114.604 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.19 41.68 2.18 Favored Glycine 0 CA--C 1.544 1.889 0 C-N-CA 125.611 1.576 . . . . 0.0 113.878 -173.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -80.94 132.27 35.4 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -150.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.2 p -96.1 -164.0 1.11 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.228 1.811 . . . . 0.0 113.389 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.06 -151.99 41.37 Favored Glycine 0 CA--C 1.551 2.329 0 O-C-N 119.67 -1.894 . . . . 0.0 115.863 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -71.64 62.02 2.93 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 123.993 3.128 . . . . 0.0 114.97 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.1 p -71.76 32.04 0.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -170.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -145.74 97.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 120.006 -1.684 . . . . 0.0 112.121 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.8 m -59.99 155.85 15.9 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.39 152.69 45.24 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.857 1.263 . . . . 0.0 112.622 162.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 t -62.3 171.37 1.89 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.21 -57.6 1.11 Allowed Glycine 0 CA--C 1.543 1.792 0 C-N-CA 124.172 0.891 . . . . 0.0 112.951 -164.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.7 p -76.52 145.95 38.76 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.1 m -99.09 142.28 30.79 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.806 2.043 . . . . 0.0 113.871 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.6 t -70.84 86.28 0.69 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.846 1.259 . . . . 0.0 110.82 163.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.436 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 23.5 mm-40 -64.08 177.39 0.81 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 117.875 2.546 . . . . 0.0 117.875 -165.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 p -140.37 50.75 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 122.515 1.15 . . . . 0.0 113.544 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -56.65 -44.6 81.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.328 1.851 . . . . 0.0 113.362 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -147.38 164.51 22.59 Favored Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 126.072 1.749 . . . . 0.0 110.02 162.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -43.37 -39.49 9.13 Favored 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 123.97 3.113 . . . . 0.0 116.969 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.17 -33.05 44.37 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -95.5 83.55 3.82 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.638 1.975 . . . . 0.0 113.523 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 t -105.16 104.93 14.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.643 0.777 . . . . 0.0 111.776 156.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -115.91 157.59 24.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.638 2.375 . . . . 0.0 112.16 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.9 m -71.26 79.83 0.72 Allowed 'General case' 0 CA--C 1.554 1.111 0 O-C-N 121.472 -0.767 . . . . 0.0 112.806 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.436 ' HB2' ' HG3' ' A' ' 26' ' ' GLN . 76.6 mt . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.432 1.893 . . . . 0.0 112.162 168.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -67.8 128.33 36.09 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.737 1.615 . . . . 0.0 111.572 174.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.3 m -72.12 161.96 30.14 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.953 1.301 . . . . 0.0 113.599 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -43.18 135.9 3.12 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.252 1.021 . . . . 0.0 113.115 172.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 69.83 -12.06 0.49 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.05 140.83 46.96 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.033 -1.667 . . . . 0.0 113.305 170.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.18 151.66 36.85 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.681 1.741 . . . . 0.0 112.875 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.7 t -127.62 -48.33 1.4 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.565 1.546 . . . . 0.0 113.062 -168.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.97 17.97 2.55 Favored Glycine 0 CA--C 1.548 2.106 0 N-CA-C 120.288 2.875 . . . . 0.0 120.288 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.11 68.69 2.82 Favored Glycine 0 CA--C 1.545 1.924 0 CA-C-N 120.756 2.278 . . . . 0.0 113.463 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.6 mt -46.3 128.66 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.664 1.185 . . . . 0.0 113.347 -173.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.13 -56.42 0.6 Allowed Glycine 0 N--CA 1.474 1.195 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -145.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.7 157.0 15.57 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.994 0.902 . . . . 0.0 112.586 150.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 p -140.8 137.48 33.36 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.694 1.598 . . . . 0.0 110.631 158.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.72 -173.04 46.0 Favored Glycine 0 CA--C 1.544 1.845 0 O-C-N 120.949 -1.095 . . . . 0.0 114.221 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -65.38 88.89 0.21 Allowed 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 123.414 2.743 . . . . 0.0 113.781 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 p -72.9 31.88 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -170.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.5 t -141.82 98.49 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 119.613 -1.93 . . . . 0.0 114.145 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m -65.85 157.26 30.97 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 96.47 0.47 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.178 1.391 . . . . 0.0 111.864 169.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 t -37.09 -13.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 119.913 3.301 . . . . 0.0 119.913 -166.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.07 -35.9 60.25 Favored Glycine 0 CA--C 1.547 2.032 0 CA-C-N 119.571 1.078 . . . . 0.0 113.685 160.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 p -111.12 173.43 6.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.846 2.058 . . . . 0.0 111.614 169.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 t -125.78 172.54 9.75 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.9 t -77.5 70.28 3.87 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.436 1.494 . . . . 0.0 110.973 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -57.64 167.61 1.04 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -169.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.83 117.06 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.035 1.334 . . . . 0.0 113.233 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -105.71 -53.32 2.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.562 1.545 . . . . 0.0 110.153 162.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.71 149.76 6.21 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.956 2.502 . . . . 0.0 110.426 176.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.82 17.76 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.587 0 C-N-CA 124.941 3.761 . . . . 0.0 118.458 -160.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.59 -27.94 12.8 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 126.087 1.755 . . . . 0.0 113.104 160.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -80.49 166.31 21.32 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.629 1.571 . . . . 0.0 112.467 161.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 t 153.63 81.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.032 2.533 . . . . 0.0 112.051 168.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -120.02 150.05 41.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.346 1.858 . . . . 0.0 112.585 -165.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.3 m -62.92 79.27 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.676 1.19 . . . . 0.0 113.309 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.258 1.538 0 C-N-CA 129.222 3.009 . . . . 0.0 112.267 178.233 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.26 136.12 39.65 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.755 1.222 . . . . 0.0 111.173 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -69.69 150.67 46.73 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.785 1.234 . . . . 0.0 113.929 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -42.88 133.93 3.48 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.939 1.695 . . . . 0.0 112.389 169.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 67.19 -13.73 0.2 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -171.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.02 126.69 33.88 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 120.202 -1.561 . . . . 0.0 113.628 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -75.76 132.18 40.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.039 0.936 . . . . 0.0 110.813 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.39 4.08 1.56 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -160.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.39 59.66 0.12 Allowed Glycine 0 CA--C 1.543 1.791 0 CA-C-N 118.771 0.714 . . . . 0.0 114.867 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.23 86.26 0.45 Allowed Glycine 0 N--CA 1.474 1.217 0 O-C-N 121.322 -1.105 . . . . 0.0 110.546 163.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.9 mt -54.19 109.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 118.81 1.305 . . . . 0.0 112.483 -162.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.87 -45.51 1.0 Allowed Glycine 0 CA--C 1.546 1.987 0 C-N-CA 125.364 1.459 . . . . 0.0 111.318 -151.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -177.43 0.49 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.305 1.442 . . . . 0.0 113.238 159.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.9 p -156.78 141.14 16.62 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.249 -0.907 . . . . 0.0 112.453 158.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.03 172.71 27.61 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 115.763 1.065 . . . . 0.0 115.763 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -45.88 117.83 2.02 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 125.065 3.843 . . . . 0.0 115.55 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.2 p -89.13 3.19 52.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.457 2.303 . . . . 0.0 115.782 -172.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 t -119.08 106.16 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.078 1.351 . . . . 0.0 112.697 -172.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.71 171.2 11.99 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 130.55 45.09 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.352 1.461 . . . . 0.0 113.634 167.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.3 t -55.06 117.47 3.49 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.138 -0.976 . . . . 0.0 112.025 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.15 -40.68 1.83 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.919 1.247 . . . . 0.0 113.008 -164.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.5 p -107.33 -178.87 3.76 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.875 1.27 . . . . 0.0 113.558 171.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -151.9 143.35 23.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.403 2.281 . . . . 0.0 111.673 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -67.3 82.33 0.14 Allowed 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.081 -1.637 . . . . 0.0 113.068 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -54.23 173.59 0.07 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.97 111.21 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.5 mt -98.81 -47.74 5.19 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.261 1.425 . . . . 0.0 112.32 166.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.21 161.84 29.6 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 126.785 2.034 . . . . 0.0 110.013 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.26 -9.31 6.33 Favored 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.118 1.879 . . . . 0.0 115.669 175.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.0 -18.93 23.8 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -120.66 107.58 12.97 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.841 1.656 . . . . 0.0 111.584 173.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.7 t -135.06 120.59 19.28 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.292 1.037 . . . . 0.0 112.333 156.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -136.7 145.15 44.39 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.149 2.179 . . . . 0.0 112.585 -164.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.3 m -64.67 84.13 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 120.64 -1.288 . . . . 0.0 114.123 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 C--O 1.252 1.19 0 C-N-CA 128.872 2.869 . . . . 0.0 113.167 173.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -102.36 138.62 39.05 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.426 1.49 . . . . 0.0 111.946 168.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 m -68.98 162.78 26.05 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.48 1.912 . . . . 0.0 114.958 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -47.63 137.66 8.97 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.598 1.159 . . . . 0.0 112.48 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 67.53 -15.49 0.18 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.957 2.103 . . . . 0.0 115.694 -168.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -50.27 132.07 29.57 Favored Glycine 0 CA--C 1.545 1.959 0 O-C-N 120.589 -1.319 . . . . 0.0 114.033 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.02 126.2 35.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.648 1.179 . . . . 0.0 112.196 -174.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.98 8.53 3.5 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -159.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.25 34.65 0.09 OUTLIER Glycine 0 CA--C 1.547 2.034 0 N-CA-C 117.642 1.817 . . . . 0.0 117.642 167.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.58 85.66 1.55 Allowed Glycine 0 CA--C 1.541 1.664 0 CA-C-N 119.028 1.414 . . . . 0.0 112.217 170.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.5 mt -53.9 118.2 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.988 1.315 . . . . 0.0 113.245 -164.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.18 -44.2 1.23 Allowed Glycine 0 CA--C 1.541 1.695 0 C-N-CA 125.238 1.399 . . . . 0.0 110.597 -153.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.42 173.71 3.86 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 160.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.1 p -157.98 85.07 0.88 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.969 -1.082 . . . . 0.0 112.429 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.4 167.83 33.04 Favored Glycine 0 CA--C 1.549 2.192 0 N-CA-C 116.426 1.331 . . . . 0.0 116.426 -169.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -63.61 113.42 2.12 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.977 3.785 . . . . 0.0 113.325 -170.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.5 p -72.26 -0.89 13.35 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -165.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 t -115.3 107.54 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 120.393 -1.442 . . . . 0.0 113.244 -167.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.7 m -66.24 168.36 8.79 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.07 151.37 47.01 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.964 1.305 . . . . 0.0 112.402 162.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -67.04 162.95 21.02 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.11 -56.88 4.8 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.811 1.196 . . . . 0.0 112.243 -168.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.59 162.9 17.75 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 127.672 2.389 . . . . 0.0 113.472 166.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 t -142.66 172.93 12.03 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.355 -1.466 . . . . 0.0 114.257 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 t -73.66 73.67 1.5 Allowed 'General case' 0 CA--C 1.555 1.166 0 O-C-N 120.58 -1.325 . . . . 0.0 113.269 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -66.4 93.3 0.22 Allowed 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.547 -1.346 . . . . 0.0 113.803 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.59 68.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 127.94 2.496 . . . . 0.0 115.408 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -62.46 -49.94 73.45 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 120.14 -1.6 . . . . 0.0 113.236 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -160.71 174.41 3.91 Favored Pre-proline 0 CA--C 1.569 1.675 0 O-C-N 120.641 -1.287 . . . . 0.0 114.448 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.41 -22.16 15.53 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.869 3.713 . . . . 0.0 118.189 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.1 -23.97 15.98 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.096 1.358 . . . . 0.0 113.508 170.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -120.72 93.63 4.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.992 1.717 . . . . 0.0 112.079 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 t -123.57 115.84 22.16 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.488 1.115 . . . . 0.0 109.747 150.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -148.04 147.13 29.25 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -158.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.5 m -67.55 78.79 0.18 Allowed 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.259 1.6 0 C-N-CA 125.397 1.479 . . . . 0.0 112.815 167.916 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -85.13 145.69 27.5 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.256 1.822 . . . . 0.0 111.916 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.2 p -80.42 159.83 25.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.955 1.702 . . . . 0.0 114.929 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -40.9 135.19 1.76 Allowed 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 126.09 1.756 . . . . 0.0 112.803 168.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 65.37 -21.25 0.09 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -171.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -45.31 121.78 4.93 Favored Glycine 0 CA--C 1.546 2.021 0 O-C-N 120.097 -1.627 . . . . 0.0 112.544 163.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.54 100.85 5.43 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.905 -1.35 . . . . 0.0 112.715 -173.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -65.61 -36.66 84.37 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 125.384 1.473 . . . . 0.0 114.503 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.04 -142.35 6.42 Favored Glycine 0 CA--C 1.548 2.152 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.45 50.43 37.95 Favored Glycine 0 CA--C 1.543 1.833 0 O-C-N 120.633 -1.51 . . . . 0.0 112.776 -159.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -51.33 118.4 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 125.685 1.594 . . . . 0.0 112.774 -169.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.53 -53.26 0.81 Allowed Glycine 0 CA--C 1.537 1.443 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -145.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -52.22 152.56 3.25 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 122.133 -0.628 . . . . 0.0 111.603 137.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.6 p -150.93 134.59 16.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.752 1.621 . . . . 0.0 110.728 166.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.26 -168.41 41.41 Favored Glycine 0 CA--C 1.549 2.167 0 O-C-N 121.173 -0.954 . . . . 0.0 114.872 -173.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.82 75.1 0.07 OUTLIER 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 125.153 3.902 . . . . 0.0 115.961 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.0 p -60.71 32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 128.954 2.902 . . . . 0.0 118.291 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 t -141.45 97.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 O-C-N 119.504 -1.997 . . . . 0.0 112.702 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.43 169.43 7.47 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.41 106.82 14.59 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.878 2.071 . . . . 0.0 113.971 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -35.17 114.29 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.288 1.435 . . . . 0.0 113.996 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.55 -45.34 1.16 Allowed Glycine 0 CA--C 1.543 1.832 0 C-N-CA 124.368 0.985 . . . . 0.0 112.314 -151.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.97 153.65 47.35 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.403 2.281 . . . . 0.0 112.107 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.7 m -111.04 156.86 20.66 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.054 2.542 . . . . 0.0 113.29 -174.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.6 t -63.23 77.19 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 O-C-N 120.128 -1.608 . . . . 0.0 110.72 165.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -77.88 92.28 4.24 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.242 1.017 . . . . 0.0 111.9 -158.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -63.98 59.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 128.035 2.534 . . . . 0.0 115.497 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -58.77 -46.45 87.46 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.659 -1.901 . . . . 0.0 111.703 170.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -145.29 153.31 52.18 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.786 1.634 . . . . 0.0 112.09 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.24 -36.03 96.02 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.133 2.555 . . . . 0.0 113.254 169.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.79 -6.59 2.78 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 166.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -130.11 -158.02 0.86 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 129.303 3.041 . . . . 0.0 109.288 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t 136.53 76.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 130.059 3.344 . . . . 0.0 108.285 159.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -97.26 155.29 16.93 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.032 1.333 . . . . 0.0 112.789 -164.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.4 m -70.4 78.73 0.55 Allowed 'General case' 0 CA--C 1.549 0.916 0 O-C-N 120.892 -1.13 . . . . 0.0 112.962 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.0 mt . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 116.711 -1.614 . . . . 0.0 114.592 162.921 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -89.01 133.07 34.46 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.769 2.028 . . . . 0.0 110.463 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 m -70.14 160.55 31.86 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.863 1.265 . . . . 0.0 114.345 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -49.77 134.34 20.65 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.254 1.022 . . . . 0.0 111.648 170.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 65.87 -8.0 0.34 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.0 125.09 38.77 Favored Glycine 0 CA--C 1.541 1.678 0 O-C-N 120.093 -1.629 . . . . 0.0 112.678 170.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.76 107.39 0.69 Allowed 'General case' 0 CA--C 1.554 1.106 0 O-C-N 120.954 -1.321 . . . . 0.0 110.836 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.0 t -88.51 1.1 55.51 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.291 1.836 . . . . 0.0 113.589 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.5 121.84 0.67 Allowed Glycine 0 CA--C 1.539 1.584 0 O-C-N 120.846 -1.158 . . . . 0.0 114.442 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.81 69.27 0.28 Allowed Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 162.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.5 mm -41.67 116.72 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -159.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.01 -55.22 0.74 Allowed Glycine 0 CA--C 1.539 1.533 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -147.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -52.93 153.36 3.41 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.539 0.736 . . . . 0.0 112.713 144.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.3 p -151.58 150.92 30.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.755 2.022 . . . . 0.0 111.401 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.92 -167.81 32.25 Favored Glycine 0 CA--C 1.542 1.756 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.61 84.28 0.09 OUTLIER 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.255 3.303 . . . . 0.0 113.765 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -68.51 42.5 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 127.08 2.152 . . . . 0.0 115.945 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -146.16 102.61 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 119.959 -1.713 . . . . 0.0 113.175 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.4 m -60.58 158.05 13.16 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.76 151.69 33.35 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.986 1.314 . . . . 0.0 112.487 161.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.2 t -59.58 166.92 2.21 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.31 -59.49 0.26 Allowed Glycine 0 CA--C 1.546 2.011 0 C-N-CA 124.271 0.938 . . . . 0.0 113.469 -161.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.5 p -72.1 150.8 43.56 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.747 1.219 . . . . 0.0 114.189 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.2 p -125.45 143.95 50.76 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.839 -1.163 . . . . 0.0 113.371 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.8 t -67.6 74.12 0.16 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.435 1.494 . . . . 0.0 110.407 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -22.59 6.37 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 119.375 3.102 . . . . 0.0 119.375 -151.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.297 6.8 p 41.76 47.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.94 -45.33 90.69 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.687 1.595 . . . . 0.0 112.459 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -154.07 163.67 23.26 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 125.295 1.438 . . . . 0.0 110.9 168.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.35 -19.35 21.76 Favored 'Trans proline' 0 CA--C 1.556 1.594 0 C-N-CA 122.256 1.971 . . . . 0.0 116.831 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.47 -14.9 26.14 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 170.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -135.19 105.45 6.31 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.509 1.524 . . . . 0.0 113.299 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -121.15 96.65 5.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.03 2.532 . . . . 0.0 110.201 153.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -96.0 142.76 27.84 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.861 1.264 . . . . 0.0 111.772 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.3 m -68.66 87.88 0.34 Allowed 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.604 -1.31 . . . . 0.0 112.322 170.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.077 -1.439 . . . . 0.0 111.949 171.197 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -90.52 138.46 31.54 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.867 1.667 . . . . 0.0 112.069 171.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -66.87 173.9 3.3 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.781 1.633 . . . . 0.0 114.257 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.26 140.65 26.06 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.919 1.288 . . . . 0.0 112.475 167.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 63.78 42.57 6.07 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.86 130.74 9.23 Favored Glycine 0 CA--C 1.544 1.902 0 C-N-CA 126.001 1.763 . . . . 0.0 112.627 167.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -74.78 66.08 1.45 Allowed 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 119.639 1.72 . . . . 0.0 114.681 -172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.8 t -31.09 -39.16 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 129.682 3.193 . . . . 0.0 117.613 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.38 83.6 0.12 Allowed Glycine 0 CA--C 1.537 1.41 0 O-C-N 121.233 -0.917 . . . . 0.0 115.339 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.91 63.98 0.27 Allowed Glycine 0 CA--C 1.543 1.784 0 C-N-CA 124.582 1.087 . . . . 0.0 112.525 167.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.3 7.6 tt -74.01 27.3 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 119.405 3.113 . . . . 0.0 119.405 -128.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.82 -38.63 76.2 Favored Glycine 0 CA--C 1.544 1.876 0 O-C-N 120.408 -1.433 . . . . 0.0 111.945 138.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -50.1 150.01 2.56 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.103 1.361 . . . . 0.0 113.279 159.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.1 p -142.13 154.69 45.07 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.322 1.449 . . . . 0.0 111.856 166.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 17' ' ' THR . . . 158.46 -167.8 34.63 Favored Glycine 0 CA--C 1.542 1.747 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -65.54 69.64 0.34 Allowed 'Trans proline' 0 CA--C 1.554 1.505 0 C-N-CA 124.824 3.683 . . . . 0.0 114.36 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 15' ' ' GLY . 33.4 p -60.95 32.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -173.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.0 t -132.95 96.83 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 O-C-N 119.622 -1.924 . . . . 0.0 112.677 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.04 170.04 2.37 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 127.651 2.381 . . . . 0.0 117.163 -175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.7 120.0 29.7 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.953 1.701 . . . . 0.0 113.526 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 t -34.04 103.04 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.683 1.993 . . . . 0.0 115.43 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.23 -53.8 0.79 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.761 1.648 . . . . 0.0 110.715 -165.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.7 p -86.8 157.82 19.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.319 1.848 . . . . 0.0 112.955 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -142.85 165.2 28.03 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -73.15 74.48 1.26 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 128.245 2.618 . . . . 0.0 110.922 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -8.59 2.65 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 -154.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 14.9 p 30.49 63.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.0 mt -60.68 -34.76 74.82 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 120.474 -1.391 . . . . 0.0 113.06 167.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.21 159.16 5.19 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 127.802 2.441 . . . . 0.0 111.119 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -46.77 -34.02 14.98 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 124.061 3.174 . . . . 0.0 115.774 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.15 -27.39 66.39 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 172.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -144.07 104.91 4.19 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.583 1.553 . . . . 0.0 113.489 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 t -116.15 138.48 51.22 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.662 1.585 . . . . 0.0 111.837 146.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -138.44 148.81 44.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.562 1.945 . . . . 0.0 112.03 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.4 m -67.51 102.07 1.09 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.918 0.887 . . . . 0.0 111.783 168.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.894 2.078 . . . . 0.0 112.085 174.166 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -99.22 129.29 45.45 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.63 1.572 . . . . 0.0 112.365 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -53.69 154.82 3.5 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.966 1.706 . . . . 0.0 115.163 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -49.35 133.07 20.17 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.803 0.841 . . . . 0.0 111.337 164.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 73.08 -23.55 0.21 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.438 2.295 . . . . 0.0 115.73 -167.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.4 112.0 2.11 Favored Glycine 0 CA--C 1.545 1.958 0 O-C-N 120.505 -1.372 . . . . 0.0 113.823 171.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -76.86 123.95 27.0 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -166.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 71.8 m -62.9 -44.77 95.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.803 1.241 . . . . 0.0 114.015 173.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.89 -129.28 4.26 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.562 2.029 . . . . 0.0 112.683 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.47 54.5 19.36 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 121.686 -0.891 . . . . 0.0 110.874 -151.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -49.08 121.14 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.152 0.981 . . . . 0.0 113.021 -171.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.18 -50.39 0.89 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -142.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.94 163.05 0.54 Allowed 'General case' 0 CA--C 1.563 1.452 0 O-C-N 121.774 -0.839 . . . . 0.0 112.315 141.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.1 p -151.6 4.82 0.44 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.18 -134.07 8.22 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 116.794 1.477 . . . . 0.0 116.794 -171.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.91 138.42 16.6 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.624 2.883 . . . . 0.0 113.997 -167.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.4 p -105.68 -19.37 13.78 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.549 1.94 . . . . 0.0 115.217 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.36 96.65 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 O-C-N 120.174 -1.579 . . . . 0.0 114.03 -162.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.0 m -56.49 159.88 3.48 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.37 146.68 42.81 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.349 1.86 . . . . 0.0 113.777 167.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.0 t -59.79 111.74 1.57 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.765 1.226 . . . . 0.0 113.413 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.01 -55.18 0.52 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.1 1.809 . . . . 0.0 111.409 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 t -87.52 -176.58 5.64 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.673 1.589 . . . . 0.0 112.315 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -153.64 143.45 21.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.426 2.29 . . . . 0.0 110.672 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 t -58.08 81.17 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 127.582 2.353 . . . . 0.0 114.196 -171.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -74.48 83.99 1.99 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.505 1.922 . . . . 0.0 114.652 -164.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.91 76.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 C-N-CA 128.395 2.678 . . . . 0.0 115.608 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.7 -41.09 24.23 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.689 -1.257 . . . . 0.0 113.168 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -138.69 155.44 73.41 Favored Pre-proline 0 CA--C 1.553 1.093 0 O-C-N 120.756 -1.215 . . . . 0.0 112.765 173.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -38.58 -46.34 2.49 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.639 2.893 . . . . 0.0 115.027 165.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.91 -57.24 5.28 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -83.97 122.33 28.61 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.5 t -137.64 135.94 37.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.031 0.933 . . . . 0.0 111.43 149.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -129.4 147.5 51.23 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.253 1.421 . . . . 0.0 113.383 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.54 67.14 2.01 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 120.463 -1.398 . . . . 0.0 110.952 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 C--O 1.251 1.183 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.087 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -76.13 163.22 27.31 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 118.634 0.652 . . . . 0.0 110.855 153.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -87.1 -169.57 2.68 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -65.44 150.34 48.51 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.066 1.347 . . . . 0.0 111.184 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 61.1 16.07 6.81 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.37 126.07 7.95 Favored Glycine 0 CA--C 1.544 1.862 0 O-C-N 119.928 -1.732 . . . . 0.0 113.353 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -71.7 92.17 1.17 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.774 1.229 . . . . 0.0 111.616 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 p -103.78 12.62 34.37 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.682 2.393 . . . . 0.0 114.196 -169.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.04 68.83 0.07 OUTLIER Glycine 0 CA--C 1.544 1.894 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.82 88.08 0.47 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 162.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.1 mt -53.23 108.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 118.459 1.129 . . . . 0.0 112.838 -161.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.81 -42.28 1.27 Allowed Glycine 0 CA--C 1.544 1.885 0 C-N-CA 125.302 1.43 . . . . 0.0 111.228 -153.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -179.84 0.24 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.038 0.935 . . . . 0.0 112.905 155.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.2 p -151.24 139.37 20.16 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.045 -1.034 . . . . 0.0 111.894 157.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.78 173.85 24.08 Favored Glycine 0 CA--C 1.544 1.896 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.2 113.28 1.13 Allowed 'Trans proline' 0 CA--C 1.546 1.115 1 C-N-CA 125.329 4.019 . . . . 0.0 117.332 -168.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.4 p -82.74 20.73 1.1 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 128.706 2.802 . . . . 0.0 116.137 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.23 114.35 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 120.043 -1.661 . . . . 0.0 113.059 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.2 m -83.19 174.75 10.5 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 127.64 2.376 . . . . 0.0 116.643 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 117.86 9.81 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.645 1.578 . . . . 0.0 112.812 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -39.3 113.01 0.29 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.187 1.395 . . . . 0.0 114.283 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.8 -25.76 7.46 Favored Glycine 0 CA--C 1.545 1.955 0 C-N-CA 124.762 1.173 . . . . 0.0 114.319 -162.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.3 p -124.94 149.92 47.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.182 1.793 . . . . 0.0 114.398 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.1 m -115.74 137.39 52.13 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.795 2.838 . . . . 0.0 112.544 -173.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.84 84.03 0.31 Allowed 'General case' 0 CA--C 1.559 1.316 0 O-C-N 120.266 -1.521 . . . . 0.0 112.435 172.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -55.63 171.23 0.22 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 118.673 2.842 . . . . 0.0 118.673 -161.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.48 49.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.598 -1.314 . . . . 0.0 113.872 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.17 -50.62 67.42 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.711 1.604 . . . . 0.0 112.96 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -162.51 161.7 19.79 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 126.646 1.978 . . . . 0.0 110.118 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -56.81 -13.13 10.53 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.051 2.501 . . . . 0.0 117.323 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.53 -23.14 17.81 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 125.664 1.585 . . . . 0.0 114.831 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -115.0 97.4 6.2 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.64 1.576 . . . . 0.0 112.036 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.6 t -113.91 120.01 39.22 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.966 0.906 . . . . 0.0 110.774 148.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -130.26 146.3 51.85 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.909 1.684 . . . . 0.0 111.843 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.1 m -63.9 85.8 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 36' ' ' LEU . 40.5 mt . . . . . 0 C--O 1.25 1.088 0 C-N-CA 127.931 2.492 . . . . 0.0 112.81 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 44.5 p . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 118.852 -0.594 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -63.01 168.6 3.91 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 119.749 1.159 . . . . 0.0 112.051 147.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -117.97 -173.98 2.55 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.413 1.485 . . . . 0.0 110.915 163.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -47.89 135.24 12.54 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.123 0.969 . . . . 0.0 112.653 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 75.45 1.58 3.67 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.642 2.377 . . . . 0.0 114.838 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.06 114.52 4.79 Favored Glycine 0 CA--C 1.541 1.703 0 O-C-N 118.094 -2.879 . . . . 0.0 116.326 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -53.94 139.75 33.02 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 118.473 1.137 . . . . 0.0 112.924 160.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 p -154.8 -13.89 0.12 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -163.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.46 72.67 0.11 Allowed Glycine 0 CA--C 1.542 1.774 0 N-CA-C 117.358 1.703 . . . . 0.0 117.358 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.27 114.64 0.62 Allowed Glycine 0 CA--C 1.543 1.789 0 C-N-CA 125.918 1.723 . . . . 0.0 111.571 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 mm -54.38 115.96 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 118.875 1.337 . . . . 0.0 112.987 -170.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.63 -48.49 0.94 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 125.592 1.568 . . . . 0.0 110.255 -154.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.16 168.48 6.71 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 121.786 -0.832 . . . . 0.0 112.16 158.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.5 p -153.35 148.76 27.12 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.123 -0.986 . . . . 0.0 111.926 152.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.87 -165.97 24.1 Favored Glycine 0 CA--C 1.544 1.897 0 C-N-CA 124.268 0.937 . . . . 0.0 115.246 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.43 156.37 21.97 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 124.153 3.235 . . . . 0.0 114.057 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 p -129.28 54.74 1.79 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.305 1.042 . . . . 0.0 113.383 -169.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.5 t -152.14 122.43 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 121.089 -1.007 . . . . 0.0 113.017 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.2 m -82.18 172.12 13.53 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.62 2.082 . . . . 0.0 116.62 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.81 117.05 23.03 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.709 1.604 . . . . 0.0 112.763 168.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 t -47.38 136.27 9.77 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.93 -65.18 0.25 Allowed Glycine 0 CA--C 1.541 1.675 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -151.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.8 p -88.64 161.0 17.12 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.539 1.135 . . . . 0.0 113.516 171.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 t -149.48 166.54 28.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.454 -1.404 . . . . 0.0 113.67 170.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 t -82.1 85.81 6.71 Favored 'General case' 0 CA--C 1.552 1.058 0 O-C-N 120.244 -1.535 . . . . 0.0 113.771 -166.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -88.38 90.73 8.52 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 122.353 1.073 . . . . 0.0 113.678 -163.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -70.9 81.46 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -176.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.44 -47.31 82.15 Favored 'General case' 0 CA--C 1.555 1.141 0 O-C-N 120.324 -1.485 . . . . 0.0 114.929 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.82 144.79 1.57 Allowed Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 125.503 1.521 . . . . 0.0 111.259 -169.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . 0.278 8.2 Cg_endo -48.92 -37.91 37.58 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 124.246 3.298 . . . . 0.0 119.176 -153.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.87 -40.14 95.84 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 120.323 1.42 . . . . 0.0 113.652 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -91.06 154.76 19.17 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.469 1.908 . . . . 0.0 113.36 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.4 t 158.79 112.94 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 128.687 2.795 . . . . 0.0 111.158 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -151.95 148.28 27.56 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -153.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 m -79.08 92.31 5.0 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.166 1.787 . . . . 0.0 112.004 168.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.271 -1.824 . . . . 0.0 111.767 165.845 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -79.02 142.54 36.49 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.271 1.828 . . . . 0.0 111.916 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -73.16 159.01 34.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.668 1.587 . . . . 0.0 115.193 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -40.03 136.86 1.07 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 126.069 1.747 . . . . 0.0 113.107 166.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 66.89 -11.11 0.27 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -174.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.12 152.17 20.0 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-N 120.433 1.47 . . . . 0.0 114.133 168.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -89.04 114.01 25.17 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 117.679 0.739 . . . . 0.0 112.031 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.4 t -92.59 -44.39 8.63 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 126.755 2.022 . . . . 0.0 115.57 -171.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.08 35.38 0.45 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 119.423 2.529 . . . . 0.0 119.423 -168.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.62 66.08 2.75 Favored Glycine 0 CA--C 1.545 1.948 0 CA-C-N 119.301 1.55 . . . . 0.0 113.447 175.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.4 mt -41.35 115.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.568 1.547 . . . . 0.0 113.825 -167.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.69 -54.27 0.79 Allowed Glycine 0 N--CA 1.476 1.324 0 N-CA-C 108.291 -1.923 . . . . 0.0 108.291 -151.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -55.91 156.69 4.97 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 121.498 0.666 . . . . 0.0 112.311 140.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.7 p -143.94 138.54 28.56 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.004 1.722 . . . . 0.0 111.115 162.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.26 -174.64 44.93 Favored Glycine 0 CA--C 1.55 2.223 0 N-CA-C 116.584 1.394 . . . . 0.0 116.584 -174.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -65.98 80.46 0.28 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 125.043 3.829 . . . . 0.0 114.202 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.3 p -63.79 33.15 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -167.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.0 t -139.02 93.79 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 O-C-N 119.566 -1.958 . . . . 0.0 114.182 -171.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.8 m -58.79 159.21 7.06 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.046 2.138 . . . . 0.0 115.991 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.33 158.56 11.53 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.116 1.366 . . . . 0.0 113.065 164.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.7 t -69.96 176.34 3.8 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.17 -58.25 2.33 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 121.023 -1.048 . . . . 0.0 112.828 -166.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.4 169.55 17.07 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 126.228 1.811 . . . . 0.0 113.201 168.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.1 t -134.95 170.1 16.39 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.847 2.459 . . . . 0.0 114.832 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.5 t -86.12 69.19 10.47 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 127.889 2.476 . . . . 0.0 112.194 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -54.26 160.75 1.53 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 118.974 2.953 . . . . 0.0 118.974 -161.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.11 59.4 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 127.41 2.284 . . . . 0.0 112.857 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.42 -55.03 6.91 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.304 -1.497 . . . . 0.0 112.695 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -157.32 152.67 21.93 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 126.719 2.007 . . . . 0.0 109.975 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -51.13 -28.81 26.47 Favored 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 122.886 2.391 . . . . 0.0 117.536 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.43 -18.14 63.01 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 120.585 1.539 . . . . 0.0 114.904 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -124.89 135.37 52.81 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.531 2.332 . . . . 0.0 112.997 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 t -158.59 108.25 2.01 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.041 -1.037 . . . . 0.0 109.778 165.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -119.52 149.49 41.82 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.043 1.737 . . . . 0.0 111.596 -166.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -66.46 84.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.224 0.609 . . . . 0.0 112.0 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 C--O 1.252 1.21 0 C-N-CA 127.118 2.167 . . . . 0.0 112.563 -177.834 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -95.81 132.78 40.7 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.03 1.732 . . . . 0.0 111.813 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 m -65.29 170.33 4.83 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -50.97 132.95 27.5 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.86 1.264 . . . . 0.0 111.918 167.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 67.55 53.09 0.74 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.643 1.977 . . . . 0.0 115.324 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.33 126.07 5.82 Favored Glycine 0 CA--C 1.543 1.819 0 C-N-CA 126.384 1.945 . . . . 0.0 111.945 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -74.1 60.77 0.8 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 119.517 1.658 . . . . 0.0 114.086 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.8 t -16.07 -59.62 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.928 3.291 . . . . 0.0 117.495 172.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.05 79.85 0.21 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.402 1.001 . . . . 0.0 112.992 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.5 60.58 0.47 Allowed Glycine 0 CA--C 1.543 1.8 0 C-N-CA 124.99 1.281 . . . . 0.0 111.421 163.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.6 mt -49.39 112.46 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 125.163 1.385 . . . . 0.0 113.804 -156.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.99 -53.19 0.79 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -150.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -50.54 154.07 1.43 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 121.634 0.73 . . . . 0.0 112.165 137.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 p -149.27 151.06 33.56 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.81 1.644 . . . . 0.0 111.141 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.76 -168.04 31.08 Favored Glycine 0 CA--C 1.549 2.159 0 C-N-CA 124.718 1.151 . . . . 0.0 113.572 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.16 113.78 1.74 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.228 3.285 . . . . 0.0 113.82 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -99.38 16.26 23.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -124.7 96.95 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.688 -1.258 . . . . 0.0 112.847 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.1 m -60.47 160.03 9.46 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.296 1.838 . . . . 0.0 115.683 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.6 165.21 5.16 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.112 1.365 . . . . 0.0 113.411 164.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.9 t -75.68 173.67 10.77 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 169.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.35 -63.06 0.16 Allowed Glycine 0 CA--C 1.539 1.581 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -159.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.9 p -62.95 168.92 3.61 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.577 1.551 . . . . 0.0 114.53 167.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -153.38 158.29 41.27 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.906 1.282 . . . . 0.0 112.525 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.8 t -63.46 75.81 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.757 1.223 . . . . 0.0 111.069 170.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.22 89.53 0.87 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.703 1.201 . . . . 0.0 111.892 -165.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.18 94.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 C-N-CA 126.215 1.806 . . . . 0.0 113.485 170.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -96.41 -44.03 7.38 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.416 1.486 . . . . 0.0 111.012 168.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -147.2 156.55 46.55 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 126.852 2.061 . . . . 0.0 112.347 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -40.52 -45.16 4.51 Favored 'Trans proline' 0 CA--C 1.554 1.514 0 C-N-CA 123.887 3.058 . . . . 0.0 115.748 159.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.01 -16.02 61.07 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 171.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -140.51 90.64 2.37 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.316 1.846 . . . . 0.0 112.675 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.4 t -109.31 124.59 51.18 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.237 -0.915 . . . . 0.0 111.063 148.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -138.27 141.58 39.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.728 1.211 . . . . 0.0 113.696 -168.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.3 79.67 0.06 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.678 1.591 . . . . 0.0 112.712 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.072 0.949 . . . . 0.0 112.408 165.219 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -80.37 144.27 32.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.048 1.339 . . . . 0.0 111.588 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -88.3 172.28 9.54 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -41.39 132.54 2.67 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 127.579 2.352 . . . . 0.0 113.191 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 67.1 -13.16 0.21 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.68 141.42 44.64 Favored Glycine 0 CA--C 1.55 2.234 0 O-C-N 120.063 -1.648 . . . . 0.0 112.911 167.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -75.48 108.37 8.24 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.999 -1.295 . . . . 0.0 113.318 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.6 t -74.6 -37.88 62.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.444 1.898 . . . . 0.0 112.94 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.23 158.84 28.44 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-O 123.07 1.372 . . . . 0.0 114.923 -173.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.67 46.71 0.02 OUTLIER Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.521 2.01 . . . . 0.0 110.342 -169.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.7 mt -50.8 117.89 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.836 1.254 . . . . 0.0 112.268 -158.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.54 -59.52 0.69 Allowed Glycine 0 CA--C 1.536 1.399 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -148.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.21 156.27 5.86 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-O 121.737 0.779 . . . . 0.0 112.264 145.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.6 p -138.68 147.98 43.43 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.251 1.82 . . . . 0.0 110.343 160.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.31 -161.85 32.0 Favored Glycine 0 CA--C 1.543 1.804 0 O-C-N 120.65 -1.281 . . . . 0.0 115.615 -175.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -71.16 79.09 1.42 Allowed 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.631 2.887 . . . . 0.0 113.605 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.2 p -71.18 25.82 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 -167.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 t -140.61 100.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 119.742 -1.849 . . . . 0.0 113.659 -173.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m -63.64 163.58 11.12 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.7 122.48 28.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.72 1.608 . . . . 0.0 113.093 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.9 t -44.34 135.21 4.69 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.9 1.28 . . . . 0.0 114.109 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.97 -40.97 2.28 Favored Glycine 0 CA--C 1.545 1.943 0 C-N-CA 124.209 0.909 . . . . 0.0 112.58 -154.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p -118.06 151.32 37.76 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.851 1.66 . . . . 0.0 114.264 175.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.8 m -109.58 142.95 39.96 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.02 2.528 . . . . 0.0 113.668 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.9 t -73.28 84.2 1.4 Allowed 'General case' 0 CA--C 1.552 1.021 0 O-C-N 121.101 -0.999 . . . . 0.0 111.099 167.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -57.79 178.28 0.09 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.59 49.95 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.479 1.133 . . . . 0.0 112.678 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.72 -44.49 96.09 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.563 1.545 . . . . 0.0 111.931 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -142.65 160.33 54.08 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.724 1.61 . . . . 0.0 110.065 159.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -45.05 -39.52 14.83 Favored 'Trans proline' 0 CA--C 1.555 1.53 0 C-N-CA 122.051 1.834 . . . . 0.0 113.203 161.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.91 -25.95 63.0 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -122.18 90.63 3.34 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.836 1.655 . . . . 0.0 111.948 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.0 t -116.23 107.28 14.66 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.973 0.892 . . . . 0.0 111.838 158.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -113.32 152.89 29.34 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.352 1.861 . . . . 0.0 111.552 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.27 84.97 0.15 Allowed 'General case' 0 CA--C 1.55 0.953 0 O-C-N 121.374 -0.829 . . . . 0.0 112.673 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 C--O 1.25 1.129 0 C-N-CA 128.81 2.844 . . . . 0.0 111.835 179.584 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -71.97 141.47 49.4 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.619 0.767 . . . . 0.0 111.987 166.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -91.55 155.69 18.2 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -38.16 132.03 1.07 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 127.181 2.192 . . . . 0.0 113.528 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 67.65 -27.52 0.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -170.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -42.58 119.91 2.26 Favored Glycine 0 CA--C 1.545 1.934 0 O-C-N 120.674 -1.267 . . . . 0.0 113.879 171.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -75.47 136.65 40.65 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.688 1.195 . . . . 0.0 111.959 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.0 p -144.67 28.36 1.3 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.369 1.067 . . . . 0.0 113.737 -166.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.05 69.97 0.03 OUTLIER Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.686 1.612 . . . . 0.0 114.981 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.25 86.17 0.4 Allowed Glycine 0 N--CA 1.471 0.996 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 152.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.6 mt -53.92 110.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 118.901 1.351 . . . . 0.0 111.987 -164.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.15 -48.59 0.86 Allowed Glycine 0 CA--C 1.544 1.89 0 C-N-CA 125.032 1.301 . . . . 0.0 110.401 -149.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.68 170.81 1.32 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.498 1.119 . . . . 0.0 112.718 153.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.2 p -152.27 147.61 26.57 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.425 -0.797 . . . . 0.0 111.957 158.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.55 175.89 25.39 Favored Glycine 0 CA--C 1.54 1.602 0 N-CA-C 115.319 0.888 . . . . 0.0 115.319 175.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.6 122.39 3.95 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.826 3.684 . . . . 0.0 114.595 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.3 p -83.32 -55.38 4.36 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.4 1.88 . . . . 0.0 113.117 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.2 t -66.0 111.36 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 C-N-CA 125.46 1.504 . . . . 0.0 114.102 -170.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.4 m -73.25 172.68 10.71 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.48 130.03 38.86 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 126.47 1.908 . . . . 0.0 114.087 172.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -52.14 113.78 1.13 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.244 1.018 . . . . 0.0 112.982 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.44 -45.23 1.03 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.034 1.302 . . . . 0.0 111.915 -163.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.4 p -127.41 -176.35 3.72 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 127.348 2.259 . . . . 0.0 111.827 170.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -148.06 155.44 41.49 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 119.358 -2.089 . . . . 0.0 112.344 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.7 t -69.46 77.32 0.4 Allowed 'General case' 0 CA--C 1.557 1.245 0 O-C-N 120.421 -1.424 . . . . 0.0 111.032 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 87.27 0.68 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.428 1.491 . . . . 0.0 113.624 -167.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.9 93.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.269 1.027 . . . . 0.0 113.757 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -93.5 -39.83 10.66 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.356 1.462 . . . . 0.0 111.408 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -150.39 163.67 23.38 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.934 1.694 . . . . 0.0 113.308 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.31 -14.66 35.66 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 123.357 2.705 . . . . 0.0 114.938 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.9 -11.91 27.82 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 125.974 1.71 . . . . 0.0 115.026 165.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -140.88 97.3 3.16 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.163 1.785 . . . . 0.0 112.767 -175.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -119.96 136.25 54.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.273 1.029 . . . . 0.0 110.702 145.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -146.44 146.14 30.47 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.216 1.406 . . . . 0.0 112.578 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.9 m -70.52 81.44 0.58 Allowed 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 176.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.8 mt . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.219 1.808 . . . . 0.0 115.359 177.681 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -72.21 141.73 49.01 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.879 0.872 . . . . 0.0 111.763 167.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.5 m -65.54 148.88 51.0 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -47.2 133.71 11.72 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.237 0.615 . . . . 0.0 111.545 157.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 63.06 53.57 2.3 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.759 1.224 . . . . 0.0 113.883 -169.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.08 117.76 2.67 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 124.923 1.249 . . . . 0.0 114.036 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -67.73 63.93 0.08 Allowed 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 125.538 1.535 . . . . 0.0 114.552 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.2 p -66.24 43.73 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 128.146 2.578 . . . . 0.0 115.689 174.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.68 78.93 0.03 OUTLIER Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.666 -1.271 . . . . 0.0 113.591 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.33 88.52 0.39 Allowed Glycine 0 CA--C 1.534 1.236 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 148.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.2 mt -50.63 108.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 119.746 1.773 . . . . 0.0 113.089 -163.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.28 -48.51 0.86 Allowed Glycine 0 CA--C 1.544 1.886 0 C-N-CA 125.612 1.577 . . . . 0.0 110.081 -152.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.57 166.07 0.14 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.156 0.982 . . . . 0.0 112.624 145.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.6 p -152.32 157.99 42.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.29 1.036 . . . . 0.0 111.468 156.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.39 -175.11 20.64 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -46.23 115.36 1.11 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 125.063 3.842 . . . . 0.0 115.024 -173.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.7 p -72.35 -65.94 0.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.008 1.723 . . . . 0.0 112.414 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -50.22 107.29 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 126.799 2.04 . . . . 0.0 114.31 -169.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.0 m -66.0 179.22 0.94 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 128.196 2.598 . . . . 0.0 117.119 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 129.28 37.52 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.685 1.594 . . . . 0.0 111.36 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -45.13 112.86 0.49 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.47 -44.78 1.37 Allowed Glycine 0 CA--C 1.549 2.162 0 C-N-CA 125.444 1.497 . . . . 0.0 113.68 -167.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 p -89.87 148.02 23.41 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 127.0 2.12 . . . . 0.0 113.198 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 m -124.56 142.26 51.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.324 1.85 . . . . 0.0 113.927 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -73.19 83.73 1.35 Allowed 'General case' 0 CA--C 1.554 1.109 0 O-C-N 120.357 -1.464 . . . . 0.0 111.257 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -12.81 8.59 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 -150.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.304 7.9 p 39.45 46.24 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 126.936 2.094 . . . . 0.0 115.5 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.07 -45.06 74.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.014 1.326 . . . . 0.0 111.801 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -136.61 157.11 75.76 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.111 1.364 . . . . 0.0 110.196 159.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.7 -16.94 16.34 Favored 'Trans proline' 0 CA--C 1.558 1.701 0 C-N-CA 122.318 2.012 . . . . 0.0 114.974 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.43 -18.23 25.77 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 127.165 2.186 . . . . 0.0 115.811 167.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -140.79 93.94 2.66 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.042 1.737 . . . . 0.0 112.606 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 t -122.35 91.64 3.55 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.052 1.741 . . . . 0.0 111.239 167.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.96 146.07 24.19 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.815 1.246 . . . . 0.0 113.735 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.9 m -66.07 95.13 0.26 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.328 -0.857 . . . . 0.0 111.929 156.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.9 mt . . . . . 0 C--O 1.257 1.462 0 CA-C-O 117.049 -1.453 . . . . 0.0 110.511 161.446 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.949 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -70.95 153.11 42.94 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 119.584 1.084 . . . . 0.0 112.156 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 m -74.58 161.36 29.8 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.59 1.556 . . . . 0.0 114.873 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -50.42 132.61 24.94 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.305 1.042 . . . . 0.0 110.696 159.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 63.39 65.57 0.75 Allowed 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -171.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.43 -89.54 0.03 OUTLIER Glycine 0 CA--C 1.555 2.557 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -84.84 170.96 12.63 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 129.607 3.163 . . . . 0.0 115.153 -6.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.97 11.44 13.41 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 128.053 2.541 . . . . 0.0 114.865 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.18 -164.29 10.78 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 126.487 1.994 . . . . 0.0 114.837 169.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.97 60.53 3.33 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.969 -0.724 . . . . 0.0 112.121 -164.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.3 mt -51.43 108.49 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 126.032 1.733 . . . . 0.0 111.745 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.38 -47.56 0.87 Allowed Glycine 0 CA--C 1.541 1.699 0 C-N-CA 124.705 1.145 . . . . 0.0 110.331 -147.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.33 164.42 0.96 Allowed 'General case' 0 CA--C 1.554 1.099 0 O-C-N 121.893 -0.769 . . . . 0.0 111.156 139.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.3 p -154.58 164.13 39.17 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.537 1.135 . . . . 0.0 111.972 164.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.19 179.22 19.01 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 116.052 1.181 . . . . 0.0 116.052 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -50.68 119.7 5.53 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 125.239 3.959 . . . . 0.0 116.648 -168.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.7 p -77.39 -39.53 46.91 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.626 1.57 . . . . 0.0 114.631 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.76 102.31 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 125.045 1.338 . . . . 0.0 114.393 -161.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -85.46 -177.92 6.57 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.18 146.2 55.27 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.73 1.612 . . . . 0.0 113.622 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.4 p -77.43 73.58 4.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.025 -1.047 . . . . 0.0 111.832 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.02 -50.71 0.04 OUTLIER Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.956 1.741 . . . . 0.0 110.764 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.2 p -74.08 177.44 5.71 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.564 1.146 . . . . 0.0 113.482 161.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.8 m -148.25 143.31 26.89 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.821 -1.174 . . . . 0.0 113.975 165.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.3 t -64.76 86.42 0.05 Allowed 'General case' 0 CA--C 1.558 1.278 0 O-C-N 120.414 -1.429 . . . . 0.0 111.954 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.12 161.15 11.45 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -160.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.09 134.54 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 O-C-N 120.629 -1.295 . . . . 0.0 111.253 164.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -152.68 -53.43 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.241 1.017 . . . . 0.0 111.866 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -158.04 164.09 22.46 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 124.772 1.229 . . . . 0.0 111.091 165.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -41.63 -42.3 5.99 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.808 3.006 . . . . 0.0 115.818 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.11 -4.67 18.21 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -143.65 118.1 9.7 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.751 1.621 . . . . 0.0 113.645 -170.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 t -135.48 95.59 3.29 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.38 -0.825 . . . . 0.0 110.996 153.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -109.8 150.12 28.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.893 1.277 . . . . 0.0 113.148 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.2 m -79.08 89.56 4.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.617 1.167 . . . . 0.0 113.064 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.258 1.513 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.98 163.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -69.57 136.25 51.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.938 1.695 . . . . 0.0 111.492 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -75.83 158.38 32.22 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -49.92 132.65 22.76 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.145 1.378 . . . . 0.0 111.619 167.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 64.5 42.44 5.01 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.03 129.15 6.43 Favored Glycine 0 CA--C 1.544 1.881 0 C-N-CA 125.844 1.688 . . . . 0.0 112.872 168.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -66.72 72.73 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.219 1.51 . . . . 0.0 114.589 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.7 t -31.31 -54.77 0.24 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 128.127 2.571 . . . . 0.0 116.012 171.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.74 45.69 0.5 Allowed Glycine 0 CA--C 1.539 1.566 0 N-CA-C 118.095 1.998 . . . . 0.0 118.095 -168.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.22 65.52 1.27 Allowed Glycine 0 CA--C 1.546 1.981 0 O-C-N 121.159 -1.2 . . . . 0.0 113.723 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.2 mt -44.1 114.27 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 118.984 1.392 . . . . 0.0 113.892 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.1 -54.62 0.78 Allowed Glycine 0 CA--C 1.537 1.425 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -154.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.82 160.72 4.34 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 122.071 0.939 . . . . 0.0 111.757 139.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.0 p -148.54 149.37 31.48 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.15 1.78 . . . . 0.0 111.138 163.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 17' ' ' THR . . . 163.07 -166.95 37.21 Favored Glycine 0 CA--C 1.546 2.007 0 O-C-N 120.96 -1.087 . . . . 0.0 114.949 -175.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.73 80.97 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.894 3.062 . . . . 0.0 113.027 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 15' ' ' GLY . 25.7 p -70.73 33.0 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 118.151 2.648 . . . . 0.0 118.151 -166.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 t -137.93 96.28 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 O-C-N 120.132 -1.605 . . . . 0.0 113.317 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.47 156.87 7.41 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.19 167.12 0.13 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.997 0.919 . . . . 0.0 112.71 153.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.8 t -82.75 -178.02 6.94 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.47 -66.07 1.02 Allowed Glycine 0 CA--C 1.539 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 111.898 -165.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.42 161.25 30.0 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.352 1.461 . . . . 0.0 114.069 170.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.7 p -128.94 151.12 50.02 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 130.936 3.694 . . . . 0.0 111.839 -168.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.6 t -74.42 74.94 1.91 Allowed 'General case' 0 CA--C 1.559 1.29 0 O-C-N 120.238 -1.538 . . . . 0.0 111.571 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -63.71 165.15 8.72 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -167.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 p -137.13 105.83 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 C-N-CA 125.534 1.533 . . . . 0.0 114.558 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.86 -50.33 6.1 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.451 1.5 . . . . 0.0 111.899 167.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.76 157.17 36.11 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 128.013 2.525 . . . . 0.0 108.85 171.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -50.07 -39.62 50.78 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 122.844 2.363 . . . . 0.0 115.107 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -50.96 -25.4 4.62 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -122.56 135.6 54.67 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.08 2.152 . . . . 0.0 113.342 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.74 111.18 1.15 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.229 -0.919 . . . . 0.0 113.427 165.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -122.71 151.75 41.25 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.47 1.908 . . . . 0.0 112.75 -169.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.5 m -61.79 88.88 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.9 0.48 . . . . 0.0 111.378 168.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.256 1.432 0 C-N-CA 128.456 2.702 . . . . 0.0 112.638 174.953 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -90.36 133.29 35.08 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 127.303 2.241 . . . . 0.0 111.276 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.1 p -75.81 166.67 23.18 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.938 1.695 . . . . 0.0 113.784 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -58.83 147.27 34.26 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 58.39 -11.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -161.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.06 122.67 24.32 Favored Glycine 0 CA--C 1.542 1.747 0 O-C-N 119.687 -1.883 . . . . 0.0 113.65 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -68.42 76.51 0.26 Allowed 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 118.946 1.373 . . . . 0.0 112.632 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . 52.5 t -51.19 -31.2 19.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.037 1.735 . . . . 0.0 115.373 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.75 106.86 0.29 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 117.498 1.759 . . . . 0.0 117.498 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.45 85.43 0.34 Allowed Glycine 0 CA--C 1.534 1.237 0 O-C-N 120.895 -1.356 . . . . 0.0 109.961 154.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.3 mt -49.84 113.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 118.903 1.351 . . . . 0.0 113.052 -161.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.64 -45.94 1.1 Allowed Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.339 1.447 . . . . 0.0 110.6 -151.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.69 171.5 0.21 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 125.273 1.429 . . . . 0.0 112.714 153.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.8 p -153.63 174.47 14.44 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.693 1.197 . . . . 0.0 111.505 160.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 -175.29 19.55 Favored Glycine 0 CA--C 1.546 2.031 0 C-N-CA 124.233 0.92 . . . . 0.0 114.353 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.03 100.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 124.626 3.551 . . . . 0.0 116.804 -168.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -83.55 22.78 1.02 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.964 2.506 . . . . 0.0 114.2 -175.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -149.09 114.27 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 120.171 -1.581 . . . . 0.0 111.924 -173.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.0 m -70.14 167.13 18.45 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.93 140.29 38.09 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.662 1.585 . . . . 0.0 113.81 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 t -49.94 111.93 0.59 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.359 1.064 . . . . 0.0 113.55 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.94 -47.26 1.0 Allowed Glycine 0 CA--C 1.543 1.838 0 C-N-CA 125.34 1.448 . . . . 0.0 112.921 -164.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.63 149.61 40.41 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.294 2.237 . . . . 0.0 113.055 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.4 m -121.05 142.01 50.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.295 1.438 . . . . 0.0 112.749 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 t -57.52 88.85 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 126.31 1.844 . . . . 0.0 111.463 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -10.35 51.35 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -149.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.308 9.3 p 34.53 52.93 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 127.883 2.473 . . . . 0.0 116.663 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.0 -45.07 78.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.543 1.537 . . . . 0.0 112.413 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -152.28 169.77 9.03 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 125.49 1.516 . . . . 0.0 110.976 164.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -48.55 -33.11 22.77 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.257 2.638 . . . . 0.0 116.802 178.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.42 -10.76 48.13 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -137.68 101.5 4.49 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.456 1.502 . . . . 0.0 113.723 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 t -122.47 91.96 3.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.874 2.469 . . . . 0.0 110.505 158.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -92.65 152.4 19.57 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 120.503 -1.373 . . . . 0.0 112.588 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 76.1 m -78.21 78.13 4.69 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.697 -1.252 . . . . 0.0 110.989 162.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.188 -1.387 . . . . 0.0 112.485 161.671 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -79.24 145.06 33.79 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.953 1.301 . . . . 0.0 112.37 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.3 m -80.29 158.17 26.21 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.734 1.214 . . . . 0.0 113.82 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -38.59 132.55 1.14 Allowed 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.875 1.67 . . . . 0.0 112.573 167.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 70.05 -23.12 0.16 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -55.69 137.72 45.46 Favored Glycine 0 CA--C 1.55 2.261 0 O-C-N 120.233 -1.542 . . . . 0.0 113.561 168.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -71.87 133.89 45.73 Favored 'General case' 0 CA--C 1.551 1.004 0 O-C-N 120.694 -1.474 . . . . 0.0 112.183 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.5 t -106.07 -33.34 7.91 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.73 2.012 . . . . 0.0 113.847 -176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -164.16 -166.45 23.07 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 120.664 -1.273 . . . . 0.0 115.769 -169.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.05 -98.2 0.97 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.147 1.832 . . . . 0.0 113.349 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.77 71.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 126.053 1.741 . . . . 0.0 114.604 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 40.19 41.68 2.18 Favored Glycine 0 CA--C 1.544 1.889 0 C-N-CA 125.611 1.576 . . . . 0.0 113.878 -173.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -80.94 132.27 35.4 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -150.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.2 p -96.1 -164.0 1.11 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.228 1.811 . . . . 0.0 113.389 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.06 -151.99 41.37 Favored Glycine 0 CA--C 1.551 2.329 0 O-C-N 119.67 -1.894 . . . . 0.0 115.863 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -71.64 62.02 2.93 Favored 'Trans proline' 0 CA--C 1.548 1.175 0 C-N-CA 123.993 3.128 . . . . 0.0 114.97 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 56.1 p -71.76 32.04 0.05 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 -170.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -145.74 97.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 O-C-N 120.006 -1.684 . . . . 0.0 112.121 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.8 m -59.99 155.85 15.9 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.39 152.69 45.24 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.857 1.263 . . . . 0.0 112.622 162.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 t -62.3 171.37 1.89 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.21 -57.6 1.11 Allowed Glycine 0 CA--C 1.543 1.792 0 C-N-CA 124.172 0.891 . . . . 0.0 112.951 -164.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.7 p -76.52 145.95 38.76 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 175.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.1 m -99.09 142.28 30.79 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.806 2.043 . . . . 0.0 113.871 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.6 t -70.84 86.28 0.69 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 124.846 1.259 . . . . 0.0 110.82 163.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.436 ' HG3' ' HB2' ' A' ' 36' ' ' LEU . 23.5 mm-40 -64.08 177.39 0.81 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 117.875 2.546 . . . . 0.0 117.875 -165.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 p -140.37 50.75 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 CA-C-O 122.515 1.15 . . . . 0.0 113.544 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -56.65 -44.6 81.49 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.328 1.851 . . . . 0.0 113.362 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -147.38 164.51 22.59 Favored Pre-proline 0 CA--C 1.559 1.324 0 C-N-CA 126.072 1.749 . . . . 0.0 110.02 162.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -43.37 -39.49 9.13 Favored 'Trans proline' 0 CA--C 1.549 1.272 0 C-N-CA 123.97 3.113 . . . . 0.0 116.969 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.17 -33.05 44.37 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -95.5 83.55 3.82 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.638 1.975 . . . . 0.0 113.523 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.1 t -105.16 104.93 14.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.643 0.777 . . . . 0.0 111.776 156.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -115.91 157.59 24.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.638 2.375 . . . . 0.0 112.16 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.9 m -71.26 79.83 0.72 Allowed 'General case' 0 CA--C 1.554 1.111 0 O-C-N 121.472 -0.767 . . . . 0.0 112.806 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.436 ' HB2' ' HG3' ' A' ' 26' ' ' GLN . 76.6 mt . . . . . 0 C--O 1.251 1.181 0 C-N-CA 126.432 1.893 . . . . 0.0 112.162 168.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -67.8 128.33 36.09 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.737 1.615 . . . . 0.0 111.572 174.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.3 m -72.12 161.96 30.14 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.953 1.301 . . . . 0.0 113.599 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -43.18 135.9 3.12 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.252 1.021 . . . . 0.0 113.115 172.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 69.83 -12.06 0.49 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.05 140.83 46.96 Favored Glycine 0 CA--C 1.545 1.948 0 O-C-N 120.033 -1.667 . . . . 0.0 113.305 170.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.18 151.66 36.85 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 119.681 1.741 . . . . 0.0 112.875 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 41.7 t -127.62 -48.33 1.4 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.565 1.546 . . . . 0.0 113.062 -168.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.97 17.97 2.55 Favored Glycine 0 CA--C 1.548 2.106 0 N-CA-C 120.288 2.875 . . . . 0.0 120.288 -165.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.11 68.69 2.82 Favored Glycine 0 CA--C 1.545 1.924 0 CA-C-N 120.756 2.278 . . . . 0.0 113.463 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.6 mt -46.3 128.66 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.664 1.185 . . . . 0.0 113.347 -173.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.13 -56.42 0.6 Allowed Glycine 0 N--CA 1.474 1.195 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -145.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.7 157.0 15.57 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.994 0.902 . . . . 0.0 112.586 150.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 53.0 p -140.8 137.48 33.36 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.694 1.598 . . . . 0.0 110.631 158.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.72 -173.04 46.0 Favored Glycine 0 CA--C 1.544 1.845 0 O-C-N 120.949 -1.095 . . . . 0.0 114.221 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -65.38 88.89 0.21 Allowed 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 123.414 2.743 . . . . 0.0 113.781 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 p -72.9 31.88 0.07 Allowed 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 -170.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.5 t -141.82 98.49 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 119.613 -1.93 . . . . 0.0 114.145 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m -65.85 157.26 30.97 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 117.559 2.429 . . . . 0.0 117.559 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.23 96.47 0.47 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.178 1.391 . . . . 0.0 111.864 169.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 t -37.09 -13.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 119.913 3.301 . . . . 0.0 119.913 -166.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.07 -35.9 60.25 Favored Glycine 0 CA--C 1.547 2.032 0 CA-C-N 119.571 1.078 . . . . 0.0 113.685 160.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 p -111.12 173.43 6.34 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.846 2.058 . . . . 0.0 111.614 169.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 t -125.78 172.54 9.75 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.9 t -77.5 70.28 3.87 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 125.436 1.494 . . . . 0.0 110.973 172.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -57.64 167.61 1.04 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 -169.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.83 117.06 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.035 1.334 . . . . 0.0 113.233 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -105.71 -53.32 2.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.562 1.545 . . . . 0.0 110.153 162.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.71 149.76 6.21 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.956 2.502 . . . . 0.0 110.426 176.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -65.82 17.76 0.09 OUTLIER 'Trans proline' 0 CA--C 1.556 1.587 0 C-N-CA 124.941 3.761 . . . . 0.0 118.458 -160.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.59 -27.94 12.8 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 126.087 1.755 . . . . 0.0 113.104 160.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -80.49 166.31 21.32 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.629 1.571 . . . . 0.0 112.467 161.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 t 153.63 81.62 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.032 2.533 . . . . 0.0 112.051 168.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -120.02 150.05 41.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.346 1.858 . . . . 0.0 112.585 -165.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.3 m -62.92 79.27 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.676 1.19 . . . . 0.0 113.309 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.258 1.538 0 C-N-CA 129.222 3.009 . . . . 0.0 112.267 178.233 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.5 p . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.26 136.12 39.65 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.755 1.222 . . . . 0.0 111.173 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -69.69 150.67 46.73 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.785 1.234 . . . . 0.0 113.929 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -42.88 133.93 3.48 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.939 1.695 . . . . 0.0 112.389 169.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 67.19 -13.73 0.2 Allowed 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -171.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.02 126.69 33.88 Favored Glycine 0 CA--C 1.541 1.701 0 O-C-N 120.202 -1.561 . . . . 0.0 113.628 170.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -75.76 132.18 40.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.039 0.936 . . . . 0.0 110.813 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -142.39 4.08 1.56 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -160.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.39 59.66 0.12 Allowed Glycine 0 CA--C 1.543 1.791 0 CA-C-N 118.771 0.714 . . . . 0.0 114.867 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.23 86.26 0.45 Allowed Glycine 0 N--CA 1.474 1.217 0 O-C-N 121.322 -1.105 . . . . 0.0 110.546 163.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.9 mt -54.19 109.04 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 118.81 1.305 . . . . 0.0 112.483 -162.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.87 -45.51 1.0 Allowed Glycine 0 CA--C 1.546 1.987 0 C-N-CA 125.364 1.459 . . . . 0.0 111.318 -151.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -177.43 0.49 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.305 1.442 . . . . 0.0 113.238 159.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.9 p -156.78 141.14 16.62 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.249 -0.907 . . . . 0.0 112.453 158.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.03 172.71 27.61 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 115.763 1.065 . . . . 0.0 115.763 175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -45.88 117.83 2.02 Favored 'Trans proline' 0 CA--C 1.549 1.249 0 C-N-CA 125.065 3.843 . . . . 0.0 115.55 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.2 p -89.13 3.19 52.67 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.457 2.303 . . . . 0.0 115.782 -172.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 t -119.08 106.16 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 125.078 1.351 . . . . 0.0 112.697 -172.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.71 171.2 11.99 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 117.178 2.288 . . . . 0.0 117.178 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.15 130.55 45.09 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 125.352 1.461 . . . . 0.0 113.634 167.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.3 t -55.06 117.47 3.49 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.138 -0.976 . . . . 0.0 112.025 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 125.15 -40.68 1.83 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.919 1.247 . . . . 0.0 113.008 -164.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.5 p -107.33 -178.87 3.76 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 124.875 1.27 . . . . 0.0 113.558 171.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.2 m -151.9 143.35 23.45 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.403 2.281 . . . . 0.0 111.673 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -67.3 82.33 0.14 Allowed 'General case' 0 CA--C 1.565 1.525 0 O-C-N 120.081 -1.637 . . . . 0.0 113.068 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.8 mm-40 -54.23 173.59 0.07 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -172.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -140.97 111.21 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.5 mt -98.81 -47.74 5.19 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.261 1.425 . . . . 0.0 112.32 166.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.21 161.84 29.6 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 126.785 2.034 . . . . 0.0 110.013 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.26 -9.31 6.33 Favored 'Trans proline' 0 CA--C 1.557 1.646 0 C-N-CA 122.118 1.879 . . . . 0.0 115.669 175.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.0 -18.93 23.8 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -120.66 107.58 12.97 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 125.841 1.656 . . . . 0.0 111.584 173.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.7 t -135.06 120.59 19.28 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.292 1.037 . . . . 0.0 112.333 156.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -136.7 145.15 44.39 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.149 2.179 . . . . 0.0 112.585 -164.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.3 m -64.67 84.13 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 120.64 -1.288 . . . . 0.0 114.123 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 C--O 1.252 1.19 0 C-N-CA 128.872 2.869 . . . . 0.0 113.167 173.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -102.36 138.62 39.05 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 125.426 1.49 . . . . 0.0 111.946 168.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 m -68.98 162.78 26.05 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.48 1.912 . . . . 0.0 114.958 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -47.63 137.66 8.97 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.598 1.159 . . . . 0.0 112.48 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 67.53 -15.49 0.18 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.957 2.103 . . . . 0.0 115.694 -168.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -50.27 132.07 29.57 Favored Glycine 0 CA--C 1.545 1.959 0 O-C-N 120.589 -1.319 . . . . 0.0 114.033 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -90.02 126.2 35.68 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.648 1.179 . . . . 0.0 112.196 -174.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 p -134.98 8.53 3.5 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -159.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.25 34.65 0.09 OUTLIER Glycine 0 CA--C 1.547 2.034 0 N-CA-C 117.642 1.817 . . . . 0.0 117.642 167.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.58 85.66 1.55 Allowed Glycine 0 CA--C 1.541 1.664 0 CA-C-N 119.028 1.414 . . . . 0.0 112.217 170.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.5 mt -53.9 118.2 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.988 1.315 . . . . 0.0 113.245 -164.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.18 -44.2 1.23 Allowed Glycine 0 CA--C 1.541 1.695 0 C-N-CA 125.238 1.399 . . . . 0.0 110.597 -153.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.42 173.71 3.86 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 160.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.1 p -157.98 85.07 0.88 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 120.969 -1.082 . . . . 0.0 112.429 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.4 167.83 33.04 Favored Glycine 0 CA--C 1.549 2.192 0 N-CA-C 116.426 1.331 . . . . 0.0 116.426 -169.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -63.61 113.42 2.12 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.977 3.785 . . . . 0.0 113.325 -170.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.5 p -72.26 -0.89 13.35 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -165.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 t -115.3 107.54 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 O-C-N 120.393 -1.442 . . . . 0.0 113.244 -167.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.7 m -66.24 168.36 8.79 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.07 151.37 47.01 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.964 1.305 . . . . 0.0 112.402 162.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.8 t -67.04 162.95 21.02 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.11 -56.88 4.8 Favored Glycine 0 CA--C 1.543 1.831 0 C-N-CA 124.811 1.196 . . . . 0.0 112.243 -168.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.59 162.9 17.75 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 127.672 2.389 . . . . 0.0 113.472 166.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 t -142.66 172.93 12.03 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.355 -1.466 . . . . 0.0 114.257 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 t -73.66 73.67 1.5 Allowed 'General case' 0 CA--C 1.555 1.166 0 O-C-N 120.58 -1.325 . . . . 0.0 113.269 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -66.4 93.3 0.22 Allowed 'General case' 0 CA--C 1.556 1.188 0 O-C-N 120.547 -1.346 . . . . 0.0 113.803 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -61.59 68.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 C-N-CA 127.94 2.496 . . . . 0.0 115.408 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -62.46 -49.94 73.45 Favored 'General case' 0 CA--C 1.556 1.186 0 O-C-N 120.14 -1.6 . . . . 0.0 113.236 173.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -160.71 174.41 3.91 Favored Pre-proline 0 CA--C 1.569 1.675 0 O-C-N 120.641 -1.287 . . . . 0.0 114.448 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.41 -22.16 15.53 Favored 'Trans proline' 0 CA--C 1.548 1.221 0 C-N-CA 124.869 3.713 . . . . 0.0 118.189 178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -97.1 -23.97 15.98 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.096 1.358 . . . . 0.0 113.508 170.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -120.72 93.63 4.1 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.992 1.717 . . . . 0.0 112.079 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.0 t -123.57 115.84 22.16 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.488 1.115 . . . . 0.0 109.747 150.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -148.04 147.13 29.25 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -158.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.5 m -67.55 78.79 0.18 Allowed 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.259 1.6 0 C-N-CA 125.397 1.479 . . . . 0.0 112.815 167.916 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.5 2.067 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -85.13 145.69 27.5 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.256 1.822 . . . . 0.0 111.916 171.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.2 p -80.42 159.83 25.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.955 1.702 . . . . 0.0 114.929 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -40.9 135.19 1.76 Allowed 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 126.09 1.756 . . . . 0.0 112.803 168.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 65.37 -21.25 0.09 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 117.231 2.308 . . . . 0.0 117.231 -171.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -45.31 121.78 4.93 Favored Glycine 0 CA--C 1.546 2.021 0 O-C-N 120.097 -1.627 . . . . 0.0 112.544 163.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -76.54 100.85 5.43 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.905 -1.35 . . . . 0.0 112.715 -173.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.7 t -65.61 -36.66 84.37 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 125.384 1.473 . . . . 0.0 114.503 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -121.04 -142.35 6.42 Favored Glycine 0 CA--C 1.548 2.152 0 N-CA-C 117.659 1.824 . . . . 0.0 117.659 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.45 50.43 37.95 Favored Glycine 0 CA--C 1.543 1.833 0 O-C-N 120.633 -1.51 . . . . 0.0 112.776 -159.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.4 mt -51.33 118.4 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 C-N-CA 125.685 1.594 . . . . 0.0 112.774 -169.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.53 -53.26 0.81 Allowed Glycine 0 CA--C 1.537 1.443 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -145.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -52.22 152.56 3.25 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 122.133 -0.628 . . . . 0.0 111.603 137.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.6 p -150.93 134.59 16.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.752 1.621 . . . . 0.0 110.728 166.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.26 -168.41 41.41 Favored Glycine 0 CA--C 1.549 2.167 0 O-C-N 121.173 -0.954 . . . . 0.0 114.872 -173.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.82 75.1 0.07 OUTLIER 'Trans proline' 0 CA--C 1.559 1.749 0 C-N-CA 125.153 3.902 . . . . 0.0 115.961 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.0 p -60.71 32.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 128.954 2.902 . . . . 0.0 118.291 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.9 t -141.45 97.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 O-C-N 119.504 -1.997 . . . . 0.0 112.702 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.3 m -66.43 169.43 7.47 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 117.369 2.359 . . . . 0.0 117.369 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.41 106.82 14.59 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.878 2.071 . . . . 0.0 113.971 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.6 t -35.17 114.29 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.288 1.435 . . . . 0.0 113.996 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 126.55 -45.34 1.16 Allowed Glycine 0 CA--C 1.543 1.832 0 C-N-CA 124.368 0.985 . . . . 0.0 112.314 -151.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.97 153.65 47.35 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.403 2.281 . . . . 0.0 112.107 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.7 m -111.04 156.86 20.66 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 128.054 2.542 . . . . 0.0 113.29 -174.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.6 t -63.23 77.19 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.0 0 O-C-N 120.128 -1.608 . . . . 0.0 110.72 165.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -77.88 92.28 4.24 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.242 1.017 . . . . 0.0 111.9 -158.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -63.98 59.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 128.035 2.534 . . . . 0.0 115.497 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -58.77 -46.45 87.46 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 119.659 -1.901 . . . . 0.0 111.703 170.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -145.29 153.31 52.18 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 125.786 1.634 . . . . 0.0 112.09 168.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.24 -36.03 96.02 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 123.133 2.555 . . . . 0.0 113.254 169.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.79 -6.59 2.78 Favored 'General case' 0 CA--C 1.56 1.349 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 166.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -130.11 -158.02 0.86 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 129.303 3.041 . . . . 0.0 109.288 177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t 136.53 76.98 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 130.059 3.344 . . . . 0.0 108.285 159.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -97.26 155.29 16.93 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.032 1.333 . . . . 0.0 112.789 -164.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.4 m -70.4 78.73 0.55 Allowed 'General case' 0 CA--C 1.549 0.916 0 O-C-N 120.892 -1.13 . . . . 0.0 112.962 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.0 mt . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 116.711 -1.614 . . . . 0.0 114.592 162.921 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -89.01 133.07 34.46 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.769 2.028 . . . . 0.0 110.463 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 m -70.14 160.55 31.86 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 124.863 1.265 . . . . 0.0 114.345 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -49.77 134.34 20.65 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.254 1.022 . . . . 0.0 111.648 170.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 65.87 -8.0 0.34 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -170.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.0 125.09 38.77 Favored Glycine 0 CA--C 1.541 1.678 0 O-C-N 120.093 -1.629 . . . . 0.0 112.678 170.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.76 107.39 0.69 Allowed 'General case' 0 CA--C 1.554 1.106 0 O-C-N 120.954 -1.321 . . . . 0.0 110.836 172.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.0 t -88.51 1.1 55.51 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.291 1.836 . . . . 0.0 113.589 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 175.5 121.84 0.67 Allowed Glycine 0 CA--C 1.539 1.584 0 O-C-N 120.846 -1.158 . . . . 0.0 114.442 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.81 69.27 0.28 Allowed Glycine 0 CA--C 1.534 1.255 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 162.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.5 mm -41.67 116.72 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -159.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.01 -55.22 0.74 Allowed Glycine 0 CA--C 1.539 1.533 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -147.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -52.93 153.36 3.41 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.539 0.736 . . . . 0.0 112.713 144.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.3 p -151.58 150.92 30.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.755 2.022 . . . . 0.0 111.401 167.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.92 -167.81 32.25 Favored Glycine 0 CA--C 1.542 1.756 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.61 84.28 0.09 OUTLIER 'Trans proline' 0 CA--C 1.55 1.304 0 C-N-CA 124.255 3.303 . . . . 0.0 113.765 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.3 p -68.51 42.5 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 127.08 2.152 . . . . 0.0 115.945 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -146.16 102.61 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 119.959 -1.713 . . . . 0.0 113.175 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.4 m -60.58 158.05 13.16 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.115 2.265 . . . . 0.0 117.115 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.76 151.69 33.35 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.986 1.314 . . . . 0.0 112.487 161.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.2 t -59.58 166.92 2.21 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.31 -59.49 0.26 Allowed Glycine 0 CA--C 1.546 2.011 0 C-N-CA 124.271 0.938 . . . . 0.0 113.469 -161.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.5 p -72.1 150.8 43.56 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.747 1.219 . . . . 0.0 114.189 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.2 p -125.45 143.95 50.76 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.839 -1.163 . . . . 0.0 113.371 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.8 t -67.6 74.12 0.16 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 125.435 1.494 . . . . 0.0 110.407 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -22.59 6.37 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 119.375 3.102 . . . . 0.0 119.375 -151.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.297 6.8 p 41.76 47.38 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.94 -45.33 90.69 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.687 1.595 . . . . 0.0 112.459 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -154.07 163.67 23.26 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 125.295 1.438 . . . . 0.0 110.9 168.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.35 -19.35 21.76 Favored 'Trans proline' 0 CA--C 1.556 1.594 0 C-N-CA 122.256 1.971 . . . . 0.0 116.831 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.47 -14.9 26.14 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 170.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -135.19 105.45 6.31 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.509 1.524 . . . . 0.0 113.299 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.9 t -121.15 96.65 5.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 128.03 2.532 . . . . 0.0 110.201 153.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -96.0 142.76 27.84 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.861 1.264 . . . . 0.0 111.772 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.3 m -68.66 87.88 0.34 Allowed 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.604 -1.31 . . . . 0.0 112.322 170.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.077 -1.439 . . . . 0.0 111.949 171.197 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.5 p . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -90.52 138.46 31.54 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.867 1.667 . . . . 0.0 112.069 171.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -66.87 173.9 3.3 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.781 1.633 . . . . 0.0 114.257 177.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.26 140.65 26.06 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 124.919 1.288 . . . . 0.0 112.475 167.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 63.78 42.57 6.07 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.86 130.74 9.23 Favored Glycine 0 CA--C 1.544 1.902 0 C-N-CA 126.001 1.763 . . . . 0.0 112.627 167.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -74.78 66.08 1.45 Allowed 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 119.639 1.72 . . . . 0.0 114.681 -172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 43.8 t -31.09 -39.16 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 129.682 3.193 . . . . 0.0 117.613 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.38 83.6 0.12 Allowed Glycine 0 CA--C 1.537 1.41 0 O-C-N 121.233 -0.917 . . . . 0.0 115.339 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.91 63.98 0.27 Allowed Glycine 0 CA--C 1.543 1.784 0 C-N-CA 124.582 1.087 . . . . 0.0 112.525 167.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.3 7.6 tt -74.01 27.3 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 N-CA-C 119.405 3.113 . . . . 0.0 119.405 -128.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.82 -38.63 76.2 Favored Glycine 0 CA--C 1.544 1.876 0 O-C-N 120.408 -1.433 . . . . 0.0 111.945 138.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -50.1 150.01 2.56 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.103 1.361 . . . . 0.0 113.279 159.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.1 p -142.13 154.69 45.07 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.322 1.449 . . . . 0.0 111.856 166.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 17' ' ' THR . . . 158.46 -167.8 34.63 Favored Glycine 0 CA--C 1.542 1.747 0 N-CA-C 115.53 0.972 . . . . 0.0 115.53 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -65.54 69.64 0.34 Allowed 'Trans proline' 0 CA--C 1.554 1.505 0 C-N-CA 124.824 3.683 . . . . 0.0 114.36 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 15' ' ' GLY . 33.4 p -60.95 32.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 118.898 2.925 . . . . 0.0 118.898 -173.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.0 t -132.95 96.83 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 O-C-N 119.622 -1.924 . . . . 0.0 112.677 -176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 64.4 m -62.04 170.04 2.37 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 127.651 2.381 . . . . 0.0 117.163 -175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.7 120.0 29.7 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.953 1.701 . . . . 0.0 113.526 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 t -34.04 103.04 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.683 1.993 . . . . 0.0 115.43 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.23 -53.8 0.79 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.761 1.648 . . . . 0.0 110.715 -165.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 29.7 p -86.8 157.82 19.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.319 1.848 . . . . 0.0 112.955 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -142.85 165.2 28.03 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.7 t -73.15 74.48 1.26 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 128.245 2.618 . . . . 0.0 110.922 -176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -8.59 2.65 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 -154.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.276 14.9 p 30.49 63.08 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 173.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.0 mt -60.68 -34.76 74.82 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 120.474 -1.391 . . . . 0.0 113.06 167.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.21 159.16 5.19 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 127.802 2.441 . . . . 0.0 111.119 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -46.77 -34.02 14.98 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 124.061 3.174 . . . . 0.0 115.774 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.15 -27.39 66.39 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 172.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -144.07 104.91 4.19 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.583 1.553 . . . . 0.0 113.489 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 t -116.15 138.48 51.22 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.662 1.585 . . . . 0.0 111.837 146.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -138.44 148.81 44.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.562 1.945 . . . . 0.0 112.03 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.4 m -67.51 102.07 1.09 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.918 0.887 . . . . 0.0 111.783 168.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.894 2.078 . . . . 0.0 112.085 174.166 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -99.22 129.29 45.45 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.63 1.572 . . . . 0.0 112.365 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -53.69 154.82 3.5 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.966 1.706 . . . . 0.0 115.163 -176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -49.35 133.07 20.17 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.803 0.841 . . . . 0.0 111.337 164.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 73.08 -23.55 0.21 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 127.438 2.295 . . . . 0.0 115.73 -167.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -53.4 112.0 2.11 Favored Glycine 0 CA--C 1.545 1.958 0 O-C-N 120.505 -1.372 . . . . 0.0 113.823 171.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -76.86 123.95 27.0 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -166.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 71.8 m -62.9 -44.77 95.19 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.803 1.241 . . . . 0.0 114.015 173.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.89 -129.28 4.26 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.562 2.029 . . . . 0.0 112.683 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.47 54.5 19.36 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 121.686 -0.891 . . . . 0.0 110.874 -151.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.5 mt -49.08 121.14 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 124.152 0.981 . . . . 0.0 113.021 -171.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 128.18 -50.39 0.89 Allowed Glycine 0 CA--C 1.542 1.759 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -142.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.94 163.05 0.54 Allowed 'General case' 0 CA--C 1.563 1.452 0 O-C-N 121.774 -0.839 . . . . 0.0 112.315 141.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.1 p -151.6 4.82 0.44 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.18 -134.07 8.22 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 116.794 1.477 . . . . 0.0 116.794 -171.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.91 138.42 16.6 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.624 2.883 . . . . 0.0 113.997 -167.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.4 p -105.68 -19.37 13.78 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.549 1.94 . . . . 0.0 115.217 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.36 96.65 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 O-C-N 120.174 -1.579 . . . . 0.0 114.03 -162.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.0 m -56.49 159.88 3.48 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.37 146.68 42.81 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.349 1.86 . . . . 0.0 113.777 167.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.0 t -59.79 111.74 1.57 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.765 1.226 . . . . 0.0 113.413 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.01 -55.18 0.52 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.1 1.809 . . . . 0.0 111.409 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 t -87.52 -176.58 5.64 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.673 1.589 . . . . 0.0 112.315 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m -153.64 143.45 21.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.426 2.29 . . . . 0.0 110.672 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 t -58.08 81.17 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 127.582 2.353 . . . . 0.0 114.196 -171.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -74.48 83.99 1.99 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.505 1.922 . . . . 0.0 114.652 -164.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.7 p -53.91 76.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 C-N-CA 128.395 2.678 . . . . 0.0 115.608 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -80.7 -41.09 24.23 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.689 -1.257 . . . . 0.0 113.168 176.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -138.69 155.44 73.41 Favored Pre-proline 0 CA--C 1.553 1.093 0 O-C-N 120.756 -1.215 . . . . 0.0 112.765 173.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -38.58 -46.34 2.49 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.639 2.893 . . . . 0.0 115.027 165.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.91 -57.24 5.28 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 169.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -83.97 122.33 28.61 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.5 t -137.64 135.94 37.0 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.031 0.933 . . . . 0.0 111.43 149.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -129.4 147.5 51.23 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.253 1.421 . . . . 0.0 113.383 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.54 67.14 2.01 Favored 'General case' 0 CA--C 1.55 0.969 0 O-C-N 120.463 -1.398 . . . . 0.0 110.952 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 C--O 1.251 1.183 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.087 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -76.13 163.22 27.31 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 118.634 0.652 . . . . 0.0 110.855 153.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.3 t -87.1 -169.57 2.68 Favored 'General case' 0 CA--C 1.552 1.028 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -65.44 150.34 48.51 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 125.066 1.347 . . . . 0.0 111.184 172.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 61.1 16.07 6.81 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.37 126.07 7.95 Favored Glycine 0 CA--C 1.544 1.862 0 O-C-N 119.928 -1.732 . . . . 0.0 113.353 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -71.7 92.17 1.17 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.774 1.229 . . . . 0.0 111.616 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.5 p -103.78 12.62 34.37 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.682 2.393 . . . . 0.0 114.196 -169.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.04 68.83 0.07 OUTLIER Glycine 0 CA--C 1.544 1.894 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.82 88.08 0.47 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 162.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.1 mt -53.23 108.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 118.459 1.129 . . . . 0.0 112.838 -161.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.81 -42.28 1.27 Allowed Glycine 0 CA--C 1.544 1.885 0 C-N-CA 125.302 1.43 . . . . 0.0 111.228 -153.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.01 -179.84 0.24 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.038 0.935 . . . . 0.0 112.905 155.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 96.2 p -151.24 139.37 20.16 Favored 'General case' 0 CA--C 1.548 0.869 0 O-C-N 121.045 -1.034 . . . . 0.0 111.894 157.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.78 173.85 24.08 Favored Glycine 0 CA--C 1.544 1.896 0 N-CA-C 116.783 1.473 . . . . 0.0 116.783 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.2 113.28 1.13 Allowed 'Trans proline' 0 CA--C 1.546 1.115 1 C-N-CA 125.329 4.019 . . . . 0.0 117.332 -168.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.4 p -82.74 20.73 1.1 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 128.706 2.802 . . . . 0.0 116.137 -173.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 t -131.23 114.35 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 120.043 -1.661 . . . . 0.0 113.059 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.2 m -83.19 174.75 10.5 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 127.64 2.376 . . . . 0.0 116.643 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.21 117.86 9.81 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.645 1.578 . . . . 0.0 112.812 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -39.3 113.01 0.29 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.187 1.395 . . . . 0.0 114.283 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 119.8 -25.76 7.46 Favored Glycine 0 CA--C 1.545 1.955 0 C-N-CA 124.762 1.173 . . . . 0.0 114.319 -162.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.3 p -124.94 149.92 47.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.182 1.793 . . . . 0.0 114.398 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.1 m -115.74 137.39 52.13 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 128.795 2.838 . . . . 0.0 112.544 -173.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.84 84.03 0.31 Allowed 'General case' 0 CA--C 1.559 1.316 0 O-C-N 120.266 -1.521 . . . . 0.0 112.435 172.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -55.63 171.23 0.22 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 118.673 2.842 . . . . 0.0 118.673 -161.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -130.48 49.76 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 120.598 -1.314 . . . . 0.0 113.872 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.17 -50.62 67.42 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.711 1.604 . . . . 0.0 112.96 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -162.51 161.7 19.79 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 126.646 1.978 . . . . 0.0 110.118 169.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -56.81 -13.13 10.53 Favored 'Trans proline' 0 CA--C 1.559 1.727 0 C-N-CA 123.051 2.501 . . . . 0.0 117.323 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.53 -23.14 17.81 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 125.664 1.585 . . . . 0.0 114.831 169.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -115.0 97.4 6.2 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.64 1.576 . . . . 0.0 112.036 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.6 t -113.91 120.01 39.22 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.966 0.906 . . . . 0.0 110.774 148.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -130.26 146.3 51.85 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.909 1.684 . . . . 0.0 111.843 -177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 92.1 m -63.9 85.8 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 36' ' ' LEU . 40.5 mt . . . . . 0 C--O 1.25 1.088 0 C-N-CA 127.931 2.492 . . . . 0.0 112.81 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 44.5 p . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 118.852 -0.594 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -63.01 168.6 3.91 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 119.749 1.159 . . . . 0.0 112.051 147.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -117.97 -173.98 2.55 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.413 1.485 . . . . 0.0 110.915 163.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -47.89 135.24 12.54 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.123 0.969 . . . . 0.0 112.653 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 75.45 1.58 3.67 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.642 2.377 . . . . 0.0 114.838 -172.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.06 114.52 4.79 Favored Glycine 0 CA--C 1.541 1.703 0 O-C-N 118.094 -2.879 . . . . 0.0 116.326 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -53.94 139.75 33.02 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 118.473 1.137 . . . . 0.0 112.924 160.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.5 p -154.8 -13.89 0.12 Allowed 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 -163.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.46 72.67 0.11 Allowed Glycine 0 CA--C 1.542 1.774 0 N-CA-C 117.358 1.703 . . . . 0.0 117.358 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.27 114.64 0.62 Allowed Glycine 0 CA--C 1.543 1.789 0 C-N-CA 125.918 1.723 . . . . 0.0 111.571 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 19.4 mm -54.38 115.96 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 118.875 1.337 . . . . 0.0 112.987 -170.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.63 -48.49 0.94 Allowed Glycine 0 CA--C 1.539 1.576 0 C-N-CA 125.592 1.568 . . . . 0.0 110.255 -154.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.16 168.48 6.71 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 121.786 -0.832 . . . . 0.0 112.16 158.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.5 p -153.35 148.76 27.12 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.123 -0.986 . . . . 0.0 111.926 152.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.87 -165.97 24.1 Favored Glycine 0 CA--C 1.544 1.897 0 C-N-CA 124.268 0.937 . . . . 0.0 115.246 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.43 156.37 21.97 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 124.153 3.235 . . . . 0.0 114.057 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.7 p -129.28 54.74 1.79 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.305 1.042 . . . . 0.0 113.383 -169.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.5 t -152.14 122.43 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 121.089 -1.007 . . . . 0.0 113.017 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.2 m -82.18 172.12 13.53 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.62 2.082 . . . . 0.0 116.62 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.81 117.05 23.03 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.709 1.604 . . . . 0.0 112.763 168.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 t -47.38 136.27 9.77 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.93 -65.18 0.25 Allowed Glycine 0 CA--C 1.541 1.675 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 -151.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 38.8 p -88.64 161.0 17.12 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.539 1.135 . . . . 0.0 113.516 171.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 t -149.48 166.54 28.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.454 -1.404 . . . . 0.0 113.67 170.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.8 t -82.1 85.81 6.71 Favored 'General case' 0 CA--C 1.552 1.058 0 O-C-N 120.244 -1.535 . . . . 0.0 113.771 -166.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -88.38 90.73 8.52 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 122.353 1.073 . . . . 0.0 113.678 -163.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.6 p -70.9 81.46 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -176.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.2 mt -57.44 -47.31 82.15 Favored 'General case' 0 CA--C 1.555 1.141 0 O-C-N 120.324 -1.485 . . . . 0.0 114.929 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.82 144.79 1.57 Allowed Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 125.503 1.521 . . . . 0.0 111.259 -169.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . 0.278 8.2 Cg_endo -48.92 -37.91 37.58 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 124.246 3.298 . . . . 0.0 119.176 -153.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.87 -40.14 95.84 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 120.323 1.42 . . . . 0.0 113.652 172.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -91.06 154.76 19.17 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.469 1.908 . . . . 0.0 113.36 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.4 t 158.79 112.94 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 128.687 2.795 . . . . 0.0 111.158 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -151.95 148.28 27.56 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -153.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.4 m -79.08 92.31 5.0 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.166 1.787 . . . . 0.0 112.004 168.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--O 1.247 0.958 0 CA-C-O 116.271 -1.824 . . . . 0.0 111.767 165.845 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -79.02 142.54 36.49 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 126.271 1.828 . . . . 0.0 111.916 171.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -73.16 159.01 34.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.668 1.587 . . . . 0.0 115.193 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -40.03 136.86 1.07 Allowed 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 126.069 1.747 . . . . 0.0 113.107 166.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 66.89 -11.11 0.27 Allowed 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 116.774 2.139 . . . . 0.0 116.774 -174.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -56.12 152.17 20.0 Favored Glycine 0 CA--C 1.542 1.761 0 CA-C-N 120.433 1.47 . . . . 0.0 114.133 168.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -89.04 114.01 25.17 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 117.679 0.739 . . . . 0.0 112.031 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.4 t -92.59 -44.39 8.63 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 126.755 2.022 . . . . 0.0 115.57 -171.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.08 35.38 0.45 Allowed Glycine 0 N--CA 1.486 2.009 0 N-CA-C 119.423 2.529 . . . . 0.0 119.423 -168.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.62 66.08 2.75 Favored Glycine 0 CA--C 1.545 1.948 0 CA-C-N 119.301 1.55 . . . . 0.0 113.447 175.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.4 mt -41.35 115.7 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.568 1.547 . . . . 0.0 113.825 -167.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.69 -54.27 0.79 Allowed Glycine 0 N--CA 1.476 1.324 0 N-CA-C 108.291 -1.923 . . . . 0.0 108.291 -151.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -55.91 156.69 4.97 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 121.498 0.666 . . . . 0.0 112.311 140.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.7 p -143.94 138.54 28.56 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.004 1.722 . . . . 0.0 111.115 162.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.26 -174.64 44.93 Favored Glycine 0 CA--C 1.55 2.223 0 N-CA-C 116.584 1.394 . . . . 0.0 116.584 -174.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -65.98 80.46 0.28 Allowed 'Trans proline' 0 CA--C 1.548 1.181 0 C-N-CA 125.043 3.829 . . . . 0.0 114.202 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.3 p -63.79 33.15 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 -167.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.0 t -139.02 93.79 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 O-C-N 119.566 -1.958 . . . . 0.0 114.182 -171.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.8 m -58.79 159.21 7.06 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.046 2.138 . . . . 0.0 115.991 175.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.33 158.56 11.53 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.116 1.366 . . . . 0.0 113.065 164.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.7 t -69.96 176.34 3.8 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.17 -58.25 2.33 Favored Glycine 0 CA--C 1.544 1.854 0 O-C-N 121.023 -1.048 . . . . 0.0 112.828 -166.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.4 169.55 17.07 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 126.228 1.811 . . . . 0.0 113.201 168.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.1 t -134.95 170.1 16.39 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.847 2.459 . . . . 0.0 114.832 174.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.5 t -86.12 69.19 10.47 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 127.889 2.476 . . . . 0.0 112.194 -176.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -54.26 160.75 1.53 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 118.974 2.953 . . . . 0.0 118.974 -161.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.11 59.4 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 C-N-CA 127.41 2.284 . . . . 0.0 112.857 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.42 -55.03 6.91 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 120.304 -1.497 . . . . 0.0 112.695 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -157.32 152.67 21.93 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 126.719 2.007 . . . . 0.0 109.975 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -51.13 -28.81 26.47 Favored 'Trans proline' 0 CA--C 1.552 1.418 0 C-N-CA 122.886 2.391 . . . . 0.0 117.536 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.43 -18.14 63.01 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 120.585 1.539 . . . . 0.0 114.904 173.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -124.89 135.37 52.81 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.531 2.332 . . . . 0.0 112.997 -175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 t -158.59 108.25 2.01 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.041 -1.037 . . . . 0.0 109.778 165.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -119.52 149.49 41.82 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.043 1.737 . . . . 0.0 111.596 -166.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -66.46 84.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.224 0.609 . . . . 0.0 112.0 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 C--O 1.252 1.21 0 C-N-CA 127.118 2.167 . . . . 0.0 112.563 -177.834 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.498 1.954 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -95.81 132.78 40.7 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 126.03 1.732 . . . . 0.0 111.813 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 m -65.29 170.33 4.83 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -50.97 132.95 27.5 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.86 1.264 . . . . 0.0 111.918 167.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 67.55 53.09 0.74 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.643 1.977 . . . . 0.0 115.324 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.33 126.07 5.82 Favored Glycine 0 CA--C 1.543 1.819 0 C-N-CA 126.384 1.945 . . . . 0.0 111.945 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -74.1 60.77 0.8 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 119.517 1.658 . . . . 0.0 114.086 -174.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 50.8 t -16.07 -59.62 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.928 3.291 . . . . 0.0 117.495 172.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.05 79.85 0.21 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.402 1.001 . . . . 0.0 112.992 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.5 60.58 0.47 Allowed Glycine 0 CA--C 1.543 1.8 0 C-N-CA 124.99 1.281 . . . . 0.0 111.421 163.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.6 mt -49.39 112.46 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 125.163 1.385 . . . . 0.0 113.804 -156.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.99 -53.19 0.79 Allowed Glycine 0 CA--C 1.537 1.436 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -150.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -50.54 154.07 1.43 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 121.634 0.73 . . . . 0.0 112.165 137.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.5 p -149.27 151.06 33.56 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.81 1.644 . . . . 0.0 111.141 161.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.76 -168.04 31.08 Favored Glycine 0 CA--C 1.549 2.159 0 C-N-CA 124.718 1.151 . . . . 0.0 113.572 -172.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.16 113.78 1.74 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.228 3.285 . . . . 0.0 113.82 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.8 p -99.38 16.26 23.66 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -171.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -124.7 96.95 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.688 -1.258 . . . . 0.0 112.847 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 56.1 m -60.47 160.03 9.46 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 126.296 1.838 . . . . 0.0 115.683 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.6 165.21 5.16 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.112 1.365 . . . . 0.0 113.411 164.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.9 t -75.68 173.67 10.77 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 169.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.35 -63.06 0.16 Allowed Glycine 0 CA--C 1.539 1.581 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -159.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.9 p -62.95 168.92 3.61 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.577 1.551 . . . . 0.0 114.53 167.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -153.38 158.29 41.27 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.906 1.282 . . . . 0.0 112.525 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 18.8 t -63.46 75.81 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.757 1.223 . . . . 0.0 111.069 170.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.22 89.53 0.87 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.703 1.201 . . . . 0.0 111.892 -165.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.18 94.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 C-N-CA 126.215 1.806 . . . . 0.0 113.485 170.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -96.41 -44.03 7.38 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.416 1.486 . . . . 0.0 111.012 168.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -147.2 156.55 46.55 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 126.852 2.061 . . . . 0.0 112.347 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -40.52 -45.16 4.51 Favored 'Trans proline' 0 CA--C 1.554 1.514 0 C-N-CA 123.887 3.058 . . . . 0.0 115.748 159.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.01 -16.02 61.07 Favored 'General case' 0 CA--C 1.554 1.119 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 171.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -140.51 90.64 2.37 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.316 1.846 . . . . 0.0 112.675 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.4 t -109.31 124.59 51.18 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.237 -0.915 . . . . 0.0 111.063 148.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -138.27 141.58 39.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.728 1.211 . . . . 0.0 113.696 -168.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.5 m -65.3 79.67 0.06 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.678 1.591 . . . . 0.0 112.712 174.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--O 1.254 1.313 0 C-N-CA 124.072 0.949 . . . . 0.0 112.408 165.219 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -80.37 144.27 32.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.048 1.339 . . . . 0.0 111.588 169.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -88.3 172.28 9.54 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -41.39 132.54 2.67 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 127.579 2.352 . . . . 0.0 113.191 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 67.1 -13.16 0.21 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -57.68 141.42 44.64 Favored Glycine 0 CA--C 1.55 2.234 0 O-C-N 120.063 -1.648 . . . . 0.0 112.911 167.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -75.48 108.37 8.24 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.999 -1.295 . . . . 0.0 113.318 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.6 t -74.6 -37.88 62.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.444 1.898 . . . . 0.0 112.94 175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.23 158.84 28.44 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-O 123.07 1.372 . . . . 0.0 114.923 -173.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.67 46.71 0.02 OUTLIER Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.521 2.01 . . . . 0.0 110.342 -169.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 74.7 mt -50.8 117.89 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.836 1.254 . . . . 0.0 112.268 -158.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.54 -59.52 0.69 Allowed Glycine 0 CA--C 1.536 1.399 0 N-CA-C 108.789 -1.724 . . . . 0.0 108.789 -148.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.21 156.27 5.86 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-O 121.737 0.779 . . . . 0.0 112.264 145.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.6 p -138.68 147.98 43.43 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.251 1.82 . . . . 0.0 110.343 160.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.31 -161.85 32.0 Favored Glycine 0 CA--C 1.543 1.804 0 O-C-N 120.65 -1.281 . . . . 0.0 115.615 -175.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -71.16 79.09 1.42 Allowed 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.631 2.887 . . . . 0.0 113.605 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.2 p -71.18 25.82 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 -167.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 t -140.61 100.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 O-C-N 119.742 -1.849 . . . . 0.0 113.659 -173.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.0 m -63.64 163.58 11.12 Favored 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.7 122.48 28.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.72 1.608 . . . . 0.0 113.093 172.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.9 t -44.34 135.21 4.69 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.9 1.28 . . . . 0.0 114.109 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.97 -40.97 2.28 Favored Glycine 0 CA--C 1.545 1.943 0 C-N-CA 124.209 0.909 . . . . 0.0 112.58 -154.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.0 p -118.06 151.32 37.76 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.851 1.66 . . . . 0.0 114.264 175.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.8 m -109.58 142.95 39.96 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.02 2.528 . . . . 0.0 113.668 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.9 t -73.28 84.2 1.4 Allowed 'General case' 0 CA--C 1.552 1.021 0 O-C-N 121.101 -0.999 . . . . 0.0 111.099 167.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -57.79 178.28 0.09 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.59 49.95 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 CA-C-O 122.479 1.133 . . . . 0.0 112.678 174.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.72 -44.49 96.09 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.563 1.545 . . . . 0.0 111.931 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -142.65 160.33 54.08 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.724 1.61 . . . . 0.0 110.065 159.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -45.05 -39.52 14.83 Favored 'Trans proline' 0 CA--C 1.555 1.53 0 C-N-CA 122.051 1.834 . . . . 0.0 113.203 161.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.91 -25.95 63.0 Favored 'General case' 0 CA--C 1.559 1.302 0 N-CA-C 116.599 2.074 . . . . 0.0 116.599 171.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -122.18 90.63 3.34 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.836 1.655 . . . . 0.0 111.948 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.0 t -116.23 107.28 14.66 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.973 0.892 . . . . 0.0 111.838 158.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -113.32 152.89 29.34 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.352 1.861 . . . . 0.0 111.552 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.27 84.97 0.15 Allowed 'General case' 0 CA--C 1.55 0.953 0 O-C-N 121.374 -0.829 . . . . 0.0 112.673 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 C--O 1.25 1.129 0 C-N-CA 128.81 2.844 . . . . 0.0 111.835 179.584 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -71.97 141.47 49.4 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.619 0.767 . . . . 0.0 111.987 166.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.2 m -91.55 155.69 18.2 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -38.16 132.03 1.07 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 127.181 2.192 . . . . 0.0 113.528 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 67.65 -27.52 0.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -170.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -42.58 119.91 2.26 Favored Glycine 0 CA--C 1.545 1.934 0 O-C-N 120.674 -1.267 . . . . 0.0 113.879 171.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -75.47 136.65 40.65 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.688 1.195 . . . . 0.0 111.959 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.0 p -144.67 28.36 1.3 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.369 1.067 . . . . 0.0 113.737 -166.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 167.05 69.97 0.03 OUTLIER Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.686 1.612 . . . . 0.0 114.981 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.25 86.17 0.4 Allowed Glycine 0 N--CA 1.471 0.996 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 152.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.6 mt -53.92 110.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 118.901 1.351 . . . . 0.0 111.987 -164.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.15 -48.59 0.86 Allowed Glycine 0 CA--C 1.544 1.89 0 C-N-CA 125.032 1.301 . . . . 0.0 110.401 -149.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.68 170.81 1.32 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.498 1.119 . . . . 0.0 112.718 153.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.2 p -152.27 147.61 26.57 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.425 -0.797 . . . . 0.0 111.957 158.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.55 175.89 25.39 Favored Glycine 0 CA--C 1.54 1.602 0 N-CA-C 115.319 0.888 . . . . 0.0 115.319 175.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.6 122.39 3.95 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.826 3.684 . . . . 0.0 114.595 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.3 p -83.32 -55.38 4.36 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.4 1.88 . . . . 0.0 113.117 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.2 t -66.0 111.36 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.279 0 C-N-CA 125.46 1.504 . . . . 0.0 114.102 -170.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 71.4 m -73.25 172.68 10.71 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.48 130.03 38.86 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 126.47 1.908 . . . . 0.0 114.087 172.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -52.14 113.78 1.13 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.244 1.018 . . . . 0.0 112.982 174.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 139.44 -45.23 1.03 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.034 1.302 . . . . 0.0 111.915 -163.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 58.4 p -127.41 -176.35 3.72 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 127.348 2.259 . . . . 0.0 111.827 170.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -148.06 155.44 41.49 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 119.358 -2.089 . . . . 0.0 112.344 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.7 t -69.46 77.32 0.4 Allowed 'General case' 0 CA--C 1.557 1.245 0 O-C-N 120.421 -1.424 . . . . 0.0 111.032 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 87.27 0.68 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.428 1.491 . . . . 0.0 113.624 -167.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -56.9 93.86 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.269 1.027 . . . . 0.0 113.757 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -93.5 -39.83 10.66 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.356 1.462 . . . . 0.0 111.408 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -150.39 163.67 23.38 Favored Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.934 1.694 . . . . 0.0 113.308 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.31 -14.66 35.66 Favored 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 123.357 2.705 . . . . 0.0 114.938 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -94.9 -11.91 27.82 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 125.974 1.71 . . . . 0.0 115.026 165.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -140.88 97.3 3.16 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.163 1.785 . . . . 0.0 112.767 -175.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.1 t -119.96 136.25 54.6 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.273 1.029 . . . . 0.0 110.702 145.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -146.44 146.14 30.47 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.216 1.406 . . . . 0.0 112.578 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 95.9 m -70.52 81.44 0.58 Allowed 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 176.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.8 mt . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.219 1.808 . . . . 0.0 115.359 177.681 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -72.21 141.73 49.01 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.879 0.872 . . . . 0.0 111.763 167.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.5 m -65.54 148.88 51.0 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -47.2 133.71 11.72 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.237 0.615 . . . . 0.0 111.545 157.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 63.06 53.57 2.3 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.759 1.224 . . . . 0.0 113.883 -169.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.08 117.76 2.67 Favored Glycine 0 CA--C 1.541 1.678 0 C-N-CA 124.923 1.249 . . . . 0.0 114.036 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -67.73 63.93 0.08 Allowed 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 125.538 1.535 . . . . 0.0 114.552 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.2 p -66.24 43.73 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 128.146 2.578 . . . . 0.0 115.689 174.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.68 78.93 0.03 OUTLIER Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.666 -1.271 . . . . 0.0 113.591 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -124.33 88.52 0.39 Allowed Glycine 0 CA--C 1.534 1.236 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 148.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.2 mt -50.63 108.45 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 119.746 1.773 . . . . 0.0 113.089 -163.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.28 -48.51 0.86 Allowed Glycine 0 CA--C 1.544 1.886 0 C-N-CA 125.612 1.577 . . . . 0.0 110.081 -152.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.57 166.07 0.14 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.156 0.982 . . . . 0.0 112.624 145.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.6 p -152.32 157.99 42.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.29 1.036 . . . . 0.0 111.468 156.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.39 -175.11 20.64 Favored Glycine 0 CA--C 1.54 1.623 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_exo -46.23 115.36 1.11 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 125.063 3.842 . . . . 0.0 115.024 -173.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.7 p -72.35 -65.94 0.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.008 1.723 . . . . 0.0 112.414 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.2 t -50.22 107.29 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 C-N-CA 126.799 2.04 . . . . 0.0 114.31 -169.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.0 m -66.0 179.22 0.94 Allowed 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 128.196 2.598 . . . . 0.0 117.119 -176.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.15 129.28 37.52 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.685 1.594 . . . . 0.0 111.36 173.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -45.13 112.86 0.49 Allowed 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.47 -44.78 1.37 Allowed Glycine 0 CA--C 1.549 2.162 0 C-N-CA 125.444 1.497 . . . . 0.0 113.68 -167.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 p -89.87 148.02 23.41 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 127.0 2.12 . . . . 0.0 113.198 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 m -124.56 142.26 51.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.324 1.85 . . . . 0.0 113.927 -172.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 t -73.19 83.73 1.35 Allowed 'General case' 0 CA--C 1.554 1.109 0 O-C-N 120.357 -1.464 . . . . 0.0 111.257 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -12.81 8.59 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 119.169 3.026 . . . . 0.0 119.169 -150.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.304 7.9 p 39.45 46.24 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 126.936 2.094 . . . . 0.0 115.5 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -68.07 -45.06 74.88 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.014 1.326 . . . . 0.0 111.801 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -136.61 157.11 75.76 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.111 1.364 . . . . 0.0 110.196 159.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.7 -16.94 16.34 Favored 'Trans proline' 0 CA--C 1.558 1.701 0 C-N-CA 122.318 2.012 . . . . 0.0 114.974 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.43 -18.23 25.77 Favored 'General case' 0 CA--C 1.563 1.45 0 C-N-CA 127.165 2.186 . . . . 0.0 115.811 167.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -140.79 93.94 2.66 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.042 1.737 . . . . 0.0 112.606 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 t -122.35 91.64 3.55 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.052 1.741 . . . . 0.0 111.239 167.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.96 146.07 24.19 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.815 1.246 . . . . 0.0 113.735 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.9 m -66.07 95.13 0.26 Allowed 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.328 -0.857 . . . . 0.0 111.929 156.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.9 mt . . . . . 0 C--O 1.257 1.462 0 CA-C-O 117.049 -1.453 . . . . 0.0 110.511 161.446 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.949 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -70.95 153.11 42.94 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-N 119.584 1.084 . . . . 0.0 112.156 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 m -74.58 161.36 29.8 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.59 1.556 . . . . 0.0 114.873 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -50.42 132.61 24.94 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 124.305 1.042 . . . . 0.0 110.696 159.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 63.39 65.57 0.75 Allowed 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -171.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.43 -89.54 0.03 OUTLIER Glycine 0 CA--C 1.555 2.557 0 N-CA-C 117.273 1.669 . . . . 0.0 117.273 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -84.84 170.96 12.63 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 129.607 3.163 . . . . 0.0 115.153 -6.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.97 11.44 13.41 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 128.053 2.541 . . . . 0.0 114.865 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -133.18 -164.29 10.78 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 126.487 1.994 . . . . 0.0 114.837 169.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.97 60.53 3.33 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 121.969 -0.724 . . . . 0.0 112.121 -164.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.3 mt -51.43 108.49 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 126.032 1.733 . . . . 0.0 111.745 -171.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.38 -47.56 0.87 Allowed Glycine 0 CA--C 1.541 1.699 0 C-N-CA 124.705 1.145 . . . . 0.0 110.331 -147.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.33 164.42 0.96 Allowed 'General case' 0 CA--C 1.554 1.099 0 O-C-N 121.893 -0.769 . . . . 0.0 111.156 139.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.3 p -154.58 164.13 39.17 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.537 1.135 . . . . 0.0 111.972 164.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.19 179.22 19.01 Favored Glycine 0 CA--C 1.551 2.311 0 N-CA-C 116.052 1.181 . . . . 0.0 116.052 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -50.68 119.7 5.53 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 125.239 3.959 . . . . 0.0 116.648 -168.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.7 p -77.39 -39.53 46.91 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.626 1.57 . . . . 0.0 114.631 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.76 102.31 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 125.045 1.338 . . . . 0.0 114.393 -161.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.4 m -85.46 -177.92 6.57 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.18 146.2 55.27 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.73 1.612 . . . . 0.0 113.622 177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.4 p -77.43 73.58 4.0 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.025 -1.047 . . . . 0.0 111.832 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.02 -50.71 0.04 OUTLIER Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.956 1.741 . . . . 0.0 110.764 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.2 p -74.08 177.44 5.71 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.564 1.146 . . . . 0.0 113.482 161.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.8 m -148.25 143.31 26.89 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.821 -1.174 . . . . 0.0 113.975 165.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.3 t -64.76 86.42 0.05 Allowed 'General case' 0 CA--C 1.558 1.278 0 O-C-N 120.414 -1.429 . . . . 0.0 111.954 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.12 161.15 11.45 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 -160.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -102.09 134.54 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 O-C-N 120.629 -1.295 . . . . 0.0 111.253 164.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -152.68 -53.43 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.241 1.017 . . . . 0.0 111.866 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -158.04 164.09 22.46 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 124.772 1.229 . . . . 0.0 111.091 165.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -41.63 -42.3 5.99 Favored 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 123.808 3.006 . . . . 0.0 115.818 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.11 -4.67 18.21 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -143.65 118.1 9.7 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.751 1.621 . . . . 0.0 113.645 -170.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 t -135.48 95.59 3.29 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.38 -0.825 . . . . 0.0 110.996 153.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -109.8 150.12 28.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.893 1.277 . . . . 0.0 113.148 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.2 m -79.08 89.56 4.81 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.617 1.167 . . . . 0.0 113.064 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.258 1.513 0 CA-C-O 117.736 -1.126 . . . . 0.0 109.98 163.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -69.57 136.25 51.06 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.938 1.695 . . . . 0.0 111.492 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -75.83 158.38 32.22 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -49.92 132.65 22.76 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.145 1.378 . . . . 0.0 111.619 167.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 64.5 42.44 5.01 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.03 129.15 6.43 Favored Glycine 0 CA--C 1.544 1.881 0 C-N-CA 125.844 1.688 . . . . 0.0 112.872 168.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -66.72 72.73 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.219 1.51 . . . . 0.0 114.589 -175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.7 t -31.31 -54.77 0.24 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 128.127 2.571 . . . . 0.0 116.012 171.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.74 45.69 0.5 Allowed Glycine 0 CA--C 1.539 1.566 0 N-CA-C 118.095 1.998 . . . . 0.0 118.095 -168.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.22 65.52 1.27 Allowed Glycine 0 CA--C 1.546 1.981 0 O-C-N 121.159 -1.2 . . . . 0.0 113.723 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 72.2 mt -44.1 114.27 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 CA-C-N 118.984 1.392 . . . . 0.0 113.892 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.1 -54.62 0.78 Allowed Glycine 0 CA--C 1.537 1.425 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -154.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.82 160.72 4.34 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 122.071 0.939 . . . . 0.0 111.757 139.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 85.0 p -148.54 149.37 31.48 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.15 1.78 . . . . 0.0 111.138 163.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 17' ' ' THR . . . 163.07 -166.95 37.21 Favored Glycine 0 CA--C 1.546 2.007 0 O-C-N 120.96 -1.087 . . . . 0.0 114.949 -175.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.73 80.97 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 123.894 3.062 . . . . 0.0 113.027 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 15' ' ' GLY . 25.7 p -70.73 33.0 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 118.151 2.648 . . . . 0.0 118.151 -166.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 t -137.93 96.28 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 O-C-N 120.132 -1.605 . . . . 0.0 113.317 -171.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.3 m -57.47 156.87 7.41 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.19 167.12 0.13 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.997 0.919 . . . . 0.0 112.71 153.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.8 t -82.75 -178.02 6.94 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.47 -66.07 1.02 Allowed Glycine 0 CA--C 1.539 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 111.898 -165.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.42 161.25 30.0 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.352 1.461 . . . . 0.0 114.069 170.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.7 p -128.94 151.12 50.02 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 130.936 3.694 . . . . 0.0 111.839 -168.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.6 t -74.42 74.94 1.91 Allowed 'General case' 0 CA--C 1.559 1.29 0 O-C-N 120.238 -1.538 . . . . 0.0 111.571 174.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -63.71 165.15 8.72 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 -167.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 p -137.13 105.83 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.274 0 C-N-CA 125.534 1.533 . . . . 0.0 114.558 -177.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.0 mt -89.86 -50.33 6.1 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 125.451 1.5 . . . . 0.0 111.899 167.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.76 157.17 36.11 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 128.013 2.525 . . . . 0.0 108.85 171.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -50.07 -39.62 50.78 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 122.844 2.363 . . . . 0.0 115.107 -178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -50.96 -25.4 4.62 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 170.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -122.56 135.6 54.67 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 127.08 2.152 . . . . 0.0 113.342 -176.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.74 111.18 1.15 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.229 -0.919 . . . . 0.0 113.427 165.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -122.71 151.75 41.25 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.47 1.908 . . . . 0.0 112.75 -169.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 62.5 m -61.79 88.88 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.9 0.48 . . . . 0.0 111.378 168.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.256 1.432 0 C-N-CA 128.456 2.702 . . . . 0.0 112.638 174.953 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -90.36 133.29 35.08 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 127.303 2.241 . . . . 0.0 111.276 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 55.1 p -75.81 166.67 23.18 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.938 1.695 . . . . 0.0 113.784 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -58.83 147.27 34.26 Favored 'General case' 0 CA--C 1.558 1.256 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 58.39 -11.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -161.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -54.06 122.67 24.32 Favored Glycine 0 CA--C 1.542 1.747 0 O-C-N 119.687 -1.883 . . . . 0.0 113.65 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -68.42 76.51 0.26 Allowed 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 118.946 1.373 . . . . 0.0 112.632 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 35' ' ' CYS . 52.5 t -51.19 -31.2 19.36 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.037 1.735 . . . . 0.0 115.373 176.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.75 106.86 0.29 Allowed Glycine 0 CA--C 1.54 1.652 0 N-CA-C 117.498 1.759 . . . . 0.0 117.498 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.45 85.43 0.34 Allowed Glycine 0 CA--C 1.534 1.237 0 O-C-N 120.895 -1.356 . . . . 0.0 109.961 154.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 43.3 mt -49.84 113.26 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 118.903 1.351 . . . . 0.0 113.052 -161.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.64 -45.94 1.1 Allowed Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.339 1.447 . . . . 0.0 110.6 -151.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -55.69 171.5 0.21 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 125.273 1.429 . . . . 0.0 112.714 153.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.8 p -153.63 174.47 14.44 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.693 1.197 . . . . 0.0 111.505 160.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 -175.29 19.55 Favored Glycine 0 CA--C 1.546 2.031 0 C-N-CA 124.233 0.92 . . . . 0.0 114.353 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.03 100.26 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.322 0 C-N-CA 124.626 3.551 . . . . 0.0 116.804 -168.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.9 m -83.55 22.78 1.02 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 127.964 2.506 . . . . 0.0 114.2 -175.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.5 t -149.09 114.27 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 120.171 -1.581 . . . . 0.0 111.924 -173.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.0 m -70.14 167.13 18.45 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.93 140.29 38.09 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.662 1.585 . . . . 0.0 113.81 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 t -49.94 111.93 0.59 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.359 1.064 . . . . 0.0 113.55 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.94 -47.26 1.0 Allowed Glycine 0 CA--C 1.543 1.838 0 C-N-CA 125.34 1.448 . . . . 0.0 112.921 -164.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.63 149.61 40.41 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 127.294 2.237 . . . . 0.0 113.055 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.4 m -121.05 142.01 50.22 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.295 1.438 . . . . 0.0 112.749 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 t -57.52 88.85 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 126.31 1.844 . . . . 0.0 111.463 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -10.35 51.35 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -149.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.308 9.3 p 34.53 52.93 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 127.883 2.473 . . . . 0.0 116.663 -178.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.0 -45.07 78.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.543 1.537 . . . . 0.0 112.413 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -152.28 169.77 9.03 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 125.49 1.516 . . . . 0.0 110.976 164.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -48.55 -33.11 22.77 Favored 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.257 2.638 . . . . 0.0 116.802 178.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.42 -10.76 48.13 Favored 'General case' 0 CA--C 1.558 1.271 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -137.68 101.5 4.49 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.456 1.502 . . . . 0.0 113.723 177.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 t -122.47 91.96 3.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.874 2.469 . . . . 0.0 110.505 158.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -92.65 152.4 19.57 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 120.503 -1.373 . . . . 0.0 112.588 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 76.1 m -78.21 78.13 4.69 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.697 -1.252 . . . . 0.0 110.989 162.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 117.188 -1.387 . . . . 0.0 112.485 161.671 . . . . . . . . 0 0 . 1 stop_ save_